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Kurzzusammenfassung 
Im Hinblick auf die Entwicklung biomimetischer Tyrosinasemodelle wurde im Rahmen dieser 
Arbeit HC(3-tBuPz)2(1-MeIm) als Bis(pyrazolyl)methan-Ligand zweiter Generation entwickelt, 
der in der Lage ist, den Cu2O2-Peroxo-Komplex (µ-η
2:η2)-[Cu2O2{HC(3-tBuPz)2 
(1-MeIm)}2][SbF6]2 zu stabilisieren. Er konnte sowohl UV/Vis- und 
röntgenabsorptionsspektroskopisch als auch massenspektrometrisch nachgewiesen werden. 
Hierbei wurde eine Blau-Verschiebung der für Komplexe dieser Art bekannten Charge-
Transfer-Banden beobachtet. Dieser Effekt wurde mit dichtefunktionaltheoretischen 
Methoden untersucht und zeigte eine starke Donorfähigkeit der Imidazolyl-Einheit des 
Liganden als Ursache. Es wurde festgestellt, dass der Komplex [Cu2O2{HC(3-tBuPz)2(1-
MeIm)}2][SbF6]2 außerdem eine effiziente Oxidations- und Oxygenierungsfähigkeit aufweist. 
In Analogie zur Tyrosinase konnte die selektive Übertragung eines Sauerstoffatoms auf 
verschiedene Substrate nach dem auch bei der Tyrosinase vorherrschenden "inner-sphere" 
Sauerstoffatomtransfermechanismus bewiesen werden. Neben dem neu entwickelten 
Liganden HC(3-tBuPz)2(1-MeIm) wurde der bekannte Ligand HC(3-tBuPz)2(Qu) auf sein 
Sauerstoffaktivierungspotential sowie seine Sauerstoffübertragungsfähigkeit getestet. 
Hierbei konnte eine sich langsamer bildende, aber ebenfalls zur Sauerstoffaktivierung und 
dem -transfer befähigte, Cu2O2-Peroxo Spezies charakterisiert werden. Aufbauend auf einer 
bereits existierenden Ligandenbibliothek wurde der iso-Propyl Substituent an den Pyrazolyl-
Einheiten eingeführt und so die Liganden HC(3-iPrPz)2(Py) und eine Mischung aus HC(3-
iPrPz)2(Qu) und HC(3-iPrPz)(5-iPrPz)(Qu) erhalten. Während der Synthese wurde der Effekt 
der Isomerisierung von Alkylgruppen an diesen Systemen von der 3- in die 5-Position 
beobachtet und ein Protokoll zur Rückisomerisierung eingeführt. Des Weiteren wurden acht 
monofaciale Bis(pyrazolyl)methan-Komplexe mit den Übergangsmetallen Kupfer, Cobalt und 
Zink, sowie drei bisfaciale Cobalt-Bis(pyrazolyl)methan-Komplexe synthetisiert und 
charakterisiert. Die monofacialen Komplexe wurden eingehend dichtefunktionaltheoretisch 
untersucht und dabei eine Donorkonkurrenz zwischen Pyrazolyl- und Pyridinyl- bzw. 
Quinolinyl- oder Imidazolyl-Einheiten festgestellt. Drei monofaciale Nitratkomplexe wiesen 
außerdem eine seltene Mischung aus mono- und bidentat gebundenen Nitratgruppen in 
einem Komplex auf. Im Hinblick auf die Aktivierung von anderen kleinen Molekülen wie 
Stickstoffmonoxid bestätigten erste Versuche mit dem NO-Donorreagenz Diazald®, dessen 
NO-Übertragungsfähigkeit auf einen Bis(pyrazolyl)methan-Kupferkomplex.  
 
 
  
Abstract 
With regard to the development of a biomimetic tyrosinase model, HC(3-tBuPz)2(1-MeIm) 
was developed in this thesis as an example for a second generation bis(pyrazolyl)methane 
ligand that is capable of stabilising the Cu2O2-peroxo complex (µ-η
2:η2)-[Cu2O2{HC(3-
tBuPz)2(1-MeIm)}2][SbF6]2. This compound could be verified UV/Vis and X-Ray absorption 
spectroscopically as well as mass spectrometrically, showing a blue-shift in the UV/Vis bands 
compared to other known complexes of this kind. This effect was investigated by means of 
density functional theory calculations and attributed to the strong donor ability of the 
imidazolyl moiety at the ligand. Furthermore the [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 
complex exhibits an efficient oxidation- as well as oxygenation ability. In analogy to 
tyrosinase, the selective oxygen atom transfer (OAT) onto different substrates according to 
the inner-sphere OAT mechanism was shown. 
In addition to the newly designed HC(3-tBuPz)2(1-MeIm) ligand, the already established 
HC(3-tBuPz)2(Qu) ligand was tested for its oxygen activation and -transfer potential. Hereby 
a slowly forming Cu2O2-peroxo species, which is also able to activate and transfer oxygen, 
was characterised. 
Based on the already existing ligand library, the isopropyl substituent was introduced to the 
pyrazolyl moieties leading to the ligands HC(3-iPrPz)2(Py) and a mixture of HC(3-iPrPz)2(Qu) 
and HC(3-iPrPz)(5-iPrPz)(Qu). During the synthesis of these ligands the isomerisation effect 
of the alkyl groups from 3- to 5-position of the pyrazolyl unit was observed and a protocol 
for their reisomerisation was established. 
Moreover eight monofacial bis(pyrazolyl)methane complexes with the transition metals 
copper, cobalt and zinc as well as three bisfacial cobalt-bis(pyrazolyl)methane complexes 
were synthesised and characterised. The monofacial complexes were investigated by means 
of density functional theory (DFT), including structural optimisation and NBO calculations. 
Here a donor competition between pyrazolyl and pyridinyl, quinolinyl or imidazolyl 
substituents, respectively, was observed. Three monofacial nitrate complexes exhibit a rare 
mixture of monofacially and bisfacially bound nitrate groups in one complex. 
Concerning the activation of another small molecule, first experiments with the NO donor 
reagent diazald® confirmed its ability to transfer NO onto a bis(pyrazolyl)methane copper 
complex.  
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XANES  X-ray absorption near edge structure 
XAS  X-ray absorption spectroscopy 
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ρ  structural parameter 
ῦ  wave number (IR) 
  
List of contents 
With * marked compounds are already known and have been resynthesised. 
 
Ligands 
 
L1 HC(3-tBuPz)2(1-MeIm) L4' HC(3-iPrPz)(5-iPrPz)(Qu) 
L2* HC(3-tBuPz)2(Qu) L5* HC(3-tBuPz)2(Py) 
L3 HC(3-iPrPz)2(Py) L6* HC(Pz)2(Py) 
L3’ HC(3-iPrPz)(5-iPrPz)(Py) L7* HC(Pz)2(Qu) 
L4 HC(3-iPrPz)2(Qu)   
 
Complexes 
 
C1 [CuCl2{HC(3-tBuPz)2(1-MeIm)}] C7 [Zn(NO3)2{HC(3-iPrPz)2(Py)}] 
C2 [CuCl{HC(3-tBuPz)2(Qu)}] C8 [Co{HC(Pz)2(Py)}2][Co(NO3)4] 
C3 [CuCl{HC(3-tBuPz)2(Py)}] CC8
2+ [Co{HC(Pz)2(Py)}2]
2+ 
C4 [CuBr2{HC(3-tBuPz)2(Py)}] C9 [Co{HC(Pz)2(Qu)}2][(OTf)2] 
CC4* [CuCl2{HC(3-tBuPz)2(Py)}] C10 [Co{HC(3-iPrPz)2(Qu)}2][(NO3)2] 
C5 [Co(NO3)2{HC(3-tBuPz)2(Py)}] C11* [CoCl2{HC(3-tBuPz)2(Py)}] 
C6 [Co(NO3)2{HC(3-iPrPz)2(Py)}]   
 
 
  
 
 
 
 
Table of Figures 
Figure 1. Structures of type I, II and III copper enzymes. ........................................................................ 4 
Figure 2. A, active centre of the met-form of tyrosinase complexated with ORF 378. B, active centre 
of the inhibitor-bound potato catechol oxidase. C, active centre of the oxy-form of octopus 
hemocyanin.[34] ........................................................................................................................................ 5 
Figure 3. O2-derived metalloenzyme intermediates, structurally characterised by X-ray 
crystallography. ..................................................................................................................................... 11 
Figure 4. Left side: Structure of β-ketiminate ligands as used by Tolman.[65]; right side: Structure of 
bidentate (1) and tridentate (2) 2-(2-pyridyl)ethylamin ligands as used by Itoh.[64] ............................ 13 
Figure 5. Structure of peralkylated diamine ligands (LPDA) as used by Stack.[63].................................... 14 
Figure 6. Top: Structure of bis-µ-oxo copper(III)-species with ligands TMPD, DMPD and PD.; bottom: 
active centre of particulate methane monooxgenase (pMMO).[70] ...................................................... 14 
Figure 7. Structure of N,N,N’,N’,N’’-pentakis[(1-methyl-2-benzimidazolyl)methyl] dipropylene-
triamine (8) and N,N-bis(2-N-methylbenzimidazol-2-yl)ethyl)benzylamine (9) as used by Casella.[71][72]
 ............................................................................................................................................................... 15 
Figure 8. Structures of an imine/pyridine (10), a bis(imine) (11), a bis(pyridine) (12), a 
benzimidazole/imine (13), an imine/pyridine containing ligand with biphenyl spacer (14) and a 
bis(pyrazolyl)(pyridinyl)methane ligand (15,L5).[18,77–79] ....................................................................... 16 
Figure 9. Coordination motives of the reaction of Co(II) species with oxygen.[83] ................................ 20 
Figure 10. Structure of the corrin ring. .................................................................................................. 20 
Figure 11. Structure of Co(tpy)2 and [CoCl4]
2−.[83] .................................................................................. 21 
Figure 12. Structure of tris(pyrazolyl)borate and tris(pyrazolyl)methane. ........................................... 23 
Figure 13. Boat conformation of a bis(pyrazolyl)methane complex. .................................................... 25 
Figure 14. Structure of bis(pyrazolyl)methane ligands with N,S-, N,N‘- and N,O-donors. .................... 26 
Figure 15. Structure of “third generation“ scorpionate ligands.[123] ..................................................... 27 
Figure 16. Possible coordination modes of Cu(I) and Cu(II) bis(pyrazolyl)methane complexes. .......... 27 
Figure 17. Imidazolyl containing ligands applied in the activation of oxygen.[128–130] ........................... 32 
Figure 18. Molecular structure of L1. .................................................................................................... 34 
Figure 19. Molecular structure of [CuCl2{HC(3-tBuPz)2(1-MeIm)}] (C1). ............................................... 35 
Figure 20. Electronic structure of the peroxide-Cu(II) bond in (μ-η2:η2) bridged species.adapted from[31].. 38 
Figure 21. UV/Vis spectrum of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2). ............................ 40 
Figure 22. Theoretical model of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2]
2+ (P1). (Gaussian09, TPSSh/6-31G(d). 
Hydrogen atoms are omitted for clarity).[135,137,141] ............................................................................... 42 
Figure 23. Calculated UV/Vis spectrum of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2) (TD-DFT, 
Gaussian09, TPSSh, 6-31G(d)).[135,137,141] ................................................................................................ 42 
Figure 24. NTO-analysis of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2]
2+ (P1).[141] ................................................ 44 
Figure 25. Cryo UHR-ESI mass spectrum of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]
+.[145] ..................... 46 
Figure 26. Cu K-edge XANES spectrum of P1[SbF6]2.
[148] ....................................................................... 47 
Figure 27. Filtered Fourier backtransformed Cu K-edge EXAFS spectrum (black solid line: experiment, 
grey dashed line: fitted function) of P1[SbF6]2.
[148] ............................................................................... 48 
Figure 28. Structure of the active site of tyrosinase. Green: Carbon, blue: Nitrogen, orange: Copper, 
red: Oxygen.[34] ...................................................................................................................................... 49 
Figure 29. Reaction of para-substituted phenols with oxygen under Cu-catalysis.[80].......................... 50 
Figure 30. UV/Vis spectrum of the formation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (orange) and 
the formation of the quinone (blue). Between 260 and 310 nm the spectrum does not follow Lambert 
Beer’s law due to high concentration. .................................................................................................. 51 
Figure 31. UV/Vis spectrum of the formation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (black) and 
the formation of the quinone (all colours). ........................................................................................... 52 
Figure 32. Molecular structure of [CuCl{HC(3-tBuPz)2(Qu)}] (C2). ........................................................ 55 
Figure 33. Molecular structures of [CuCl{HC(3-tBuPz)2(Py)}] (C3a, b). ................................................. 56 
Figure 34. Molecular structure of [CuBr2{HC(3-tBuPz)2(Py)}] (C4). ....................................................... 57 
Figure 35. Molecular structure of CC4.[125] ............................................................................................ 57 
Figure 36. UV/Vis spectrum of [Cu2O2{HC(3-tBupz)2(Qu)}2][SbF6]2 (P2[SbF6]2) (red: experimental,  
black: theoretical[141]) and the final UV/Vis spectrum of the formation of the quinone in the self-
assembly mode (green)[168].................................................................................................................... 64 
Figure 37. Pseudo-first order plot for the determination of the rate constant of the formation of P1. 
Red: linear fit (R = 0.997) ....................................................................................................................... 65 
Figure 38. NTO-analysis of [Cu2O2{HC(3-tBuPz)2(Qu)}2]
2+ (P2).[141] ........................................................ 66 
Figure 39. Molecular structures of [Co(NO3-κO)(NO3-κ
2OO’){HC(3-tBuPz)2(Py)}] (C5) and [Co(NO3-
κO)(NO3-κ
2OO’){HC(3-iPrPz)2(Py)}] (C6). ................................................................................................ 70 
Figure 40. Molecular structure of [Co(NO3-κO)(NO3-κ
2OO’){HC(3-iPrPz)2(Py)}] (C6). ........................... 71 
Figure 41. Quantification of the binding mode for the nitrate groups.[175] ........................................... 74 
Figure 42. Structure of NO transferring reagents diazald® and tritylthionitrite (TTN). ........................ 79 
Figure 43. Experimental UV/Vis spectra of the reaction of [Cu{HC(3-tBuPz)2(Py)}]
+ with 
nitrosobenzene. ..................................................................................................................................... 80 
Figure 44. Structural optimisation of singlet [Cu{HC(3-tBuPz)2(Py)}(PhNO-κO)]
+ and [Cu{HC(3-
tBuPz)2(Py)}(PhNO-κN)]
+ (B3LYP, 6-31G(d), Gaussian09).[186] ............................................................... 81 
Figure 45. UV/Vis spectra of the reaction of [Cu{HC(3-tBuPz)2(Py)}]
+ with diazald® (black) and NO gas 
(blue). .................................................................................................................................................... 83 
Figure 46. Expected reaction product of the reaction of [Cu{HC(3-tBuPz)2(Py)}]
+ with NO donor 
agents. ................................................................................................................................................... 83 
Figure 47. Structures of ligands L1–L7 as well as L3' and L4'. With * marked ligands were 
resynthesised according to [117]. ......................................................................................................... 85 
Figure 48. Molecular structures of HC(3-tBuPz)2(Qu) (L2) and HC(3-iPrPz)(5-iPrPz)(Py) (L3'). ............. 87 
Figure 49. Molecular structure of [Co{HC(Pz)2(Py)}2]
2+[194] (C82+) in crystals of [Co{HC(Pz)2(Py)}2] 
[Co(NO3)4] (C8) and of [Co{HC(Pz)2(Qu)}2]
2+ (C92+) in crystals of [Co{HC(Pz)2(Qu)}2][(OTf)2] (C9). In C8 
pyrazolyl and pyridinyl moieties are disordered. Here only one isomer is shown for clarity. .............. 89 
Figure 50. Molecular structure of [{HC(3-iPrPz)(5-iPrPz)(Qu)}2Co]
2+ (C102+) in crystals of [Co{HC(3-
iPrPz)(5-iPrPz)(Qu)}2][(NO3)2] (C10). ...................................................................................................... 91 
Figure 51. Molecular structure of [CoCl2{HC(3-tBuPz)2(Py)}] (C11). ...................................................... 92 
Figure 52. Structures of newly synthesised bis(pyrazolyl)methane ligands L1, L3 and L4/L4’. ............ 95 
Figure 53. Structures of newly synthesised transition metal bis(pyrazolyl)methane complexes ......... 97 
Figure 54. Molecular structure of HC(3-tBuPz)2(1-MeIm) (L1, top) and [CuCl2{HC(3-tBuPz)2 (1-MeIm)] 
(C1, bottom). Thermal ellipsoids represent 50% particular probability. ............................................ 133 
Figure 55. Molecular structure of [CuCl{HC(3-tBuPz)2(Qu)}] (C2, top) and [CuCl{HC(3-tBuPz)2(Py)}] (C3, 
bottom). Thermal ellipsoids represent 50% particular probability. .................................................... 135 
Figure 56. Molecular structure of [CuBr2{HC(3-tBuPz)2(Py)}] (C4, top) and [Co(NO3-κO)(NO3-
κ2OO’){HC(3-tBuPz)2(Py)}]∙CH2Cl2(C5, bottom). In C5 it was not possible to model the disordered 
 
 
 
 
solvent molecules of CH2Cl2 in an adequate manner, so the data set was treated with the SQUEEZE 
facility of PLATON.[216,217] Thermal ellipsoids represent 50% particular probability. .......................... 137 
Figure 57. Molecular structure of [Co(NO3-κO)(NO3-κ
2OO’){HC(3-iPrPz)2(Py)}] (C6, top) and [Zn(NO3-
κO)(NO3-κ
2OO’){HC(3-iPrPz)2(Py)}] (C7, bottom). Thermal ellipsoids represent 50% particular 
probability. .......................................................................................................................................... 139 
Figure 58. Molecular structure of HC(3-tBuPz)2(Qu) (L2, top) and of HC(3-iPrPz)(5-iPrPz)(Qu) (L3’, 
bottom). In L2 three molecules are present, two of which have one threefold disordered tBu-group 
each. Refinement of those was not possible due to the minor quality of the data set. Thermal 
ellipsoids represent 50% particular probability. ................................................................................. 141 
Figure 59. Molecular structure of [Co{HC(Pz)2(Py)}2][Co(NO3)4]∙C3H6O (C8, top) and of 
[Co{HC(Pz)2(Qu)}2][(OTf)2] (C9, bottom). In C8 it was not possible to model the disordered solvent 
molecules of acetone in an adequate manner, the data set was treated with the SQUEEZE facility of 
PLATON.[216,217] Thermal ellipsoids represent 50% particular probability. .......................................... 143 
Figure 60. Molecular structure of [Co{HC(iPrPz)2(Qu)}2][(NO3)2]∙2MeOH (C10, top) and of 
[CoCl2{HC(Pz)2(Py)}]∙THF (C11, bottom). Thermal ellipsoids represent 50% particular probability.... 145 
Figure 61. Overview of all newly synthesised bis(pyrazolyl)methane ligands and transition metal 
bis(pyrazolyl)methane complexes. ...................................................................................................... 145 
 
Table of Schemes 
Scheme 1. Monophenolase and diphenolase reaction, catalysed by tyrosinase.adapted from [46] ................ 6 
Scheme 2. Reaction of tyrosinase to dopaquinone, catalysed by tyrosinase.[49] .................................... 7 
Scheme 3. Catalytic cycle of tyrosinase.[50,51] .......................................................................................... 8 
Scheme 4. Left side: reaction of [Cu(HB(3,5-iPr2Pz)3)] with oxygen; right side: reaction of [Cu(TMPA)] 
with oxygen.[61,68] ................................................................................................................................... 12 
Scheme 5. Reaction of [Cu(I)(R-PYAN)] with oxygen.[57] ....................................................................... 18 
Scheme 6. Reaction mechanism of NO-synthases.[88] ........................................................................... 21 
Scheme 7. Reactions of the microbial denitrification. .......................................................................... 22 
Scheme 8. Reaction scheme of the synthesis of substituted tris(pyrazolyl)methanes.[111] .................. 25 
Scheme 9. Reaction from pyrazole to bis(pyrazolyl)methane by using triphosgene and 2-
hydroxybenzaldehyde.[116] ..................................................................................................................... 25 
Scheme 10. Reaction mechanism of the Co-catalysed Peterson-like rearrangement. ......................... 26 
Scheme 11. Different routes for the synthesis of 1-methyl-2-imidazolecarboxaldehyde. ................... 33 
Scheme 12. Applied route for the synthesis of 1-methyl-2-imidazolecarboxaldehyde. ....................... 33 
Scheme 13. Synthesis of [HC(3-tBuPz)2(1-MeIm)] (L1). ........................................................................ 34 
Scheme 14. Synthesis of [CuCl2{HC(3-tBuPz)2(1-MeIm)}] (C1). ............................................................. 35 
Scheme 15. Synthesis of the precursor complex [Cu{HC(3-tBuPz)2(1-MeIm)}][SbF6]. .......................... 39 
Scheme 16. Formation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2). .................................... 39 
Scheme 17. Proposed reaction pathway for model complexes of tyrosinase. adapted from [46] ................. 49 
Scheme 18. Competitive pathways in catalytic aerobic oxidations of phenols.adapted from [156] ............... 50 
Scheme 19. Synthesis of [CuCl{HC(3-tBuPz)2(Qu)}] (C2). ...................................................................... 55 
Scheme 20. Synthesis of [CuCl{HC(3-tBuPz)2(Py)}] (C3a, b). ................................................................. 56 
Scheme 21. Synthesis of [CuBr2{HC(3-tBuPz)2(Py)}] (C4). ..................................................................... 56 
Scheme 22. Oxygenation of Cu(I)-tris(1,2-dimethyl-1H-imidazole) in 2-MeTHF.[144] ............................ 62 
Scheme 23. Synthesis of [Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2 (P2[SbF6]2). ............................................. 63 
Scheme 24. Synthesis of [Co(NO3-κO)(NO3-κ
2OO’){HC(3-tBuPz)2(Py)}] (C5), [Co(NO3-κO)(NO3-
κ2OO’){HC(3-iPrPz)2(Py)}] (C6) and ........................................................................................................ 70 
Scheme 25. Structure of tris(3,5-dimethyl(pyrazolyl))methylamine (21) and synthesis of 
[Ni(21)(O2NO)][NO3] (22) and [Cd(21)(O2NO)(ONO2)].
adapted from [174,175] ................................................. 73 
Scheme 26. Synthesis of [Me6trenCu(PhNO-κO)]
+ adapted from [184]. .......................................................... 79 
Scheme 27. Synthesis of HC(3-iPrPz)2(Py) (L3) and a mixture of HC(3-iPrPz)2Qu) (L4) and HC(3-
iPrPz)(5-iPrPz)(Qu) (L4'). ........................................................................................................................ 86 
Scheme 28. Synthesis of [Co{HC(Pz)2(Py)}2][Co(NO3)4] (C8) and [Co{HC(Pz)2(Qu)}2][(OTf)2] (C9). ........ 88 
Scheme 29. Synthesis of [Co{HC(3-iPrPz)(5-iPrPz)(Qu)}2][(NO3)2] (C10). .............................................. 90 
Scheme 30. Synthesis of of [CoCl2{HC(3-tBuPz)2(Py)}] (C11).
[125] .......................................................... 92 
 
Tables 
Table 1. Structural features of Cu2O2 and CuO2 species.
[55] .................................................................... 9 
Table 2. Spectroscopic features of (μ-η2:η2)- and bis(μ-oxo)-complexes.[47,55] ..................................... 10 
Table 3. Overview of built species concerning the reaction of [Cu(I)(R-PYAN)] with oxygen. Reactions 
were performed at −78°C. Content in brackets symbolises minor product.[57] .................................... 19 
Table 4. Selected bond lengths and angles of L1. ................................................................................. 35 
Table 5. Selected bond lengths and angles for C1. ............................................................................... 36 
Table 6. Charge-transfer energies for C1 and P1. (Gaussian09, TPSSh/6-31G(d) and  NBO 
6.0).[135,137,142] ......................................................................................................................................... 41 
Table 7. Calculated atom distances in P1 (Gaussian09, TPSSh, 6-31G(d)).[135,137,141] ............................. 43 
Table 8. Most important isotopes of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]
+. .................................... 45 
Table 9. Structural parameters obtained by fitting the experimental EXAFS functions with theoretical 
models.[148] ............................................................................................................................................. 48 
Table 10. Catalytic efficiency of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 with phenolic substrates. .... 52 
Table 11. Yield of catechol after treatment of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 with 
stoichiometric amounts of para-substituted phenol. ........................................................................... 53 
Table 12. Selected bond lengths [Å] of C2–C4 and CC4. ....................................................................... 58 
Table 13. Selected bond angles [°] of C2–C4 and CC4 and according τ-values. .................................... 59 
Table 14. Calculated key bond lengths [Å] of C2–C4 and CC4 (Gaussian09, TPSSh/6-31G(d)).[135,137] .. 60 
Table 15. Calculated key bond angles [°] of C2–C4 and CC4 (Gaussian09, TPSSh/6-31G(d)).[135,137] ..... 61 
Table 16. Charge-transfer energies [kcal mol−1] for C2–C4, as well as CC4 and P2 (Gaussian09, 
TPSSh/6-31G(d) and NBO 6.0).[135,137,142] ............................................................................................... 61 
Table 17. Selected bond lengths for C5, C6 and C7. .............................................................................. 71 
Table 18. Selected bond angles for C5, C6 and C7. ............................................................................... 72 
Table 19. Selected octahedron angles of C5–C7. .................................................................................. 72 
Table 20. Binding modes for nitrate groups of C5, C6 and C7. ............................................................. 75 
Table 21. Charge-transfer energies [kcal mol−1] for C5–C7 (Gaussian09, BP86/6-31G(d) and 
NBO 6.0).[135,142,162] ................................................................................................................................. 76 
Table 22. NBO charge distribution in C5, C6 and C7 (Gaussian09, BP86/6-31G(d) and 
NBO 6.0).[135,142,162] ................................................................................................................................. 76 
Table 23. Overview of extinction coefficients of the reaction of [Cu{HC(3-tBuPz)2(Py}]
+ with 
nitrosobenzene at λ = 454 and λ = 558 nm. .......................................................................................... 80 
 
 
 
 
Table 24. TD-DFT calculated UV/Vis absorption maxima for singlet [Cu{HC(3-tBuPz)2(Py)}(PhNO-κO)]
+ 
and [Cu{HC(3-tBuPz)2(Py)}(PhNO-κN)]
+ (B3LYP, 6-31G(d), Gaussian09) in comparison to experimental 
values.[186] .............................................................................................................................................. 82 
Table 25. Key bond lengths [Å] and angles [°] in L2 and L3’. ................................................................. 87 
Table 26. Key bond lengths [Å] and angles [°] in C82+, CC82+ and C92+. ................................................. 89 
Table 27. Key bond lengths [Å] and angles [°] in C102+. ........................................................................ 91 
Table 28. Key bond lengths [Å] and angles [°] in C11 and CC11[125] and τ5-values of both. .................. 93 
Table 29. Crystallographic data collection and refinement information for L1 and C1. ..................... 132 
Table 30. Crystallographic data collection and refinement information for C2 and C3. .................... 134 
Table 31. Crystallographic data collection and refinement information for C4 and C5. .................... 136 
Table 32. Crystallographic data collection and refinement information for C6 and C7. .................... 138 
Table 33. Crystallographic data collection and refinement information for L2 and L3’. .................... 140 
Table 34. Crystallographic data collection and refinement information for C8 and C9. .................... 142 
Table 35. Crystallographic data collection and refinement information for C10 and C11. ................ 144 
 
 
  
Table of Contents 
1 Introduction ..................................................................................................................................... 1 
1.1 Catalysis in Bioinorganic Chemistry ......................................................................................... 1 
1.2 Enzyme modelling ................................................................................................................... 2 
1.3 Metallooxygenases and Metallooxidases ............................................................................... 3 
1.4 Copper enzymes[31] .................................................................................................................. 4 
1.5 Tyrosinase, catechol oxidase and hemocyanin ....................................................................... 5 
1.6 Reaction mechanism of tyrosinase ......................................................................................... 6 
1.7 Oxygen activation .................................................................................................................... 9 
1.8 State of research in oxygen activation .................................................................................. 11 
1.9 (µ-η2:η2)-peroxo dicopper(II) vs. bis(μ-oxo) dicopper(III) ...................................................... 18 
1.10 Cobalt complex chemistry[83] ................................................................................................. 19 
1.11 NO in Bioinorganic Chemistry ............................................................................................... 21 
1.12 Microbial denitrification ........................................................................................................ 22 
1.13 Poly(pyrazolyl)methanes ....................................................................................................... 23 
2 Objectives & Contents ................................................................................................................... 28 
2.1 Objectives .............................................................................................................................. 28 
2.2 Contents ................................................................................................................................ 29 
3 Results & Discussion ...................................................................................................................... 31 
3.1 Synthesis of a new bis(pyrazolyl)methane ligand and its copper(II) complex ...................... 31 
3.1.1 Optimisation of reaction conditions for the synthesis of  1-methyl-2-
imidazolecarboxaldehyde.............................................................................................................. 32 
3.1.2 Structural characterisation of HC(3-tBuPz)2(1-MeIm) and [CuCl2{HC(3-tBuPz)2 
(1-MeIm)}] ..................................................................................................................................... 34 
3.1.3 Definition of the τ-parameter........................................................................................ 37 
3.2 Efficient biomimetic hydroxylation catalysis with a bis(pyrazolyl)imidazolylmethanecopper-
peroxide complex .............................................................................................................................. 38 
3.2.1 General Introduction ..................................................................................................... 38 
3.2.2 Characterisation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 ......................................... 39 
3.2.3 Catalytic studies on P1[SbF6]2 ........................................................................................ 49 
3.2.4 Summary ........................................................................................................................ 54 
3.3 Biomimetic hydroxylation catalysis through self-assembly of a 
bis(pyrazolyl)methanecopper-peroxo complex[160] ........................................................................... 55 
3.3.1 Structural characterisation of bis(pyrazolyl)methanecopper complexes ..................... 55 
3.3.2 Biomimetic hydroxylation catalysis through self-assembly of  [Cu2O2{HC(3-
tBuPz)2(Qu)}2][SbF6]2 ..................................................................................................................... 62 
 
 
 
 
3.3.3 Theoretical investigations ............................................................................................. 66 
3.3.4 Summary ........................................................................................................................ 67 
3.4 Analysis and Characterisation of bis(pyrazolyl)methane nitrate complexes ........................ 69 
3.4.1 Introduction ................................................................................................................... 69 
3.4.2 Structural characterisation of bis(pyrazolyl)methane nitrate complexes ..................... 69 
3.4.3 Calculation of the binding mode ................................................................................... 73 
3.4.4 Evaluation of NBO calculations ..................................................................................... 75 
3.4.5 Summary ........................................................................................................................ 77 
3.5 Investigations towards a copper(II)-superoxide mimic and NO activation with 
bis(pyrazolyl)methanes ..................................................................................................................... 79 
3.5.1 Introduction ................................................................................................................... 79 
3.5.2 Copper nitrosobenzene species as superoxide mimics ................................................. 80 
3.5.3 Diazald and TTN as NO transferring agents ................................................................... 82 
3.5.4 Summary ........................................................................................................................ 83 
3.6 Basic studies on bis(pyrazolyl)methane ligands and their complexation behaviour ............ 85 
3.6.1 Isomerisation and structural properties ........................................................................ 85 
3.6.2 Structural studies on cobalt bis(pyrazolyl)methane complexes ................................... 88 
3.6.3 Summary ........................................................................................................................ 93 
4 Conclusion & Outlook .................................................................................................................... 95 
4.1 Conclusion ............................................................................................................................. 95 
4.2 Outlook .................................................................................................................................. 98 
5 Experimental Section ................................................................................................................... 100 
5.1 General ................................................................................................................................ 100 
5.2 Physical Methods ................................................................................................................ 100 
5.3 Computational details ......................................................................................................... 102 
5.4 Chemicals ............................................................................................................................. 103 
5.5 Syntheses ............................................................................................................................. 103 
5.5.1 Synthesis of starting materials .................................................................................... 103 
5.5.2 Synthesis of 1-methyl-2-imidazolealdehyde adapted from[215] ........................................... 104 
5.5.3 Synthesis of ligands L2, L5, L6 and L7 .......................................................................... 104 
5.5.4 Synthesis of transition metal complexes ..................................................................... 108 
5.5.5 Synthesis of Bis(2-(1-Methylimidazolyl))bis(3-tertbutylpyrazolyl)methane)-
copper(II)peroxide dihexafluoridoantimonate [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 
(P1[SbF6]2) .................................................................................................................................... 115 
5.5.6 Synthesis of Bis(bis(3-tert-butylpyrazolyl)(2-Quinolinyl)methanecopper(II)-peroxide 
dihexafluoridoantimonate [Cu2O2{HC(3-tBuPz)2(Qu)}2] [SbF6]2 (P2[SbF6]2) ................................ 115 
5.5.7 Oxidation of catalytic amounts of exogenous substrate with (P1[SbF6]2) (25 eq of 
phenol, 50 eq. of NEt3) ................................................................................................................ 116 
5.5.8 Oxidation of catalytic amounts of exogenous substrate with (P2[SbF6]2) (25 eq of 
phenol, 50 eq. of NEt3)
[160,168] ...................................................................................................... 116 
5.5.9 Oxidation of stoichiometric amounts (5 eq) of exogenous substrate with 
(P1(SbF6)2) .................................................................................................................................... 117 
5.5.10 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with nitrosobenzene .............................. 118 
5.5.11 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with NO gas............................................ 119 
5.5.12 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with diazald
® .......................................... 119 
6 References ................................................................................................................................... 120 
7 Appendix ...................................................................................................................................... 132 
 
  
 
 
 
 
1  Introduction 
1 
 
1 Introduction 
1.1 Catalysis in Bioinorganic Chemistry 
With enzymes being Nature’s highly efficient motors of reactions, the great effort in the 
search for new efficient, ecological and stereospecific ways to catalyse chemical reactions, as 
well as to understand enzyme reaction pathways does not surprise. 
While the two big branches to distinguish are homogenous and heterogeneous catalysis, this 
work will only focus on homogenous catalysis, which can be divided into three sub domains: 
- Transition metal catalysis with the important section of coordination and metal-
organic catalysis, in which transition metal complexes act as catalysts and allow for a 
broad spectrum of possible reactions.[1–4] 
- Biocatalysis, also known as enzymatic catalysis, which is substrate- and reaction 
specific due to the unique composition of the enzymes’ active centres.[5–10] 
- Organocatalysis, in which small organic molecules function as metal free 
catalysts.[11,12] 
Organocatalysts offer certain advantages compared to bio- or metal-organic catalysts. 
Mostly they are soluble in organic solvents, which offers an additional substrate spectrum. 
Furthermore examples for many synthetic reactions show a practicability of organo 
catalysed reactions compared to their metal-organic catalysed counterparts, resulting in 
simplified versions of formerly challenging reactions.[11] Typical organocatalysts include 
proline and thiourease, which are available from biological materials, are inexpensive and 
easy to prepare, simple to use and stable in air and water.[12] Moreover, based on its metal 
free and therefore often less cytotoxic species, organocatalysis is of major importance in the 
field of drug development.[13,14] 
Transition metal catalysis offers its potential in its flexibility, as the central atom and ligands 
can be varied as desired in order to create the ideal catalyst for a specific reaction.[1–4] Here, 
depending on the metal, disadvantages include toxicity of the metal complexes, high costs 
for the metals, difficult purification and instability towards oxidation.[15] 
Enzymes are essential for almost every reaction taking place in the human body.[16,17] They 
are Nature's perfect combination of organo- and metal catalysis and their reactions have 
become highly specific and efficient throughout evolution.[18,19] The sheer number of 
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enzymes (> 10000) already stresses their importance. Reactions take place at their active 
site, which consists of a metal centre that is surrounded by specific peptide chains. Common 
metals in the centre of enzymes belong to the first row of transition metals, including 
copper, iron, manganese and zinc. Enzymes always catalyse very specific reactions, so that 
mostly different enzymes are necessary to convert a substrate to its desired end form that 
can be metabolised by the human body. This fact is known as substrate specificity.[18,19] 
Enzymes also work very efficiently, which is determined by their turnover number (TON). 
Turnover is the number of substrate molecules that can be converted by an enzyme per 
active site per unit of time.[20] Here efficiency is optimised by nature, but good enzymatic 
models can achieve remarkable TONs as well.  
Because of their physiological environment they function under the influence of oxygen and 
are mostly soluble in water. Problems arise, when working on corresponding model systems 
outside the human body, as their organic ligands are not soluble in water.[21,22] 
The field of Bioinorganic Chemistry is a combination of complex chemistry and 
enzymology.[23] By merging coordination catalysis with biocatalysis, each method’s 
advantages can be combined. The high efficiency of metal enzymes and the modification 
possibilities of metal complexes lead to a larger substrate variety. Additional variation of 
solvent and reaction conditions result in a maximum optimisation potential.[19] 
1.2 Enzyme modelling 
As nature optimised reaction ways over millions of years[18,19] – and enzyme extraction is 
sometimes expensive, as well as challenging – chemists have attempted to recreate these 
natural motors of reactions in vitro for a long time. To achieve this task, scientists have to 
firstly decode the structure of a specific enzyme. Obtaining crystals and solving a single 
crystal X-ray structure of an enzyme remains challenging due to the dimensions, concerning 
space and mass, of most enzymes.[24] Enzyme modelling takes place in three steps.  
1. The enzyme is simplified by reducing it to its active site including the metal core and 
the amino acids that are in close proximity to build a structural model. 
This core is then built from metal salts and appropriate ligands resembling the amino 
acids.[22] Histidine for example is often present around the enzyme core for deprotonation 
reactions, but more importantly for its coordinative properties. A bioinorganic substitute 
1  Introduction 
3 
 
would be imidazole, as the aromatic N-donor ring is the key component of histidine, but also 
other aromatic N-donors, such as pyridine or pyrazole, are often used.  
2. Discovering and understanding the reaction mechanism of the enzyme. 
Often theories have been postulated, based on the proven reaction products and a chemist’s 
intuition. Verifying the mechanism however is a difficult and time consuming task. The 
reaction has to be quenched at different stages and intermediates have to be isolated and 
characterised.  
3. The structural model is extended to a functional model, which in addition executes 
the same catalytic reactions as the enzyme. 
While replicating the active site of an enzyme is relatively easy, having the model function as 
a true enzymatic model is much more difficult. Reactions in enzymes take place at the active 
site, but still the enzyme in general is much larger and has an amino acidic sheath around the 
metal centre, which plays an important part in the catalytic efficiency of enzymes.[25] 
1.3 Metallooxygenases and Metallooxidases 
The selective oxidation of organic compounds is of great importance to the chemical 
industry.[26,27] Thereby enzyme catalysed oxidation reactions are particularly interesting, 
since they make use of molecular oxygen as a cheap oxidising agent and offer high substrate 
specificity, as well as an excellent regio- and stereoselectivity. Moreover these reactions 
function under mild conditions. This type of enzyme may also facilitate the accessibility to 
reactions, synthetic chemists only have limited access to (e.g. the conversion of methane to 
methanol).[26,28]  
Concerning oxidation reactions, two types of enzymes have to be distinguished; oxygenases 
and oxidases. Oxygenases are enzymes that transfer oxygen onto their substrate. Therein 
NADP/NADPH is often used as a source of protons and electrons. Typical reactions catalysed 
by oxygenases are monohydroxylations of aromatics, epoxidations of C-C double bonds or 
the insertion of oxygen in a Baeyer-Villiger like reaction.[29] Depending on whether oxygen 
atoms or molecules are transferred, mono- and dioxygenases have to be differentiated. A 
well-known example for monooxygenases is tyrosinase, whereas catecholoxidase acts as a 
dioxygenase. 
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Oxidases on the other hand are enzymes that catalyse a redox reaction. Here, molecular 
oxygen functions as an electron acceptor. Products of these reactions are water or hydrogen 
peroxide.[30] The most prominent example is the cytochrome-c-oxidase.  
1.4 Copper enzymes[31] 
A large amount of enzymes incorporate copper in their active centres. Depending on the 
structure of their active core, they can be divided into different categories. The most 
important for this work are copper enzymes of type I, II and III (Figure 1). 
 
 
Type I and II are mononuclear complexes; type I enzymes are surrounded by two sulphur 
and two nitrogen atoms, more specifically two histidines, one methionine and one cysteine. 
Type I enzymes are referred to as “blue copper centres”, because of their strong UV 
absorption around 600 nm.[32] Common examples are plastocyanin, azurin and nitrate 
reductase. The geometry around the copper centre is strongly distorted from a tetrahedral 
coordination (3+1 coordination). In type II the copper atom is surrounded by three histidine 
moieties and one aqua ligand. Type II enzymes are known as common “non-blue” copper 
centres. Examples include galactose-oxidase, (CuZn)-dismutase or the non-blue copper 
Figure 1. Structures of type I, II and III copper enzymes. 
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centre in cytochrome-c-oxidase. The geometry is considered as planar with a weak 
additional coordination. Type III copper enzymes contain copper atoms which are 
surrounded by three histidine residues in their inactive form. To get to the active form, 
dioxygen is bound in a O-bridging (µ-η2:η2)-mode. Common examples are tyrosinase and 
hemocyanin.[33] 
Type I copper enzymes are involved in reversible electron transfer, while type II enzymes 
activate oxygen in cooperation with organic co-factors. Type III enzymes are also involved in 
oxygen activation and additionally in oxygen transfer. 
 
1.5 Tyrosinase, catechol oxidase and hemocyanin 
Tyrosinase is a type III copper enzyme that is involved in the activation of oxygen in nature. 
The active site of tyrosinase consists of a (μ-η2:η2)-peroxodicopper(II) core that was 
confirmed by Matoba et al. in 2006 by crystal structure analysis of Streptomyces 
castaneoglobisporus tyrosinase in combination with a caddie protein (Figure 2, A).[34] 
Tyrosinase displays phenolase and catecholase activity. It is involved in the first reaction step 
of the synthesis of melanin out of tyrosine. Melanin is a pigment found for example in the 
skin, hair and feathers of animals and in plants.[35–38] Catechols are common structural 
motives in bioactive natural products and therefore important for the industry, e.g. in the 
production of pigments, the aroma of vanillin or photosensitive materials.[39] Their efficient 
and ecological synthesis – e.g. by selectively oxidising phenols in the ortho-position – is 
highly interesting for synthetic chemistry. Until now, the transformation from phenol to 
Figure 2. A, active centre of the met-form of tyrosinase complexated with ORF 378. B, active centre 
of the inhibitor-bound potato catechol oxidase. C, active centre of the oxy-form of octopus 
hemocyanin.[34] 
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catechol was difficult to realise by transition metal catalysis, because multi-step synthesis 
and the use of expensive reagents in stoichiometric quantities were necessary.[40,41] 
The fact that quinones are always coloured makes them to common components in naturally 
originated pigments, for example in bacteria, fungi or flowers. Moreover they are often 
found in antibiotics as they have antibacterial properties.[42] 
Catechol oxidase (Figure 2, B) is a ubiquitous plant enzyme, also belonging to type III copper 
enzymes that catalyses the oxidation of a broad range of catechols to the corresponding o-
quinones.[43] It differs from tyrosinase, which can catalyse both the monooxygenation of 
monophenols and the oxidation of catechols to quinones. Catechol oxidase can for instance 
be found in potatoes[34] and also has antiseptic values. It is located in the cell cytoplasm, 
whereas catechol is present in the cell vacuoles, resulting in the generation of the natural 
antiseptic o-quinone, when plant tissue is damaged.[44] 
Hemocyanin (Figure 2, C) is the transporter of oxygen in the blue blood of molluscs and 
arthropods, like octopuses or crabs (e.g. horseshoe crab). It can consist of two (dimer), six 
(hexamer) or even ten (decamer) monomer subunits which can bind an oxygen molecule 
each in a Cu-peroxo binding mode. Remarkable is that – depending on the species – 
hemocyanin can be composed of up to eight hexamers (e.g. horseshoe crab) or two 
decamers (e.g. octopus). Because of its large size, hemocyanin usually floats free in the 
blood.[45] 
1.6 Reaction mechanism of tyrosinase 
As mentioned before, tyrosinase exhibits monophenolase and diphenolase activity, which 
means that both the reaction of phenol to o-catechol and the subsequent reaction to 
o-quinone are catalysed (Scheme 1).[46] 
Scheme 1. Monophenolase and diphenolase reaction, catalysed by tyrosinase.adapted from [46] 
1  Introduction 
7 
 
Electron transfer for this reaction follows an inner-sphere mechanism.[31] Tyrosinase is 
essential for the reaction of tyrosine to melanin. It hereby catalyses the first two reaction 
steps, from tyrosine to L-dopa and subsequently to dopaquinone (Scheme 2). Further 
reaction steps towards melanin include the oxidation of dopaquinone to dopachrome and 
several other reaction steps. Depending on the species, either tyrosinase itself can catalyse 
the reaction to melanin or the enzymes dopachrome tautomerase (DCT) and 
5,6-dihydroxyindole-2-carboxylic-acid oxidase (DHIC-oxidase) are required.[47,48]  
Scheme 2. Reaction of tyrosinase to dopaquinone, catalysed by tyrosinase.[49] 
In the catalytic cycle of tyrosinase three different tyrosinase states occur. The passive state 
of tyrosinase is called met-form, where two copper ions are bridged by small bridging ligands 
such as water or hydroxide.[34] In the oxy-form dioxygen is bound between two copper 
atoms and an O-O-bond is formed. Here the spin containing dx2-y2-orbitals of the copper 
atoms and the π*-orbitals of the oxygen atoms show antiferromagnetic coupling, resulting in 
a diamagnetic complex. This effect was shown by Matoba et al. in 2006 by crystal structure 
analysis.[34] In 1996 Solomon et al. postulated a reaction mechanism for the catalysis of 
tyrosinase which Itoh extended to the one shown in Scheme 3.[31,50] 
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Scheme 3. Catalytic cycle of tyrosinase.[50,51] 
Beginning with the desoxy-form A, the reaction starts with the oxidative addition of 
molecular oxygen to the copper atoms. Hereby the side-on peroxo-species B is formed. The 
oxy-phenolate intermediate C is generated after deprotonation of the substrate by histidine. 
Due to an interaction of histidine and the substrate, the substrate is pre-oriented, so that 
the C-O bond points towards the copper centre. Furthermore the substrate is shifted 
towards Cu, for the attack in the ortho-position to take place. For the next step the widely 
accepted mechanism now is that the electrophilic attack of an oxygen atom of the peroxo 
unit to the aromatic ring leads to the cleavage of the O-O bond.[52] Several years back, other 
reaction mechanism were discussed as well, including an initial O-O bond cleavage followed 
by hydroxylation[53] and a radical mechanism.[54] 
Proton transfer from the attacked o-phenolic position to the second oxygen leads to the 
met-catechol D. Finally, water elimination and catechol oxidation leads to the o-quinone and 
restores the desoxy-copper(I) form of the tyrosinase (A). 
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1.7 Oxygen activation 
Besides iron, copper is one of the most frequent metals in the active centre of many 
enzymes, due to its naturally high occurrence and also its electrochemical nature with easily 
accessible redox potentials.[19] 
The reaction of oxygen with copper can result in a variety of different Cu-oxygen species 
(Table 1).[55]  
Table 1. Structural features of Cu2O2 and CuO2 species.
[55] 
 
   
  
Structure 
side-on 
(μ-η2:η2)-peroxo 
SP 
end-on 
trans-(μ-1,2)-peroxo 
TP 
bis(μ-oxo) 
O 
Cu(III)-
Peroxo 
MP 
superoxo 
ES 
Oxidation 
state 
+II +II +III +III +II 
Cu–Cu 
[Å] 
3.51 4.36 2.80 
– – 
Cu–O [Å] 1.92 1.85 1.82 1.85 1.84 
O–O [Å] 1.42 1.43 2.32 1.44 1.28 
 
All dinuclear copper cores shown in Table 1 are isoelectronic to each other. SP and TP both 
are peroxides with an O-O bond, while O incorporates a bis(µ-oxo) core. Because of the 
different binding modes, the copper oxidation states are different. Regarding Cu-Cu 
distances, the longest one can be found in the TP species with 4.36 Å. The Cu-Cu distance in 
SP with 3.51 Å is still long, while it is considerably shorter in the oxo species O (2.80 Å). 
Two examples of mononuclear Cu-O2 species are shown in Table 1 as well, referred to as 
MP 
and ES. The MP core is another peroxo compound with Cu in the oxidation state of +III, while 
ES is a superoxide radical with Cu in the oxidation state +II. The O-O bond length in MP is in 
the same range as in SP and TP and therefore considerably shorter than the respective O-O 
distance in O, but longer than the one in ES. 
Considering thermodynamical investigations, the most important species are the side-on 
peroxo and bis(μ-oxo)-complexes.[56] All in all, an important factor influencing the 
thermodynamic stability of such complexes is the nature of the ligands. More precisely it 
depends on the steric properties and mostly on the basicity, as well as the donor ability of 
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the used ligands, whether the SP or the O core is generated.[57] A hybrid permethylated-
amine-guanidine ligand for example only forms the O core[58], which suggests that bidentate, 
sterically non-demanding strong σ-donors shift the equilibrium toward the O complex.[55,59] 
Because of their spectroscopic properties, O and P species can easily be distinguished 
(Table 2) and therefore the binding situation of complexes can normally be determined via 
UV/Vis and resonance Raman spectroscopy.[55] 
Table 2. Spectroscopic features of (μ-η2:η2)- and bis(μ-oxo)-complexes.[47,55] 
 side-on (μ-η2:η2) bis(μ-oxo) 
UV/Vis spectroscopy 
350 nm 
(ε = 20000 Lmol−1cm−1) 
300 nm 
(ε = 14000 Lmol−1cm−1) 
 
550 nm 
(ε = 1000 Lmol−1cm−1) 
400 nm 
(ε = 14000 Lmol−1cm−1) 
Resonance Raman 750 cm−1 (O-O) 600 cm−1 (O-O) 
  100–200 cm−1 (Cu-Cu) 
 
As listed in Table 2, side-on (μ-η2:η2)-peroxo complexes show UV/Vis absorption bands at 
around 350 and 550 nm with an intensity ratio of 20:1, as well as a characteristic resonance 
Raman valence vibration at 750 cm−1 (ν(O-O)). Bis(μ-oxo)-species on the contrary exhibit 
UV/Vis bands at 300 and 400 nm with equal intensities and two resonance Raman valence 
vibrations at 600 (ν(O-O)) and between 100 and 200 cm−1 (ν(Cu-Cu)). The origin of the UV/Vis 
bands is discussed in more detail in chapter 3.2. 
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1.8 State of research in oxygen activation 
Over the last 20 years, interest in copper-dioxygen species as well as in their catalytic 
reactions has been continuously high, owing to their promising prospects for bioinspired 
oxidation and oxygenation catalysis.[60] The crystal structures in Figure 3 depict O2-derived 
metalloenzyme intermediates, showing that the metal-O2 structure motives in Table 1 are in 
fact found in intermediate or activated structures in nature.  
 
Both copper-oxo and -peroxo complexes are popular research topics. As both species are in 
equilibrium due to their similar stabilisation energies, dependence of the generation of oxo 
vs. peroxo complex on the ligand is under continuous observation.[57] Peroxo complexes are 
investigated as model systems for enzymes like tyrosinase or hemocyanin, while bis(µ-oxo) 
complexes now serve as models for enzymes such as particulate methane monooxygenase. 
Formerly however they were studied as tyrosinase models as well. Plenty of ligand families 
have been investigated, including tris(pyrazolyl)borates[61], tris(pyrazolyl)methanes[62], alkyl 
amines[63], pyridines[64], ketiminates[65] and guanidines.[66,67]  
In 1989 Moro-oka et al. were the first to crystallise a (μ-η2:η2)-peroxo core by using the 
tris(3,5-diisopropyl(pyrazolyl)borate ligand HB(3,5-iPr2Pz)3 (Scheme 4).
[61] They obtained 
violet crystals by reduction of the solvent acetone under vacuum at −20°C followed by 
Figure 3. O2-derived metalloenzyme intermediates, structurally characterised by X-ray 
crystallography. 
From left to right: oxygenated intermediate from naphthalene dioxygenase; (µ-η2:η2-
peroxo)dicopper(II)core of oxy-tyrosinase; O2 adduct identified in peptidylglycine α-hydroxylating 
monooxygenase. 
For clarity, histidine imidazolyl donor ligands are indicated by N. Key oxygen atoms involved in 
these processes are shown in red. In the molecular models, carbon is shown in grey, oxygen in red, 
nitrogen in blue, copper in green, sulphur in yellow and iron in purple.adapted from [19] 
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cooling to −78°C. They also discovered two ways to generate the peroxo-complex, which is 
either by direct addition of O2 to the copper(I) complex or by H2O2 treatment of the hydroxo 
dicopper(II) species. A copper-peroxo species was synthesised before by Karlin et al. in 1988 
(Scheme 4), but it possessed trans-μ-1,2 coordination (end-on) and showed significantly 
different spectroscopic features than oxy-hemocyanin or oxy-tyrosinase.[68]  
Tolman and co-workers were the first who used β-ketiminate copper complexes of the type 
[LCuCl]n (n = 1 or 2) and [LCu(MeCN)] to determine structural differences of the copper 
complexes when steric properties of L were changed (Figure 4).[65] Therefore several crystal 
structures of both types were analysed. Upon reaction of ketiminate Cu complexes with 
oxygen at −80°C the formagon of a (μ-oxo)-Cu(III) species was detectable via UV/Vis 
spectroscopy. Here the alternative route upon addition of H2O2 afforded the bis(µ-oxo) 
complex as well, but only when NEt3 was added additionally. 
 
Scheme 4. Left side: reaction of [Cu(HB(3,5-iPr2Pz)3)] with oxygen; right side: reaction of [Cu(TMPA)] 
with oxygen.[61,68] 
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Pyridine substituted amine ligands were investigated in 2003 by Itoh et al. (Figure 4).[64] 
Reacting the Cu(I) species of 2 with O2 at −80°C afforded the (μ-η
2:η2)-peroxo complex, 
whereas the substitution of 2 with the sterically less demanding ligand 1 resulted in the 
bis(μ-oxo)-compound. The oxo-species was characterised by X-ray diffraction analysis, the 
peroxo species by UV/Vis and X-ray absorption spectroscopy (XAS). Both species are 
catalytically active, as has been shown by the reactions of ten different phenolic substrates. 
However keeping the reaction mechanism of tyrosinase in mind[69], substrate reactions here 
always furnished C-C coupled products, which is in contrast to the inner-sphere electron 
transfer mechanism of tyrosinase.  
Henkel and Herres-Pawlis established guanidine ligands and made progress in this field at 
the beginning of the 21st century.[66,67] A family of new bis(guanidine)copper(I) compounds 
was introduced, containing [Cu2(btmgp)2][PF6]2, [Cu2(DPipG2p)2][PF6]2, [Cu2(DMPG2p)2][PF6]2 
and [Cu2(DMEG2p)2][PF6]2·2MeCN. Each species was characterised by X-ray diffraction 
analysis to show a twelve-membered heterocyclic Cu2N4C6 ring. The first three species 
reacted with O2 to afford the oxo-species [Cu2O2(btmgp)2][PF6]2 and [Cu2O2(DPipG2p)2][PF6]2 
and the peroxo-species [Cu2O2(DMPG2p)2][PF6]2. Similar to the data observed by Itoh, the 
sterically less demanding ligand generates the bis(µ-oxo) core.  
Moreover, a few years later Henkel et al. were able to synthesise a room temperature stable 
bis(μ-oxo) complex containing a sterically demanding peralkylated bis(guanidine)-based 
ligand.[67] On this complex structural studies were performed using EXAFS and resonance 
R
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Figure 4. Left side: Structure of β-ketiminate ligands as used by Tolman.[65]; right side: Structure of 
bidentate (1) and tridentate (2) 2-(2-pyridyl)ethylamin ligands as used by Itoh.[64] 
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Raman measurements. These analytic methods helped to gain insight into the electronic 
structure, concerning the ground and excited state of the bis(µ-oxo) species.  
Stack et al. reported peralkylated diamines for the reaction with O2 at low temperatures in 
aprotic solvents (Figure 5).[63] Reactions were performed at −73°C with weakly or non-
coordinating anions, such as ClO4
−, SbF6
−, BF4
− or CF3SO3
−. Several crystal structures could be 
obtained that provided insight into the complexity of biological Cu2O2 reactions. 
For the stoichiometric ratio of Cu(I)L:O2 = 2:1 – using 3 and 4 (Figure 5) – two different 
Cu2O2-species were achieved. Using 3 in the conversion with O2 afforded the Cu(III)-μ-oxo-
species, whereas the reaction of 4 with O2 furnished a (μ-η
2:η2)-peroxo complex. Therefore 
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Figure 5. Structure of peralkylated diamine ligands (LPDA) as used by Stack.[63] 
Figure 6. Top: Structure of bis-µ-oxo copper(III)-species with ligands TMPD, DMPD and PD.; bottom: 
active centre of particulate methane monooxgenase (pMMO).[70] 
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Stack and co-workers could further proof the importance of the ligand in the reaction of 
Cu(I)-species with O2. 
Very recently, Stack et al. presented other simple primary amine ligands for the stabilisation 
of a dicopper(III)-bis(μ-oxo) complex, resembling the active centre of particulate methane 
monooxygenase (Figure 6).[70] 
Based on 5, upon the addition of 2 eq of N,N-dimethylpropylenediamine (DMPD) at −125°C, 
6 was achieved in a ligand exchange reaction. The same applies to the reaction of 5 with 
propylenediamine (PD), resulting in 7. DFT calculations showed that 6 and 7 are energetically 
more stable. 5 and 6 did not show catalytic H-abstraction activity, which was explained by 
the sterically shielded Cu2O2 core, as shown descriptively with a space filling model. 
In 1998 Casella reported a peroxo-complex, containing the very spacious ligand 
N,N,N’,N’,N’’-pentakis[(1-methyl-2-benzimidazolyl)methyl]dipropylenetriamine (Figure 7).[71] 
Using a simplified version of this ligand (9, Figure 7), Casella et al. were able to achieve the 
first monophenolase reaction using a Cu2O2-complex a few years later.
[72] They also showed 
oxidation of fluoro-phenols catalysed by tyrosinase[73] and were the first ones to trap a 
ternary complex of tyrosinase/O2/phenol at low temperatures.
[74] This experiment proofed 
that the (μ-η2:η2)-form is the only active enzyme species of tyrosinase. In general the group 
has made significant contributions in the field of O2 activation, especially concerning the 
elucidation of the catalytic cycle of tyrosinase.[74,75] 
Figure 7. Structure of N,N,N’,N’,N’’-pentakis[(1-methyl-2-benzimidazolyl)methyl] dipropylene-
triamine (8) and N,N-bis(2-N-methylbenzimidazol-2-yl)ethyl)benzylamine (9) as used by 
Casella.[71][72] 
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In 2006, Lehnert et al. described structural and electronic differences of copper(I) complexes 
with tris(pyrazolyl)methane and hydrotris(pyrazolyl)borate ligands.[62] To understand 
reactivity differences of copper(I) acetonitrile complexes towards O2, they started the 
investigation by varying certain parameters on Cu(I) complexes. Parameters included the 
solvent as a fourth ligand, the counterion, steric hindrance at the pyrazolyl substituent and 
overall charge of N3 type ligands. The ligands used in this study were tris 
(3,5-isopropyl(pyrazolyl))borate (HB(3,5-iPrPz)3), tris((3-tertbutyl,5-isopropyl)(pyrazolyl)) 
borate (HB(3-tBuPz-5-iPrPz)3), tris(3,5-isopropyl(pyrazolyl)methane (HC(3,5-iPrPz)3) and tris 
((3-tertbutyl,5-isopropyl)(pyrazolyl))methane (HC(3-tBupz-5-iPrPz)3). Differences in the 
reactivity of their Cu(I) complexes were attributed to differences in the oxidation potentials, 
as determined by cyclic voltammetry. However the oxygen species containing these ligands 
took quite a long time to build and showed no catalytic activity. 
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Figure 8. Structures of an imine/pyridine (10), a bis(imine) (11), a bis(pyridine) (12), a 
benzimidazole/imine (13), an imine/pyridine containing ligand with biphenyl spacer (14) 
and a bis(pyrazolyl)(pyridinyl)methane ligand (15,L5).[18,77–79] 
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Changing the ligand class can result in the formation of another Cu2O2-species, but one can 
also vary within a ligand class, for example by modifying one donating substituent. Herres-
Pawlis et al. have investigated the donor competition between pyridinyl and pyrazolyl 
moieties in the HC(3-tBuPz)2(Py) ligand, showing that nucleophilicity, as well as basicity have 
to be taken into account and still the topic is not trivial.[76]  
Despite the intensive research in this field over the last decades, only few systems were able 
to achieve significant catalytic phenol hydroxylation so far. Firstly in 1990 Réglier et al. 
presented a model containing a biphenyl spacer (14, Figure 8).[77] In 2010 Tuczek et al. 
followed with a mononuclear copper(I) complex consisting of pyridinyl and/or imine 
moieties as precursor (10–12, Figure 8).[78]  
To tie in with this achievement, Tuczek et al. prepared yet another (μ-η2:η2)-peroxo copper 
complex. This time a mixed benzimidazole/imine ligand was used (13, Figure 8). 
Investigations concerning the catalytic activity of [Cu2O2132] with 2,4-di-tert-butyl-phenol 
(DTBP-H) showed a TON of 31 after 6.5 h. However besides the quinone, the C-C coupling 
product of DTBP-H was detected in large quantities as well.  
Recently, Herres-Pawlis et al. generated the first tyrosinase model consisting of 
bis(pyrazolyl)methanes (15, Figure 8), where the formation of quinones from different 
phenolic substrates without the formation of C-C coupling products was demonstrated.[18]  
Showing that tyrosinase models are still a "hot topic", Tuczek et al. recently published 
another catalytic system using ligands consisting of imine and benzimidazole or imine and 
pyrazolyl moieties respectively[51,79], while Lumb et al. made use of catalytic copper-dioxygen 
chemistry to generate valuable organic products out of simple substituted phenols.[80] Meyer 
et al. observed reversible O2-uptake using bis(oxazoline) (BOX) ligands.
[60] The resulting 
(μ-η2:η2)-peroxo dicopper(II)-species was isolated as a surprisingly stable solid and was 
subject to various analytic methods. First reactivity studies using 2,4-di-tertbutylphenol 
however showed the formation of a C–C coupling product, while ortho-hydroxylation could 
not be observed. 
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1.9 (µ-η2:η2)-peroxo dicopper(II) vs. bis(μ-oxo) dicopper(III) 
Because of the small energy barrier between oxo- and peroxo-species, investigations to 
understand which influences contribute to the stabilisation of one or the other are of major 
interest. 
Based on the ligands 1 and 2 (Figure 4), it seems that sterically less demanding ligands lead 
to the formation of the bis(μ-oxo) complex. This is often the case but steric properties are 
not the only important factor to consider. Concerning this subject Karlin et al. published an 
in depth study using the pyridinyl substituted amine derivative R-PYAN (N-[2-(4-R-pyridin-2-
yl)-ethyl]-N,N′,N′-trimethyl-propane-1,3-diamine, 16R, Table 3).[57] The Cu(I)/Cu(II) redox 
potentials of copper(I)-complexes like [Cu(R-PYAN)(MeCN)n](BC6F5)4 (R = NMe2, OMe, H, Cl) 
only differ in a small range, however, depending on R, oxygen reactivity is largely influenced. 
In general oxo- and peroxo-species are stable at low temperatures. When warming the 
reaction mixture to room temperature, the stable bis(µ-hydroxo) complex is formed 
(Scheme 5). 
Besides the electron donating or withdrawing properties of different moieties R, the solvent 
also has a strong influence on the Cu2O2-equilibrium. Table 3 displays an overview of 
substituent, as well as solvent effects which shows that the solvent effect plays a minor role, 
especially with the electron donating NMe2 substituent, where the bis(µ-oxo) compound is 
built regardless of the solvent. In contrast, when the donating OMe-group is introduced into 
PYAN, mainly the peroxo-complex is formed. Regarding the likewise donating NMe2-group, 
Scheme 5. Reaction of [Cu(I)(R-PYAN)] with oxygen.[57] 
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the peroxo compound is built instead. Furthermore it was proven by resonance Raman 
spectra that better donating ligands lead to an O-O bond weakening. In summary this study 
shows that electronic ligand effects play a major role in the stabilisation of Cu2O2-species, 
while steric effects play a minor part. Solvents mostly play only a minor part as well, but in 
certain cases may lead to the generation of another product. In general coordinating 
solvents such as THF push the equilibrium towards the bis(µ-oxo) species.[56,81,82] 
Table 3. Overview of built species concerning the reaction of [Cu(I)(R-PYAN)] with oxygen. 
Reactions were performed at −78°C. Content in brackets symbolises minor product.[57] 
 
CH2Cl2 
THF, 
acetone 
R = H peroxo oxo + peroxo (1:1) 
R = Cl peroxo peroxo + (oxo) 
R = OMe peroxo + (oxo) oxo 
R = NMe2 oxo oxo 
 
The last chapters focused mostly on oxygen activation, which will be an important part of 
this work, but the ligand model systems that were used are also in the focus for the 
activation of other small molecules, such as NO or N2. In addition, besides copper complexes, 
complexes with cobalt as the central metal were found to be promising preliminary stages in 
the activation of nitrogen containing small molecules. Therefore the next chapter will 
concentrate on these subjects. 
1.10 Cobalt complex chemistry[83] 
Cobalt is a transition metal and is found in nature mostly as ore in combination with arsenic 
or sulphur. It is much more oxidation resistant than iron. Technical applications of cobalt 
include alloys and it functions as pigment to blue glass or ceramics. Cobalt(II) and cobalt(III) 
are the most common oxidation states. They both show a high complex building tendency. 
Cobalt(III) has six d-electrons and builds complexes with neutral ligands, such as NH3, H2O 
and CO2H. 
N
NN
R
R-PYAN (16R)
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Co(III) oxygen species are far less stable than Co(III) complexes with nitrogen ligands. Like 
copper, cobalt(II) also reacts with oxygen to generate different oxygen bound species. The 
difference however is that the reaction of Co(II) with oxygen results in a mononuclear 
η1-superoxo species and further reaction results in a dinuclear end-on trans-(μ-1,2)-peroxo-
species (Figure 9), whereas Cu(II) more likely exhibits peroxo-complexes with the (μ-η2:η2)-
coordination motive. 
In biochemistry, cobalt is of high importance as a micro-element, for example as part of the 
active centre of cobalamines.[84] The most well-known example hereof is coenzyme B12. 
Cobalamines are composed of a 15-membered planar macrocyclic corrin system with four 
N-donors and Co(III) in the centre, resembling the porphyrin ring of haemoglobin 
(Figure 10).[85] 
 
Mainly Co(III) complexes show an octahedral geometry with a low-spin arrangement, 
resulting in the highest ligand field splitting. Co(II) complexes have seven d-electrons and 
show a more diverse complex geometry, but primarily either octahedral high-spin or 
tetrahedral complexes with fully occupied eg-orbitals are stabilised. An example for a 
Co complex with nitrogen donors is shown in Figure 11. Regarding the geometry, less 
polarisable ligands such as oxygen or nitrogen lead to octahedral (Figure 11) and polarisable 
ligands such as Cl−, Br−, I−, SCN− lead to tetrahedral complexes (Figure 11). 
 
 
Figure 10. Structure of the corrin ring. 
Figure 9. Coordination motives of the reaction of Co(II) species with oxygen.[83] 
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1.11 NO in Bioinorganic Chemistry 
For a long time nitric oxide has only been known as a colourless, poisonous gas. It is a free 
radical with eleven valence electrons. The single electron occupies an antibonding π*-orbital, 
which explains the high reactivity of NO. Oxidation generates the nitrosyl cation NO+ and 
reduction results in the nitroxyl anion NO−.[83] From a bioinorganic perspective, the complex 
formation of transition metals with NO is highly interesting. NO is a redoxactive ligand, 
which belongs to the group of “non-innocent” ligands. In complexes, NO’s redox activity 
makes it difficult to assign an oxidation state to it. Therefore Enemark and Feltham 
introduced a nomenclature that does not need to assign specific oxidation states to neither 
metal nor ligand.[86] There, the metal ligand unit is written in curly brackets, for example 
{CoNO}10. The number ten represents all d-electrons of the neutral metal plus all unpaired 
π*-electrons of the ligand. Applying the neutral electron counting system, 10 is composed of 
9 d-electrons for Co(0) and 1 π* d-electron for the NO radical. 
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Furchgott and Ignarro recognised the physiological importance of NO and received the Nobel 
Prize in 1998 for their contribution to the finding that NO exhibits a vasodilatory effect and is 
important for the regulation of blood pressure.[87] 
NO is synthesised by NO-synthases (NOS). Here three different forms can be differentiated; 
endothelial- (eNOS), neuronal- (nNOS) and inducible-NOS (iNOS). They convert L-arginine via 
L-hydroxyarginine to L-citrulline and NO (Scheme 6).[88] 
Due to its small size and low polarity, NO can diffuse freely in the muscle layers, where it can 
activate the soluble guanylate cyclase (sGC), which most likely incorporates a low-spin Fe(II) 
haem centre.[89] The binding of NO leads to a bond cleavage between Fe and a histidine, 
resulting in the active form of GC. Activation of GC in turn leads to an increase of the cGMP 
(cyclic guanosinemonophosphate) level. As a result of a higher cGMP level, the Ca2+ level is 
reduced, which results in a relaxation of the muscle septum. However the operation mode of 
GC is not understood in detail to this point.[90] Based on its blood pressure reducing 
properties, NO releasing drugs are for example used in the treatment of heart diseases (e. g. 
angina pectoris).[91] In order to understand systems like GC in detail and for the optimisation 
of medical treatments involving NO, it is of great importance to generate biomimetic 
systems and study their structure, as well as their electronic properties. 
1.12 Microbial denitrification 
Another biologically important nitrogen species is nitrate. It is the reactant of the microbial 
denitrification. This four step process is the energy source for certain bacteria, as well as 
archaea, fungi and yeasts.[92] These reactions convert nitrate to nitrogen. Each reaction is 
catalysed by a different enzyme, which incorporate different metal atoms, such as Fe, Cu or 
Mo with different ligand environments. 
Scheme 7. Reactions of the microbial denitrification. 
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Starting point is the reduction of nitrate to nitrite. This reaction is catalysed by nitrate 
reductase and is followed by three further reactions, in order to generate nitrogen. 
Nitrate reductase is an oxido reductase that is composed of α-, β- and two γ-units, 
containing molybdenum in its active centre. It catalyses the reduction of nitrate to nitrite 
(Scheme 7). 
There are two types of nitrite reductases: one is haem based and the other one contains 
copper. The iron based enzyme catalyses the reaction to various products whereas the 
copper containing ones specifically catalyse the reaction to NO (Scheme 7). Copper-
containing nitrite reductases (CuNIRs) have at least one type I copper centre per protein, 
which are similar to azurin.[93] Additionally type II copper centres can be found in NIRs, which 
are responsible for the binding and reduction of nitrite.[93][94] In this case a Cys-His bridge is 
built, that connects a type I Cu-centre ligated Cys to a type II Cu-centre ligated His.[95] 
The nitrogenmonoxide reductase catalyses the reduction of NO to N2O (Scheme 7). It has an 
iron based active centre.[96] It also shows a co-regulation with nitrite reductase, which was 
demonstrated by mutation of the nitrite reductase gene.[97] 
The final reaction step to nitrogen is catalysed by nitrous oxide reductase (N2OR) in 
combination with cytochrome-c (Scheme 7).[98] Therefore N2OR plays a crucial role in the 
conversion/reduction of the greenhouse gas nitrous oxide.[99] 
Overall studies with bacterial NO-binding enzymes and their model complexes provide 
structural, spectroscopic and mechanistic information and can therefore help in the 
investigation of other NO binding enzymes, such as guanylate cyclase. 
1.13 Poly(pyrazolyl)methanes 
As can be seen by the vast variety of Cu2O2-species, the spectrum of N-donating ligands 
suitable for tyrosinase modelling is huge. Keeping in mind the condition of mimicking the 
active centre of tyrosinase with histidine resembling, facially N-donating ligands that can be 
adjusted by varying their substituents and therefore the steric or electronic properties, we 
used bis(pyrazolyl)methane ligands.  
Figure 12. Structure of tris(pyrazolyl)borate and tris(pyrazolyl)methane. 
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Pioneering work in this field was done by Trofimenko in 1966, when he firstly reported 
tris(pyrazolyl)borates (Figure 12) as N-donating ligands and suggested them as good mimics 
for the histidine surrounding of copper centres.[100] Tris(pyrazolyl)methanes belong to the 
class of scorpionate ligands owing it to their coordination mode, where two N-donors 
coordinate the metal from either side and the third one coordinates from the top, 
resembling the claws and sting of a scorpion.[101] Despite their water sensitive B-N bond and 
their overall charge, they dominated the field of coordination chemistry compared to 
isoelectronic tris(pyrazolyl)methanes (Figure 12) for a long time, the reason being the easy 
accessibility of the borates. Besides methane derivatives, species containing different apical 
atoms, such as silicon[102], nitrogen[103], transition metals[104], aluminium, indium, gallium[105] 
or germanium[106] are known. Originally tris(pyrazolyl)methanes were introduced to 
coordination chemistry by Hückel & Bretschneider in 1937.[107] However their synthesis was 
not selective and byproducts such as mono- and disubstituted methanes with only one or 
two pyrazole functions were formed. For many years no efficient synthesis protocol was 
known. 
Trofimenko synthesised the bis(pyrazolyl)methane H2C(Pz)2 by the conversion of pyrazole 
with dibromomethane.[108] Following the synthesis of pyrazole with dibromomethane at 
150°C yielding 45% product, finally Trofimenko reacted pyrazole with 
2,2-dimethoxypropane to obtain 75% of H2C(Pz)2.
[108] After the successful synthesis of 
bis(pyrazolyl)methanes via the reaction of the potassium salt of the substituted pyrazoles 
with diiodomethane in a phase-transfer catalysis,[109] attempts to synthesise substituted 
tris(pyrazolyl)methanes in that way failed. Progress in this area was made by Elguero et al. in 
1984[110] and finally by Reger et al., who presented a synthesis of 3,5-substituted 
tris(pyrazolyl)methanes (Scheme 8).[111] Thereby, 3 eq of a 3,5-disubstituted pyrazole are 
refluxed with an excess of sodium carbonate in a liquid-liquid phase transfer system 
(chloroform/water), followed by the reaction with tert(n-butyl)ammoniumbromide. This 
reaction resulted in yields of about 60%. Because of their three identical donor functions 
they are also referred to as homoscorpionates. In contrast to that, bis(pyrazolyl)methanes 
(where one pyrazolyl substituent is switched to another donor function) are called 
heteroscorpionates.[112] Scorpionate ligands with substituted pyrazole moieties are referred 
to as “second-generation” ligands.[101] 
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In 1989 Canty et al. extended the research field of tris(pyrazolyl)methanes to 
bis(pyrazolyl)methanes, by synthesising bis(pyrazolyl)methanes that incorporate a pyridinyl 
rest.[113] This reaction is based on a Peterson rearrangement.[114] It proceeds in two steps: 
first, the generation of bis(pyrazolyl)methanone from the reaction of pyrazole with Et3N and 
phosgene, and second the conversion of the ketone with an aldehyde that incorporates the 
third donor function. In this reaction the fleeting gas CO2 is formed. Using this method Higgs 
and Carrano synthesised several bis(pyrazolyl)methanes with disubstituted pyrazolyl 
moieties and hydroxyphenol as the third donor.[115] 
An advantage compared to the tris(pyrazolyl)methanes is the possibility to vary and optimise 
the donor abilities through the variation of the third donor. Upon reaction with a transition 
metal, the preferred binding motive is a six-membered C(μ-Pz)2M ring in its boat 
conformation (Figure 13).[101] 
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Scheme 8. Reaction scheme of the synthesis of substituted tris(pyrazolyl)methanes.[111] 
Figure 13. Boat conformation of a bis(pyrazolyl)methane complex. 
Scheme 9. Reaction from pyrazole to bis(pyrazolyl)methane by using triphosgene and 
2-hydroxybenzaldehyde.[116] 
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Burzlaff et al. developed a cobalt catalysed synthesis for N-,N-,O-scorpionate ligands 
(Scheme 9) that are able to complexate transition metals.[116] 
Based on all these reactions, a unified synthesis for substituted bis(pyrazolyl)methane 
ligands was developed in 2010 by Herres-Pawlis et al.[117] Following a modified Peterson 
rearrangement type reaction[114], this cobalt catalysed reaction allows for the synthesis of a 
variety of bis(pyrazolyl)methane ligands in a one pot reaction in good to excellent yields. An 
additional advantage is the avoidance of the very toxic phosgene. A detailed reaction 
mechanism of the CoCl2-catalysed Peterson reaction is given in Scheme 10. 
Hereby cobalt is coordinated by two pyrazolyl nitrogens (A), followed by electron transfer to 
generate a separation of charge (B, B’). Nucleophilic attack of the free electron pair of a 
pyrazolyl nitrogen results in an O–S-bond formation (C). Rearrangement of this species leads 
to the ligand L1, with SO2 being a byproduct and the Co-catalyst being regained. 
Besides the common nitrogen donors and Burzlaff’s N,N,O-systems, bis(pyrazolyl)methanes 
with sulfur-donors as the third moiety are known as well (Figure 14).[118] 
Figure 14. Structure of bis(pyrazolyl)methane ligands with N,S-, N,N‘- and N,O-donors. 
Scheme 10. Reaction mechanism of the Co-catalysed Peterson-like rearrangement. 
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Additionally, Reger et al. introduced “third generation” ligands, which are multitopic ligands 
that possess several poly(pyrazolyl)methane units in one molecule (Figure 15). Reger’s group 
reported several self-assembled supramolecules using these ligands over the past 
decade.[119–122] In general, functional groups’ specific sterical properties and non-covalent 
interactions can greatly influence the character of the ligands.[123] 
Because of their excellent donor abilities poly(pyrazolyl)methanes can coordinate a variety 
of transition metals like iron, copper, cobalt and zinc.[124] For the coordination mode not only 
the transition metal but mostly the steric properties of the ligand are important to consider. 
Unsubstituted poly(pyrazolyl)methanes generate bisfacial octahedral complexes with Cu(II) 
centres, while poly(pyrazolyl)methanes with sterically demanding substituents in the  
3-position of the pyrazole form monofacial trigonal-bipyramidal or square-pyramidal 
complex geometries (Figure 16). With Cu(I) centres square-planar or tetrahedral 
coordination modes are created (Figure 16).[125] 
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Figure 15. Structure of “third generation“ scorpionate ligands.[123] 
Figure 16. Possible coordination modes of Cu(I) and Cu(II) bis(pyrazolyl)methane complexes. 
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2 Objectives & Contents 
2.1 Objectives 
Catalysts are commonly used reagents in chemical synthesis, because they enable and speed 
up reactions, but do not influence them any further. As an example for biological catalysts, 
enzymes are biocompatible and highly selective as well as effective, but, due to their 
complex nature, a large amount of enzymes is not well understood. 
The enzyme tyrosinase however has been characterised and X-ray diffraction analysis 
showed a Cu2O2 side-on (µ-η
2:η2)-peroxo core, where each copper atom is surrounded by 
three histidine moieties.[34] Tyrosinase catalyses the first reaction step in the biosynthesis of 
melanin which is a brown pigment found in the skin or feathers of animals and in  
plants.[35–37] It shows monophenolase as well as diphenolase activity and therefore can 
convert phenols to catechols and subsequently catechols to quinones.[126] 
The main aim of this work is the development of a ligand that can activate oxygen, in order 
to build a (µ-η2:η2)-peroxo compound and, more importantly, this peroxo compound should 
ideally be catalytically active by executing the same reactions as tyrosinase itself. For this, 
the (µ-η2:η2)-peroxo Cu(II) species is treated with various phenolic substrates in order to 
determine whether and how much catechol or quinone are formed. 
Requirements for the ligand are components that resemble the metal centre surrounding of 
the enzyme tyrosinase. The approach is to use bis(pyrazolyl)methane ligands, because their 
pyrazolyl moieties, which are aromatic nitrogen donors, resemble the histidines in 
tyrosinase. They are multidentate ligands that can be functionalised at the pyrazolyl units. In 
addition to the two pyrazolyls, a third donor function is present which can be varied as well. 
Precisely, the idea was to develop an imidazolyl containing bis(pyrazolyl)methane ligand that 
can activate oxygen as well as transfer it onto natural and non-biological substrates of 
tyrosinase. 
Alongside, bis(pyrazolyl)methane complexes with different transition metal salts shall be 
synthesised. Their structural characterisation is supposed to give insight into the donor 
competition between pyrazolyl and pyridinyl, quinolinyl or imidazolyl units. Moreover 
binding modes and complex geometries shall be characterised. The evaluation of binding 
modes and the electronic structure also leans on density functional theory calculations. 
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Additionally, for the better understanding of the catalyic mechanism of tyrosinase, a 
nitrosobenzene bis(pyrazolyl)methane copper complex shall be synthesised, as a superoxide 
mimic. Such a superoxide species is supposed to be an intermediate during the activation of 
oxygen. 
Besides the activation of oxygen, the activation of other small molecules like NO shall be 
studied by using NO gas and NO donor reagents. 
 
2.2 Contents 
The results of this thesis are discussed in chapters 3.1–3.6. 
Chapter 3.1 explains the synthesis of the reactant 1-methylimidazolealdehyde and the 
bis(pyrazolyl)methane ligand HC(3-tBuPz)2(1-MeIm), which is later on used for oxygen 
activation and transfer. Structural aspects of the ligand's crystal structure are discussed 
alongside the crystal structure for a CuCl2 complex of the same ligand. 
The ligand introduced in chapter 3.1 plays a prominent role in the whole chapter 3.2. Here 
the oxygen activation with this ligand is investigated in depth by UV/Vis and X-ray absorption 
spectroscopy, UHR-ESI mass spectrometry and theoretical means such as NTO, NBO and TD-
DFT calculations. This chapter includes the evaluation of the stoichiometric and catalytic 
activity of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2), showing that P1[SbF6]2 is 
active in the hydroxylation catalysis and can convert natural and non-biological substrates of 
tyrosinase in good yields. 
Three copper halide compounds are introduced at the beginning of chapter 3.3. Their 
molecular structures are discussed in detail including density functional theory. Furthermore 
the catalytic activity of another peroxo complex ([Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2, 
P2[SbF6]2) is shown in a self-assembly approach. Chapters 3.2 and 3.3 are round off with a 
comparison of the two peroxo species that were synthesised during this work. 
In chapter 3.4 several transition metal nitrate complexes are presented. They provide 
important insight into the geometry of combined N and O ligand systems. A rare nitrate 
binding mode is shown and quantified. 
In chapter 3.5 the formation of a superoxide mimic was attempted, as a superoxide is 
assumed to be an intermediate species in the building of the (µ-η2:η2)-peroxo compound and 
an active species in other copper enzymes.[55] There, the copper(I) precursor [Cu(HC(3-
tBuPz)2(Py)][SbF6] is reacted with nitrosobenzene. These reactions were optimised while 
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they were being followed UV/Vis spectroscopically. Moreover a couple of experiments were 
conducted in order to activate other small molecules besides O2 such as NO. Preliminary 
tests with NO donor reagent diazald® and NO gas showed a possible NO activation. 
Chapter 3.6 finally introduces further new bis(pyrazolyl)methane ligands containing 
isopropyl substituents at the pyrazolyl groups. Associated with their synthesis is the 
isomerisation effect of these isopropyl groups from the 3- to the 5-position of the pyrazolyl 
moiety. In the isomerised ligands steric pressure is avoided and a bisfacial 
bis(pyrazolyl)methane complex is formed. To conclude, structural features of two bisfacial 
cobalt complexes with unsubstituted pyrazolyl moieties at the ligand are discussed and 
compared to the isopropyl substituted ligand’s complex. 
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3 Results & Discussion 
3.1 Synthesis of a new bis(pyrazolyl)methane ligand and its 
copper(II) complex 
On the basis of recent results published by Herres-Pawlis et al.[18], a new 
bis(pyrazolyl)methane ligand was developed in order to further enhance the catalytic activity 
of its copper(II)-peroxo complex. Under retention of 3-tertbutylpyrazole due to its bulky alkyl 
group preventing the formation of bisfacial complexes, pyridinyl was substituted by 
1-methylimidazolyl, which is another aromatic nitrogen donor with different electronic 
properties. Using imidazole as an N-donating ligand is obvious, because it is the key building 
block of the amino acid histidine, which is present around the active centre of many 
enzymes.[127] Keeping that in mind, it does not surprise that ligands containing imidazole 
moieties have already been used in the field of copper-oxygen chemistry (Figure 17). In 
1995, Sorrell et al. used a substituted tris(imidazolyl)phosphine ligand to stabilise a peroxo 
dicopper(II) adduct.[128] This was stable at −78°C for at least five days. Upon warming the 
solution to room temperature, the corresponding hydroxo complex was formed. Karlin and 
co-workers followed in 2009 with an imidazole containing TMPA-derivative (Figure 17)[129], 
and in 2012 Limberg presented a tripodal ligand (17) (Figure 17) containing sterically 
demanding imidazole moieties for the stabilisation of Cu(I)- and Cu(II)-species, which showed 
an intramolecular tyrosinase-like reaction.[130] Earlier this year a follow-up study of Limberg 
et al. concerning this ligand was published[131]. There the ability of the Cu(I)17 complex was 
tested for its catalytic ability in the reaction with the exogenous substrate ditertbutylphenol 
(DTBP). Following the reaction of Cu(I)17 with O2 UV/Vis spectroscopically did not show any 
evidence of a Cu2O2 species. Intermediate formation of this species however was assumed 
because of crystallographic evidence of [17Cu(OH)(OTf)Cu17ox](OTf) (see [130]) and 
formation of the corresponding ditertbutylquinone upon additon of a large excess of DTBP 
and 2 eq. of NaDTBP to a solution of Cu(I)17, followed by treatment with O2. This reaction 
resulted in a high turnover number of 22 after 20 h, however equal amounts of the biphenol 
product were formed as well. In addition a second reaction was observed which presumably 
occurred after further reaction of Cu2O2172 with O2 in combination with the quinone and 
NaDTBP, resulting in an ester consisting of DTBP and a furanone species. This reaction is a 
dioxygenation and resembles the reaction of flavanol-2,4-dioxygenase. 
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3.1.1 Optimisation of reaction conditions for the synthesis of  
1-methyl-2-imidazolecarboxaldehyde 
The ligand synthesis follows the route of Herres-Pawlis et al.,[117] in which substituted 
pyrazoles are treated with sodium hydride and thionyl chloride, before the aldehyde 
component is added. 
The preparation of desired aldehyde component 1-methylimidazole-2-carboxaldehyde was 
tried in three different ways (Scheme 11). To begin with, 2-imidazolecarboxaldehyde was 
alkylated with methyl iodide, following the synthesis of Babich et al.[132] Thereby  
2-imidazolecarboxaldehyde is dissolved in DMF and treated with an excess of potassium 
carbonate as a base, as well as catalytic amounts of potassium iodide and equimolar 
amounts of methyl iodide. The resulting mixture is heated to 110°C over night. Extraction of 
the product was tried with ethyl acetate, but resulted in extremely low yields. Another 
approach followed an advanced route, in which reaction conditions were different and 
adapted from [133]. Here, the reaction mixture was heated to only 50°C for 5 hours and the 
amount of added base was reduced, but resulted in low yields again. GC/MS spectroscopic 
analysis showed a nearly full conversion to the dimethylated product. Expansion of the 
reaction time to two days did not show any difference. Route 3 shows a modification of the 
reactant, which was the already deprotonated imidazolecarboxaldehyde. Here, reaction with 
a slight shortage of methyl iodide resulted in 45% of the desired product, but also showed a 
high amount of dimethylated product again. 
Figure 17. Imidazolyl containing ligands applied in the activation of oxygen.[128–130] 
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In the light of these results, yet another approach was tried, where the starting compound 
was substituted by 1-methylimidazole. Applying the protocol of Brook[134], 
1-methylimidazole was deprotonated regioselectively with n-butyllithium, followed by the 
addition of an excess of DMF that functions as a synthetic equivalent of the carbonyl group, 
resulting in 60% yield (Scheme 12). 
1.2 eq K
2CO
3
2.5 eq CH
3 I
GC/M
S analysis
Scheme 12. Applied route for the synthesis of 1-methyl-2-imidazolecarboxaldehyde. 
Scheme 11. Different routes for the synthesis of 1-methyl-2-imidazolecarboxaldehyde. 
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3.1.2 Structural characterisation of HC(3-tBuPz)2(1-MeIm) and [CuCl2{HC(3-tBuPz)2 
(1-MeIm)}] 
 
Ligand L1 was prepared like mentioned above, by treating the substituted pyrazolid with 
thionylchloride, resulting in the sulfoxide. Under reflux conditions and cobalt-catalysis, 
addition of 1-methyl-2-imidazolecarboxaldehyde yielded the bis(pyrazolyl)methane ligand 
HC(3-tBuPz)2(1-MeIm) (L1) as single crystals suitable for X-ray diffraction analysis 
(Scheme 13, Figure 18). A detailed mechanism for this reaction is shown in Scheme 10 in the 
introduction. 
 
L1 crystallises triclinically in the space group P1 as clear, yellowish crystals. The apical  
C-atom is surrounded by two pyrazolyl nitrogens and one imidazole carbon in an almost 
perfect tetrahedral fashion (Table 4). Compared to other known bis(pyrazolyl)methanes, 
bond lengths are in the common range.[117] 
 
Scheme 13. Synthesis of [HC(3-tBuPz)2(1-MeIm)] (L1). 
Figure 18. Molecular structure of L1. 
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Table 4. Selected bond lengths and angles of L1. 
Bond lengths [Å]  Bond angles [°]  
Cap-NPz 
1.450(2) 
1.451(2) 
NPz-Cap-NPz 111.4(1) 
Cap-CIm 1.507(2)   
NPz-NPz 
1.358(2) 
1.367(2) 
NPz-Cap-CIm 
109.9(1) 
110.7(1) 
 
Upon reaction of L1 with CuCl2 in methanol, single crystals of [CuCl2{HC(3-tBuPz)2(1-MeIm)}] 
(C1) suitable for X-ray crystallography have been obtained from the reaction mixture. C1 
crystallises triclinically in the space group P1 as dark green crystals, containing two units per 
elementary cell (Scheme 14, Figure 19). Table 5 lists important bond lengths and angles.  
In C1, the Cu-atom is coordinated monofacially in a fourfold fashion by two chloride atoms 
and two nitrogen donors. One nitrogen donor belongs to the tertbutylpyrazolyl-moiety and 
one to the imidazolyl-moiety. The second pyrazolyl moiety is in proximity, with a Cu-NPz 
Scheme 14. Synthesis of [CuCl2{HC(3-tBuPz)2(1-MeIm)}] (C1). 
Figure 19. Molecular structure of [CuCl2{HC(3-tBuPz)2(1-MeIm)}] (C1). 
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distance of 3.41 Å, but non-coordinating, leading to a four-coordinate neutral CuCl2-
complex. 
Table 5. Selected bond lengths and angles for C1. 
Bond lengths [Å] Experimental 
Calculated 
[Gaussian09, TPSSh, 
6-31G(d)]a[135] 
Cu-Cl(1) 2.225(1) 2.240 
Cu-Cl(2) 2.251(1) 2.218 
Cu-NPz 2.044(3) 2.000 
Cu-NIm 1.957(3) 1.961 
Cap-NPz 
1.455(4) 
1.462(4) 
1.457 
1.459 
Cap-CIm 1.502(5) 1.502 
Bond angles [°]   
Cl(1)-Cu-Cl(2) 97.3(1) 103.3 
Cl(1)-Cu-NPz 98.8(1) 95.5 
Cl(1)-Cu-NIm 150.8(1) 137.4 
Cl(2)-Cu-NPz 141.7(1) 146.8 
Cl(2)-Cu-NIm 93.4(1) 94.8 
NPz-Cu-NIm 89.3(1) 89.3 
τ4
[136] 0.479 0.54 
[a] this combination was found to be the most accurate in the benchmarking 
of Cu2O2 bis(pyrazolyl)methane complexes.
[137] 
 
The Cu-NIm bond is shorter than the Cu-NPz bond and also shorter than other common Cu-
Ndonor bonds (e.g. Cu-NPy). This indicates a stronger donor-ability for the imidazole donor, 
which will be discussed later on. Bond angles around the copper atom vary from 90–150°, 
showing the distortion of the structure. Based on the crystal structure of C1, a theoretical 
structural optimisation was performed. The results are also displayed in Table 5. Comparing 
experimental and calculated bond lengths for C1, no significant deviation can be detected, 
because the only bond length predicted shorter, is the Cu-Cl(2) one. For bond angles, the 
calculations are not as accurate, but clearly show the same dispersion as in the molecular 
structure of C1. For example the NPz-Cu-NIm and Cl(2)-Cu-NIm angles are predicted almost 
correct, while all others deviate not more than 6°, excluding the Cl(1)-Cu-NIm angle. 
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3.1.3 Definition of the τ-parameter 
In order to compare coordination geometries of complexes, τ4- or τ5-values are calculated, 
depending on the number of direct bonding partners. Hereby the two largest bond angles 
around the central metal are determined and inserted into the according formula (equations 
1 and 2). Reedijk et al. defined the structural parameter τ5 in 1984.
[138] Its values can range 
from 0 to 1, 0 representing a trigonal-bipyramidal coordination-sphere and 1 a square-
pyramidal one. In 2007, Houser et al. invented a formula for a τ4-value that is based on 
equation 2.[136] τ4 also ranges from 0 to 1, with 0 indicating a square-planar geometry and 1 
being the result of a perfect tetrahedron. 
605
αβτ −=                                                                   (1)[138] 
 
°
+−°=
141
)(360
4
βατ                                                            (2)[136] 
 
The τ4-value calculated for C1 is 0.48. Thus complex C1 can only be referred to as distorted, 
as its geometry is located between tetrahedral and square-planar and cannot be assigned to 
one in particular. This is also reflected by the diverse bond angles in complex C1.  
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3.2 Efficient biomimetic hydroxylation catalysis with a 
bis(pyrazolyl)imidazolylmethanecopper-peroxide complex 
 
3.2.1 General Introduction 
All Cu2O2-compounds show very distinct spectroscopic features which are visible in UV/Vis- 
or resonance Raman spectroscopy, so that their differentiation is relatively easy. For 
bis(pyrazolyl)methane-peroxo complexes the first indicator of their formation is their colour, 
which is deep purple. Consistent with the colour, the UV/Vis spectrum shows two 
characteristic bands due to ligand to metal charge-transfer transitions (LMCTs). More 
precisely, electron density is shifted from occupied, antibonding π*-orbitals of oxygen to 
dx2-y2 orbitals of copper (Figure 20).
[31] For most Cu-peroxo complexes the two UV-bands are 
located at 350 nm and 550 nm with an intensity ratio of 20:1.[55] The stronger band stems 
from a πσ*dx2-y2 transition, which is symmetry allowed, in contrast to the πv*dx2-y2 
transition, where the orbitals have no overlap. The generally high extinction coefficents 
suggest a good σ-donor ability of the peroxide unit. Small O-O-bond frequencies that appear 
in resonance Raman spectra point to a weak O-O-bond, which can be explained by the 
partial occupation of the antibonding σ*-orbital of the peroxide, resulting from a π-
backbonding from Cu to the peroxide unit (Figure 20).[31] 
 
  
Figure 20. Electronic structure of the peroxide-Cu(II) bond in (μ-η2:η2) bridged species.adapted from[31] 
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3.2.2 Characterisation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 
3.2.2.1 UV/Vis Spectroscopy 
Analogous to the method that was introduced by Lehnert in 2006[62], the peroxo species is 
generated in situ starting from the bis(pyrazolyl)methane ligand HC(3-tBuPz)2(1-MeIm), 
which is dissolved in THF and then combined with CuCl (Scheme 15). The suspension is 
stirred for 40 min to give the CuCl-complex, before it is treated with a solution of AgSbF6, in 
order to generate a free coordination site at the copper atom, due to the non-coordinating 
SbF6
−-anion (Scheme 15).  
 
This precursor is then injected into an O2-saturated CH2Cl2-solution at −78°C (Scheme 16), 
resulting in an immediate colour change of the solution to deep purple. 
Scheme 15. Synthesis of the precursor complex [Cu{HC(3-tBuPz)2(1-MeIm)}][SbF6]. 
Scheme 16. Formation of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2). 
40 
 
The formation of the resulting peroxo
(P1[SbF6]2) is monitored via UV/Vis 
 
The species P1[SbF6]2 could be generated to 85% at 
for several days. The yield of the peroxo complex was calculated based on the extinction 
coefficient of [Cu2O2L52][SbF
completed in 10–15 min. 
The decay was measured at 0
P1[SbF6]2 follows an exponential decay of the first order. This can be descri
following formula (3): 
 
 
The half-life of a species can be calculated according to formula 
 
Figure 21. UV/Vis spectrum of [Cu
3 Results & 
 complex [Cu2O2{HC(3-tBuPz)2
spectroscopy (Figure 21). 
−78°C and is stable at that temperature 
6]2.
[125] P1[SbF6]2 is built very fast, so that 
°C; at room temperature it is too fast. Decomposition of 

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The half-life of P1[SbF6]2 was calculated to 3.8 min The UV/Vis-spectrum shows two bands at 
334 nm and at 534 nm. The deep violet colour of the solution and the existence of the UV-
bands in this region, separated by 200 nm clearly show the formation of a peroxo complex. 
As it is known from other familiar copper(II)-peroxide complexes, their UV/Vis spectra 
exhibit intense oxygen to copper charge-transfer absorptions, which are consistent with the 
presence of highly covalent Cu-O-bonds.[55] The enzymes oxyTy and oxyHc also show similar 
UV transitions.[139,140]  
 
3.2.2.2 Explanation of the UV/Vis band-shift 
A striking difference however is the blue-shift of the UV/Vis bands compared to other known 
Cu2O2-peroxo species. In order to understand this phenomenon, theoretical calculations 
were performed, including second order perturbation theory calculations of C1 and P1 
(Table 6).[141] Table 6 shows for C1 that NIm has a greater donor ability, which is reflected in 
the shorter Cu-NIm compared to the Cu-NPz bond length. This factor is assumed in P1 as well. 
However, here NBO calculations show higher CT energies for pyrazolyl. This seems to be the 
case when the imidazolyl units are located at the axial positions. This conformer (Figure 22) 
was used nevertheless for all theoretical investigations, because it is the energetically 
favourable one (see also below). Reasons behind this are under current investigation by 
Herres-Pawlis et al.[141] 
 
Table 6. Charge-transfer energies for C1 and P1. (Gaussian09, TPSSh/6-31G(d) and  
NBO 6.0).[135,137,142] 
CT energies [kcal mol−1] 
 C1 P1[141] 
NPz  Cu 21.1 36.8/38.6 
NIm  Cu 22.4 23.7/23.9 
 
Continuative theoretical investigations that were perfomed are TD-DFT calculations in order 
to predict the UV/Vis spectrum of P1[SbF6]2 and NTO analysis to show the molecular orbitals 
involved in UV transitions. 
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TD-DFT calculations were perfor
spectrum is shown in Figure
(Figure 21) and also predicts the blue
Figure 22. Theoretical model of 
31G(d). Hydrogen atoms are omitted for clarity).
Figure 23. Calculated UV/Vis spectrum of 
(TD-DFT, Gaussian09, TPSSh, 6
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med with the TPSSh/6-31G(d) combination
 23. It is in excellent agreement with the experimental one 
-shift of the UV/Vis bands. Even the intensity ratio is 
[Cu2O2{HC(3-tBuPz)2(1-MeIm)}2]
2+ (P1). (Gaussian09, TPSSh/6
[135,137,141]
[Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF
-31G(d)).[135,137,141] 
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.[137] The resulting 
-
 
6]2 (P1[SbF6]2) 
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well predicted. Figure 22 shows the model of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2, on 
which theoretical calculations were based. 1-Methylimidazolyl moieties reside on the axial 
position at the copper atoms, because this conformer is energetically more stable.  
Key parameters deduced from Gaussian calculations amongst others are bond lengths and 
atom distances of the peroxo core of P1[SbF6]2 (Table 7).
[141] 
 
Table 7. Calculated atom distances in P1 (Gaussian09, TPSSh, 6-31G(d)).[135,137,141] 
Distance [Å] Broken-symmetry Singlet 
Cu         Cu 3.572 3.530 
O-O 1.471 1.451 
 
Distances for the singlet state are slightly shorter than for broken-symmetry. Analysis of  
X-ray absorption spectra (see 3.2.2.5) shows an experimental Cu-Cu distance of 3.69(6) Å, 
which is closer to the theoretical value for broken-symmetry P1. 
Energy comparison between the singlet (μ-η2:η2)-peroxo and bis(μ-oxo) compound indicates 
a 6.16 kcal/mol more stable peroxo complex, which is also the only species that is observed 
experimentally. The energy analysis of broken-symmetry (μ-η2:η2)-peroxo versus singlet 
(μ-η2:η2)-peroxo showed a 2.96 kcal mol−1 more stable broken-symmetry state.[141] 
 
3.2.2.3 Natural transition orbital (NTO) analysis 
In order to understand the band-shifting effect in more detail, a Natural Transition Orbital 
(NTO) analysis was performed as well[141], which was introduced in 2003 by R. Martin.[143] To 
understand the benefits of NTO analysis, other common methods to analyse optical 
excitations should be mentioned here as well. 
In order to describe ground states of electronic systems, the ab initio approach (Hartree-
Fock) often is too vague and therefore is combined with semi-empirical Hamiltonians. For 
the description of excited states a similar expansion can be used, called the random-phase 
approximation (RPA). Is it applied to reference states derived from density functional theory 
(DFT) and is referred to as time-dependent DFT (TD-DFT). This method is more precise than 
the analogous method, where RPA is used on Hartree-Fock reference states. Such 
calculations result in an excitation energy, paired with several coefficients, in order to 
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determine the contribution each particle-hole pair makes to the excited state excitation 
amplitudes. Evaluation of these calculations however is often difficult, as no dominant 
configuration can be found amongst the excitation amplitudes, making it impossible to 
determine the qualitative nature of an excited state.  
Therefore Martin developed the natural transition orbital analysis, which results in a 
compact orbital representation for the electronic transition density matrix. Here a maximal 
correspondence is achieved for the excited particle and the empty hole.  
 
Calculations on the geometry-optimised coordinates were performed with the TPSSh 
functional using the broken-symmetry approach, combined with the 6-31G(d) basis set.[137] 
Figure 24 shows the results of this calculation. LUNTO stands for “Lowest Unoccupied 
Natural Transition Orbital” and symbolises the orbital that accepts electrons in the transition 
process that is investigated. In our case these are both transitions visible in the UV/Vis 
spectrum. NTO-analysis provided four electronic transitions. The ones at 326, 329 and 
374 nm unite to the transition at 334 nm in the experimental spectrum, which is pretty 
accurate as the arithmetic average of these three is 343 and therefore only 9 nm above the 
Figure 24. NTO-analysis of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2]
2+ (P1).[141] 
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experimental value. The second transition is predicted very well too, as the deviation to the 
experimental value is only 4 nm. Each NTO consists of fractions of several orbital types of 
copper and the oxygen-peroxide unit. The LUNTO for example is composed of πσ* orbital 
parts at the oxygen atoms and dxy orbitals at the copper atoms. The less intensive transition 
at 534 nm originates from an NTO showing oxygen πv* and Cu dxy characteristics (NTO 4). 
For NTOs 1–3 it is not as easy to see the parts contributing to the transition orbital. NTO 1 
shows elements of πσ* at the oxygen atoms and of dxz at copper. In NTO 2 the same applies, 
with an additional O-σ* fraction mixed in. NTO 3 does not incorporate any O-orbital parts, 
but shows participation of the ligand. This π-contribution has been observed before and was 
assigned to a pyrazolyl/pyridinyl (in this case pyrazolyl/imidazolyl) π*dxy transition.
[18,144] 
 
3.2.2.4 Mass spectrometry 
Further analyses of P1[SbF6]2 included cryo-UHR ESI mass spectrometry (Figure 24), which 
confirms the formation of a (μ-η2:η2)-copper(II)-peroxo core. These measurements have 
been performed at the FAU University of Erlangen-Nürnberg in collaboration with Prof. Dr. 
Ivana Ivanović-Burmazović.[145] 
Table 8 displays the main species contributing to the mass spectrum. The different isotopes 
of carbon, copper and antimony are taken into account. 
 
Table 8. Most important isotopes of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]
+. 
Total formula m/z (calculated) 
C38H56
63Cu2N12O2
121SbF6 1073.2184 
C37
13CH56
63Cu2N12O2
121SbF6 1074.2217 
C38H56
63Cu65CuN12O2
121SbF6 
C38H56
63Cu2N12O2
123SbF6 
1075.2166 
1075.2188 
C37
13CH56
63Cu65CuN12O2
121SbF6 
C37
13CH56
63Cu2N12O2
123SbF6 
1076.2199 
1076.2221 
C38H56
63Cu65CuN12O2
123SbF6 1077.2170 
C37
13CH56
63Cu65CuN12O2
123SbF6 1078.2203 
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Figure 25 shows the excellent accordance of calculated and experimental ESI mass spectra.  
 
3.2.2.5 X-ray absorption spectroscopy[146,147] 
Alongside the analytical methods mentioned above, X-ray absorption spectroscopy was 
performed on a 10 mM CH2Cl2 solution of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 in 
collaboration with Prof. Dr. M. Bauer (University of Paderborn) at the beamline BM23 of the 
European Synchrotron Radiation Facility ESRF in Grenoble.[148] Two different X-ray 
absorption modes (XANES and EXAFS) provide conclusive evidence concerning the oxidation 
state of copper, as well as atom distances in the peroxide complex. 
XAS spectroscopy is element specific, because every element has its own distinct absorption 
edge. The absorption edge symbolises a drop in the transmitted X-ray energy, which arises, 
when the X-ray energy matches the binding energy of an electron of an atom in the sample, 
which at once increases the amount of absorbed X-rays.[149] 
Figure 25. Cryo UHR-ESI mass spectrum of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]
+.[145] 
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Figure 26 shows the Cu K-edge XANES spectrum of sample P1. XANES stands for "X-ray 
Absorption Near Edge Structure", which analyses the X-ray absorption really close to the 
absorption edge.  
The principle behind this measurement method is the absorption of an X-ray photon by the 
condensed matter of the sample, generating a core hole. This excited state has a very short 
life-time and the core hole is again filled with an electron from another level followed by 
emission of fluorescence or an Auger electron. Auger electrons are energetic electrons 
emitted from an excited atom after a series of internal relaxation events. 
Figure 26 displays a signal at 8978 eV, which is of low intensity. This points to the dipole-
forbidden 1s-3d quadrupole transition, which is characteristic of Cu(II).[150–152] At 8937 eV 
only a weak shoulder is visible. This possible 1s4p+LMCT shake-down transition[153] would 
show a sharp signal for the oxidation state +3, which therefore is ruled out. Furthermore 
Solomon et al. and Meyer et al. have observed a similar white line morphology for dinuclear 
(µ-η2:η2) side-on complexes.[60,154] All in all the features of the XANES spectrum displayed in 
Figure 26 lead to the conclusion of an oxidation state for copper of +2. 
Figure 26. Cu K-edge XANES spectrum of P1[SbF6]2.
[148] 
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The EXAFS spectrum and the according Fourier transformed function of P1 are given in 
Figure 27 and the extracted structural parameters are listed in Table 9. The abbreviation 
EXAFS stands for "Extended X-Ray Absorption Fine Structure", which analyses, as the name 
suggests, the edge-near fine structure. This method gives information about the number, 
type and distance of neighbouring atoms. 
In Figure 27 four peaks can be seen. At an average distance of 1.99 Å the oxygen atoms 
composing the peroxo core and the ligand’s nitrogen atoms are located. At 2.92 and 3.37 Å 
two more combined ligand C/N shells give a signal in the r-space, which is in reasonable 
agreement with the calculated structure for P1. The dimeric structure of P1 in solution is 
proven by a Cu-Cu distance of 3.69 Å. Higher distance multiple scattering shells were 
removed by Fourier filtering.[152,154] 
Table 9. Structural parameters obtained by fitting the experimental EXAFS functions with 
theoretical models.[148] 
 Abs-Bsa N(Bs)b r(Abs-Bs)c [Å] σd [Å] Re [%] 
P1[SbF6]2 Cu-N/O 
Cu-C/N 
Cu-C/N 
Cu-Cu 
5.4 ± 0.5 
1.4 ± 0.2 
4.6 ± 0.9 
1.3 ± 0.4 
1.99 ± 0.02 
2.92 ± 0.03 
3.37 ± 0.03 
3.69 ± 0.06 
0.063 ± 0.006 
0.032 ± 0.003 
0.112 ± 0.012 
0.110 ± 0.033 
15.05 
aAbs=X-ray absorbing atom, Bs=backscattering atom (neighbour). bNumber of neighbour atoms. 
cDistance between Abs and Bs. dDebye-Waller like factor to account for disorder. eQuality of fit. 
Figure 27. Filtered Fourier backtransformed Cu K-edge EXAFS spectrum (black solid line: 
experiment, grey dashed line: fitted function) of P1[SbF6]2.
[148] 
 
3.2.3 Catalytic studies on P1[SbF
Functional enzyme models not only need to incorporate a model of the active centre of the 
enzyme, but also be able to execute the catalytic reactions of those. 
o-form of tyrosinase again, depicting
on each copper atom. Based on this structure, the model complex 
possible reaction mechanism for 
by such complexes is shown in 
order to deprotonate the substrate before its reaction with the 
this auxiliary base has been established by Réglier 
H
O
O
LCu CuL
O
NEt3 H2O
HNEt3
Figure 28. Structure of the active site of tyrosinase. 
red: Oxygen.[34] 
Scheme 17. Proposed reaction pathway for model complexes of tyrosinase. 
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It was previously shown that an inner-sphere oxygen atom transfer (OAT) mechanism is 
present in the catalytic cycle of tyrosinase.[31,46,53,155] Thereby, selective ortho-oxygenation of 
phenols is the result of an inner-sphere OAT between the (μ-η2:η2)-peroxodicopper(II) core 
and a phenolate. The other possible reaction way for OAT would be an outer-sphere 
pathway, which would generate free radicals leading to a C-C coupled product (Scheme 18) 
and neither to a catechol, nor a quinone. Therefore functional models for tyrosinase would 
have to be able to catalyse the reaction of phenols to quinones without the generation of C-
C coupled byproducts.  
Lumb et al. recently also studied catalytic reactions of substituted phenols with Cu(I)-
iminopyridine ligand systems and O2 as a tool for organic synthesis. They showed that in 
these reactions para-substituted phenols with moieties of different steric demands 
furnished meta-C-O-coupled quinones (Figure 29).[80,156] These possible reaction products 
have to be taken into account in our studies as well.  
Scheme 18. Competitive pathways in catalytic aerobic oxidations of phenols.adapted from [156] 
Figure 29. Reaction of para-substituted phenols with oxygen under Cu-catalysis.[80] 
 
3.2.3.1 Catalytic oxidation of phenols to quinones
The ability to convert phenolic sub
p-methoxyphenol and 50 eq of triethylamine.
45 min and 2 eq in 18h (Table
This catalytic activity was calculated applying Lambert Beer’s rule with an 
coefficient for the quinone of 17
by UV/Vis spectroscopy, due to the strong UV band 
dione at 418 nm (Figure 30). 
 
Addition of 25 eq of 8-hydroxyqu
pressure of 1 atm, leads to the formation of 14
formation of the quinone naphthalene
followed UV/Vis spectroscopically
Lambert Beer’s rule with an extinction coefficient for the quinone of 1000
 
 
Figure 30. UV/Vis spectrum of the formation of [Cu
and the formation of the quinone (blue)
Lambert Beer’s law due to high concentration.
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Table 10. Catalytic efficiency of [
Substrate 
p-Methoxyphenol
8-Hydroxyquinolin
 
Table 10 depicts an overview of the catalytic efficiency of 
8-hydroxyquinoline is processed extremely 
is already reached after 20 
efficiency can be observed; after 1
The substrate p-methoxyphenol however is converted much slower 
maximum TON of 2. Here a TON of
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Figure 31. UV/Vis spectrum of the formation of [Cu
and the formation
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dione are most likely subsequent reactions of the highly reactive quinones. Concerning this, 
Lumb as well as Limberg showed some possible side reactions.[80,131,156] 
 
3.2.3.2 Stoichiometric catalysis investigations 
For stoichiometric conversions with 5 eq of each substrate, the generation of the respective 
catechol was proven at −80°C (Table 11). An H-substituted substrate, as well as one 
containing an electron withdrawing substituent and one containing an electron donating 
substituent were tested. Evaluation of NMR data proves over 95% of formed catechol for the 
unsubstituted and the electron-donating OMe-substituted phenolate. For the NO2-
substituted phenol 60% of catechol were obtained, which is also a good conversion, 
considering the electron-withdrawing effect of the nitro substituent. Neither stoichiometric 
substrate reaction showed signs of a C-C coupling product, so that a reaction mechanism 
analogous to tyrosinase can be anticipated. 
 
Table 11. Yield of catechol after treatment of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 with 
stoichiometric amounts of para-substituted phenol. 
 
R Eqivalents Reaction time % Catechol 
H 5 5 min > 95 
OMe 5 5 min > 95 
NO2 5 60 min 60 
 
  
O Na+
R
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3.2.4 Summary  
The new bis(pyrazolyl)methane ligand L1 was synthesised and reaction of L1 with CuCl2 gave 
the distorted tetrahedral complex C1. This coordination is unusual for monofacial 
bis(pyrazolyl)methane complexes, which are usually five-coordinate. In C1 one pyrazolyl 
moiety is pushed away from the central metal and does not coordinate, which is seen as a 
first indicator for the strong donor ability of imidazole. DFT calculations of bond lengths in C1 
confirmed this and an additional second order perturbation NBO analysis proved a larger 
charge-transfer energy for NImCu compared to NPzCu as well.  
The according Cu(I) complex of C1 was used as a precursor for the activation of oxygen. 
Hereby AgSbF6 was added to the in-situ formed Cu(I) compound, which was then treated 
with oxygen. UV/Vis spectroscopic analysis showed two characteristic LMCT bands at 334 
and 534 nm, indicating the formation of a (µ-η2:η2)-peroxo compound (P1[SbF6]2). It is fully 
generated in 10–15 min and has a half-life at 0°C of 3.8 min Additional analytic methods, 
such as XAS spectroscopy and cryo-ESI spectrometry verified the existence of a (µ-η2:η2)-
Cu2O2 core. 
TD-DFT and NTO calculations predicted the experimentally measured UV/Vis bands well. In 
comparison to other known copper peroxo species, these bands are blue-shifted about 
15 nm. This effect was explained by the stronger NIm donation, which leads to an increase of 
the LUMO orbital, resulting in an energetically larger LMCT transition.[70] 
Based on the formation of the peroxo complex, this compound was treated with phenolic 
substrates in order to investigate its catalytic capacity in analogy to tyrosinase. At −80°C 
stoichiometric (5 eq) amounts of nitrophenolate, 4-methoxyphenolate and phenolate were 
reacted with P1[SbF6]2 and the amount of generated catechol was determined by NMR 
analysis. Here, for activated and unsubstituted phenolates a yield of over 90% of catechol 
was found and for the deactivated phenolate 60%. The absence of NMR signals indicating a 
C-C coupling product proved a reaction mechanism analogous to tyrosinase. In addition 
catalytic amounts of 4-methoxyphenol and 8-hydroxyquinoline together with the auxiliary 
base NEt3 were added to P1[SbF6]2 at room temperature and UV/Vis spectra showed the 
formation of the according quinones. Catalytic conversion with 8-hydroxyquinoline was 
quick and efficient with a maximum TON of 14, but showed a slow decay over time, while 
conversion with 4-methoxyphenol was much slower. 
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3.3 Biomimetic hydroxylation catalysis through self-assembly 
of a bis(pyrazolyl)methanecopper-peroxo complex[160] 
 
3.3.1 Structural characterisation of bis(pyrazolyl)methanecopper complexes 
It was mentioned in the introduction that heteroscorpionate ligands can generate different 
coordination modes, depending on the nature of the ligand (mostly concerning its steric 
demands) and the oxidation state of the metal (Figure 16). Concerning this subject, 
experiments with the bis(pyrazolyl)methane ligands HC(3-tBuPz)2(Py) (L5) and HC(3-
tBuPz)2(Qu) (L2) and Cu(I) as well as Cu(II) salts were performed. L2 and L5 were 
resynthesised according to Herres-Pawlis et al.[117] The crystal structures of the resulting 
complexes C2−C4 will be discussed in the following. 
Independent dissolving of CuCl and L2, followed by their combination affords [CuCl{HC(3-
tBuPz)2(Qu)}] as crystals suitable for X-ray diffraction analysis (C2, Scheme 19, Figure 32). 
 
Figure 32. Molecular structure of [CuCl{HC(3-tBuPz)2(Qu)}] (C2). 
Scheme 19. Synthesis of [CuCl{HC(3-tBuPz)2(Qu)}] (C2). 
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C2 crystallises in the orthorhombic space group Pnma as red crystals in which the central 
atom is coordinated in a fourfold fashion by two pyrazolyl nitrogen atoms and one quinolinyl 
nitrogen atom (Figure 32). Further coordination aspects will be discussed later on (see 
Tables 12/13). 
Conversion of the bis(pyrazolyl)pyridinylmethane ligand HC(3-tBuPz)2(Py) (L5) with CuCl 
furnished the product C3 (Scheme 20, Figure 33) as yellow crystals.  
C3 crystallises in the monoclinic space group P21/c with two slightly different conformers in 
the elemental cell, referred to as C3a and C3b. Similar to C2 the copper atom is coordinated 
four-fold, this time by two pyrazolyl nitrogen atoms and the pyridinyl nitrogen atom. 
Selected bond lengths and angles are listed in Tables 10 and 11. 
Figure 33. Molecular structures of [CuCl{HC(3-tBuPz)2(Py)}] (C3a, b). 
Scheme 20. Synthesis of [CuCl{HC(3-tBuPz)2(Py)}] (C3a, b). 
CuBr2, methanol
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Scheme 21. Synthesis of [CuBr2{HC(3-tBuPz)2(Py)}] (C4). 
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The Cu(II) salt CuBr2 affords [CuBr2{HC(3-tBuPz)2(Py)}] (C4) (Scheme 21, Figure 34), when 
treated with L5 in methanol.  
 
C4 also crystallises in the monoclinic space group P21/c as dark green crystals. In C4 the 
copper atom is surrounded by five ligands, three of which belong to the 
bis(pyrazolyl)methane ligand (one pyridinyl nitrogen atom and two pyrazolyl nitrogen atoms) 
and the two bromide anions of the Cu(II) salt. Selected bond lengths and angles are listed in 
Tables 12 and 13. 
Figure 35 shows the molecular structure of [CuCl2{HC(3-tBuPz)2(Py)}] (comparing complex 
CC4), which was synthesised by A. Hoffmann from CuCl2 and HC(3-tBuPz)2(Py) (L5).
[125]  
Figure 34. Molecular structure of [CuBr2{HC(3-tBuPz)2(Py)}] (C4). 
Figure 35. Molecular structure of CC4.[125]
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Table 12. Selected bond lengths [Å] of C2–C4 and CC4. 
Bond lengths [Å] C2
a C3aa C3ba C4b CC4a 
Cu-NPz 2.124(2) 
2.106(2) 2.082(2) 2.117(6) 
2.233(3) 
2.183(2) 2.120(2) 2.421(6) 
Cu-NPy 
Cu-NQu* 
2.149(2)* 2.120(2) 2.132(2) 2.051(6) 2.058(4) 
Cu-X 2.215(1) 2.199(1) 2.187(1) 
2.388(1) 2.225(2) 
2.409(1) 2.267(1) 
Cap-NPz 1.456(2) 
1.449(3) 1.450(3) 1.441(9) 
1.448(3) 
1.449(3) 1.460(3) 1.458(9) 
Cap-CPy 
Cap-CQu* 
1.511(4)* 1.519(4) 1.507(3) 1.503(10) 1.515(6) 
[a] X = Cl, [b] X = Br 
 
All four complexes are coordinated by only one heteroscorpionate ligand, due to steric 
shielding of alkyl groups in the 3-position of the pyrazolyls.[112,161]  
Table 13 includes the τ-value, that provides an easy determination of the coordination mode 
around the metal centre and was explained earlier.[136,138] All relevant crystallographic data 
are collected in Table 30 and Table 31 in the appendix.  
In C2 and C3 the metal ion is four-coordinate, displaying a distorted tetrahedral geometry 
(Figure 32, Figure 33), with nearly identical τ-values. Bond angles deviate more from the 
ideal tetrahedral angle in C2. In both complexes C2 and C3b, Cu-NPz bond lengths are shorter 
than the corresponding Cu-NPy or Cu-NQu bond lengths, which is in contrast to C3a, C4 and 
CC4. In general bis(pyrazolyl)methane complexes show a donor competition between their 
N-donors which appears here again.[76,162] This effect is discussed in more detail in the next 
paragraph. As for the Cu-Cl bond length, it is shorter in C3 than in C2.  
In C4 and CC4 the metal ion is five-coordinate, resulting in a distorted square pyramidal 
geometry for C4 and a distorted trigonal-bipyramidal one for CC4 (Figure 34, Figure 35). Both 
in C4 and in CC4, Cu-NPy bond lengths are shorter than the corresponding Cu-NPz ones. It is 
difficult to determine, which nitrogen is the stronger donor, as basicity and nucleophilicity 
have to be taken into account. Normally the donor-competition is won by pyrazolyl (see C2 
and C3 with distorted tetrahedral environment), but in C4 and CC4 with fivefold coordination 
it is the other way round. The sterically demanding tertbutyl groups may hinder the pyrazolyl 
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unit on getting closer to the metal ion. The Cu-Cl bond length in CC4 is naturally shorter than 
the Cu-Br bond length in C4, which is in agreement with common Cu-X bond lengths. The 
NPz-Cu-Cl(1)/NPz-Cu-Br(1) and NPz-Cu-Cl(2)/NPz-Cu-Br(2) bond angles reflect, (as already 
suggested by the τ-values) that C4 is distorted and cannot be assigned to a specific geometry 
and that CC4 is of distorted trigonal-bipyramidal geometry. For CC4 the pyridinyl N-donor 
and Cl(2) reside at the axial positions, whereas the two pyrazolyl N-donors and Cl(1) form 
the equatorial positions. Capical-NPz bond lengths are equal for C4 and CC4.  
 
Table 13. Selected bond angles [°] of C2–C4 and CC4 and according τ-values. 
Bond angles [°] C2
a C3aa C3ba C4b CC4a 
NPz-Cu-X(1) 
124.2(1) 130.0(1) 130.9(1) 115.2(2) 133.6(1) 
124.2(1) 127.2(1) 129.3(1) 151.7(2) 133.6(1) 
NPz-Cu-X(2) / / / 
93.5(2) 93.5(2) 
95.2(2) 93.5(1) 
NPy-Cu-X(1) 
NQu-Cu-X(1)* 
129.2(1)* 121.5(1) 118.1(1) 92.2(2) 93.3(1) 
NPy-Cu-X(2) 
NQu-Cu-X(2)* 
/ / / 176.6(2) 175.9(1) 
NPz-Cu-NPz 89.1(1) 90.5(1) 86.6(1) 92.1(2) 92.2(2) 
NPz-Cu-NPy 
NPz-Cu-NQu* 
89.1(1)* 88.5(1) 90.8(1) 83.2(2) 83.8(1) 
89.1(1)* 86.0(1) 88.7(1) 83.7(2) 93.8(1) 
X(1)-Cu-X(2) / / / 90.6(1) 90.8(1) 
τ4
[136], τ5*
[138] 0.76 0.73 0.71 0.42* 0.71* 
[a] X = Cl, [b] X = Br 
 
In addition to structural investigations, density functional theory calculations were 
performed in order to analyse the coordination of all four complexes. The TPSSh functional 
in combination with the double-zeta basis set 6-31G(d) was used, since this combination 
yielded good results in the benchmarking of Cu2O2 complexes.
[137] Key geometric parameters 
of the theoretical calculations of C2–C4 and CC4 are listed in Tables 12 and 13. These data 
show that another conformer was found for C3, which is reflected by the significantly 
smaller NQu-Cu-Cl angle, so that these data are not discussed in this section. All attempts to 
find the other conformer failed. However the experimental structure of C2 is in good 
agreement with the theoretical values for bond lengths and angles. Only the Cu-NQu bond 
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length is predicted a bit too short. The NPz-Cu-NPz and NQu-Cu-NPz angles are predicted about 
4° too large. Moreover the NQu-Cu-Cl(1) bond angle is predicted too small, but the NPz-Cu-
Cl(1) angle is in good agreement with the experimental data. For the five-coordinate 
complexes C4 and CC4 it can be seen, that the theoretical data are in accordance with the 
experimental data as well. In complex C4 all relevant bond lengths are predicted well. The 
mirror plane in CC4 is also found for the ground state calculation. In CC4, with the exception 
of the Cu-NPz bond length, which is predicted too short, all other bond lengths conform to 
the experimental data. Looking at the bond angles in complexes C4 and CC4, it strikes, that 
the NPz-Cu-Cl(1) and NPz-Cu-Cl(2) angles in CC4 are predicted quite well, whereas the 
corresponding angles in C4 are predicted either too large or too small. With the exception of 
the NPy-Cu-Cl(2) angle, which is predicted too small, the remaining bond angles are predicted 
3–8° too large with the one other exception of the NPz-Cu-NPy angle in C4.  
 
Table 14. Calculated key bond lengths [Å] of C2–C4 and CC4 (Gaussian09, TPSSh/6-31G(d)).[135,137] 
Bond lengths [Å] C2a C3a C4a CC4a 
Cu-NPz 2.011 1.982 
2.071 
2.397 
2.161 
Cu-NPy/ 
Cu-NQu* 
1.975* 2.009 2.056 2.060 
Cu-X 2.262 2.243 
2.342 
2.352 
2.274 
2.264 
Capical-NPz 1.458 1.460 
1.459 
1.449 
1.453 
Capical-CPy/ 
Capical-CQu* 
1.522* 1.524 1.521 1.520 
[a] X = Cl, [b] X = Br 
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Table 15. Calculated key bond angles [°] of C2–C4 and CC4 (Gaussian09, TPSSh/6-31G(d)).[135,137] 
Bond angles [°] C2
a C3a C4a CC4a 
NPz-Cu-X(1) 122.7 130.0 
121.6 
138.9 
130.2 
NPz-Cu-X(2) / / 
87.4 
90.7 
90.4 
NPy-Cu-X(1)/ 
NQu-Cu-X(1)* 
122.4* 106.3 163.2 168.6 
NPy-Cu-X(2)/ 
NQu-Cu-X(2)* 
/ / 95.8 93.0 
NPz-Cu-NPz 93.7 94.1 98.6 98.2 
NPz-Cu-NPy/ 
NPz-Cu-NQu* 
93.8* 92.2 
77.7 
84.0 
82.1 
X(1)-Cu-X(2) / / 98.6 98.4 
τ4, τ5* 0.81 0.88 0.41* 0.64* 
[a] X = Cl, [b] X = Br 
 
Regarding τ-values, predicted and experimental ones coincide well. For C4 experimental and 
calculated τ-values match almost exactly. For C3a a comparison would not make sense, as 
different conformers were found. The geometry of C2 is predicted a bit more distorted 
tetrahedral as observed experimentally. For CC4 the calculated τ5-value identifies a slightly 
less distorted trigonal-bipyramidal geometry than the experimental data suggests.  
Additionally, NBO analyses were performed of the optimised structures of C2–C4 and CC4 
(Table 16).[142,163,164] The second order perturbation theory yields the charge-transfer 
energies for the donation from the pyrazolyl or pyridinyl units to copper. 
 
Table 16. Charge-transfer energies [kcal mol−1] for C2–C4, as well as CC4 and P2 (Gaussian09, 
TPSSh/6-31G(d) and NBO 6.0).[135,137,142] 
CT energies C2 C3a
a C4 CC4 P2 
      
NPzCu 32.4 29.7 17.9 14.4 39.2 
NPzCu 32.4 27.0 8.5 14.4 32.2 
NPy/NQu*Cu 32.5* 24.2 18.4 17.4 17.2* 
[a] data obtained directly from crystal structure (unoptimised) 
 
At a glance it can be seen that the charge-transfer energies mostly correlate with the M-N 
bond lengths. Both four coordinate complexes [CuCl{HC(3-tBuPz)2(Qu)}] (C2) and [CuCl{HC(3-
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tBuPz)2(Py)}] (C3a) show similar charge-transfer energy values. Additionally, in C2 the bond 
lengths for the Cu-NPz and Cu-NQu bond are similar, which is also reflected in the similar 
values for the charge-transfer energies. Different charge-transfer energies concerning the 
NPz-M bond are represented by different NPz-M bond lengths. In C3a the charge-transfer 
energy of pyridinyl to copper is smaller than the respective energy for pyrazolyl. This does 
not correlate with the medium-long Cu-NPy bond. A better correlation is found in 
[CuBr2{HC(3-tBuPz)2(Qu)}] (C4) and [CuCl2{HC(3-tBuPz)2(Qu)}] (CC4). Charge-transfer 
energies for NPz-Cu are different in C4, which is in accordance with different Cu-NPz bond 
lengths. The donor ability is predicted slightly higher for pyridinyl, therefore the Cu-NPy bond 
length should be shorter than the Cu-NPz bond length, as found experimentally. In CC4 the 
charge-transfer energies are exactly the same for both pyrazolyl-M interactions. Theoretical 
calculations showed equal Cu-NPz bond lengths due to the mirror plane in CC4, so the values 
for the charge-transfer energy tie in with that. Moreover the charge-transfer energy for 
pyridinyl is slightly larger than for pyrazolyl, which again reflects in the shorter Cu-NPy bond 
length. To sum it up, the NBO analysis shows that for the five-coordinate complexes 
[CuBr2{HC(3-tBuPz)2(Qu)}] (C4) and [CuCl2{HC(3-tBuPz)2(Qu)}] (CC4), the pyridinyl units 
donate slightly more than the pyrazolyl units, but exactly the opposite applies for 
[CuCl{HC(3-tBuPz)2(Py)}] (C3a). Therefore, here the donor rivalry between pyrazolyl and 
pyridinyl/quinolinyl that has been observed before can be seen clearly.[162]  
 
3.3.2 Biomimetic hydroxylation catalysis through self-assembly of  
[Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2 
Self-assembly is a principle that can for example be found in the field of chemistry, 
biochemistry or material science. The term stands for the autonomous organisation of an 
unordered system without human intervention. 
Scheme 22. Oxygenation of Cu(I)-tris(1,2-dimethyl-1H-imidazole) in 2-MeTHF.[144] 
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Common examples in biochemistry are the aggregation of micelles and lipid bilayers or the 
formation of double-stranded DNA. These systems elegantly show the balance of enthalpy 
and entropy in living systems.[144,165] 
An illustrative model for the concept of self-assembly in biochemistry is the tobacco mosaic 
virus (TMV).[166] It is a helical virus particle that is composed of 2130 identical subunits, each 
containing 158 amino acids, which form a helical sheath around an RNA strand.[167] The 
remarkable thing about the TMV system is that the assembling of the complete structure 
may be coded for in a gene of 500 bp length, which is only 8% of the overall virus genome, 
showing the economical aspect of self-assembly. 
As Whitesides mentioned in 2002, the term of self-assembly has been stretched and 
overused for many different processes over the years. Here, we will focus on systems that 
comply with his definition for self-assembly (“…,we limit the term to processes that involve 
pre-existing components (separate or distinct parts of a disordered structure), are reversible, 
and can be controlled by proper design of the components”[165]). Whiteside also states that 
self-assembly reflects information such as shape or surface properties in individual 
components, which determine the interactions amongst them. Therefore it is important for 
chemists to design components that organise themselves into desired patterns and 
functions. In 2012, concerning the goal of building a model complex for tyrosinase Stack et 
al. introduced the term self-assembly using very simple monodentate imidazole ligands, 
Cu(I) and O2 at −125°C, resulting in a (μ-η
2:η2)-peroxo species (independent on the order of 
component addition) that was also able to hydroxylate different phenolic substrates 
(Scheme 22).[144] The phenolic substrate however had to be added after the self-assembly of 
the peroxo compound in an extra step. 
Based on the formation of complex C2, catalytic studies were performed with the ligand 
HC(3-tBupz)2(Qu) (L2). 
O2+
Cu
HC NN
N N
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Scheme 23. Synthesis of [Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2 (P2[SbF6]2). 
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C2 was used as a building block for the 
to its insolubility, C2 could not be used directly, but had to be generated 
starting compounds. The resulting species was hence treated with AgSbF
the precursor [Cu{HC(3-tBuPz)
injected into an O2-saturated CH
Following injection of the corresponding Cu(I) precursor
tBuPz)2(Qu)}2][SbF6]2 (P2[SbF6
 
After UV/Vis spectrocopical analysis it
the peroxo species was only formed to 80% after 8
the decay of P2[SbF6]2. The spectrum shows a band at 345
one at 550 nm (due to the low peroxo concentration)
transitions. They are in good analogy with the UV/Vis
oxy-hemocyanin.[139] Additional bands in the area of 305
transitions. 
Further analyses involved the determination of the kinetics for the formation of the peroxo 
compound. It could be shown that for the first 250 minutes the reaction follows a pseudo 
first-order-kinetics with a reaction rate of 
Figure 36. UV/Vis spectrum of [Cu
black: theoretical[141]) and the final UV/Vis spectrum of
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precursor in the activation of oxygen. However, due 
2(Qu)}][SbF6] could be obtained. This precursor was then 
2Cl2-solution at −78°C (Scheme 23). 
, the peroxo species 
]2) was allowed to build at −80°C for several hours.
 was observed that the reaction is very slow, so that 
 h. Longer reaction times 
 nm and an almost not identifiable 
. These two bands stem from LMCT 
-bands found for oxy
–320 nm originate from intra
k = 5.4  10−3 s−1 (Figure 37). It is assumed that the 
2O2{HC(3-tBupz)2(Qu)}2][SbF6]2 (P2[SbF6]2) (
 the formation of the quinone in t
self-assembly mode (green)[168]. 
 
in-situ from the 
6 immediately and 
[Cu2O2{HC(3-
 
however lead to 
-tyrosinase and 
-ligand 
red: experimental,  
he 
 
speed-limiting step is the attachment of the oxygen to one copper core, resulting in a 
superoxide intermediate species, before
core already decays at −78°C with 
 
By using the self-assembly approach, an astonishing catalytic activity in
hydroxylation of the substrate 
quinone using the new [Cu2O2
In spite of the low stability of the 
copper(I) precursor, 25 eq. of 4
addition of oxygen, following the protocol of Tuczek 
subsequent oxidation yields the biomimetic quinone product
UV/Vis spectroscopy owing to its intense absorption a
1h could be monitored. This shows that the 
during oxygenation. The direct capture of the species 
possible. However, the formation of 
compete with the decay. This result shows that bis(pyrazolyl)pyridinylmethane copper 
complexes possess a large potential for further catalytic hydroxylation applications in 
synthetic organic chemistry. 
Figure 37. Pseudo-first order plot for the determination of the rate constant of the formation of P1.
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 the peroxo complex is built. After formation, the 
t1/2 of 1.46 min at 0°C. 
para-methoxyphenol and subsequent oxidation to 
{HC(3-tBuPz)2(Qu)}2][SbF6]2 system was observed.
P2 species, when all components were combined 
-methoxyphenol, 50 eq. of triethylamine
et al.[78] the hydroxylation and 
, which can be observed by 
t 418 nm. Hereby, 
P2 species has formed as a reactive intermediate 
P2 at room temperature was not 
P2[SbF6]2 and phenol hydroxylation is fast enough to 
Red: linear fit (R = 0.997) 
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3.3.3 Theoretical investigations 
Moreover natural bond orbital (NBO), TD-DFT (Figure 36) and natural transition orbital (NTO) 
calculations were carried out for the peroxo complex, in order to understand the bonding 
situation in this species, and furthermore to gain insight into the electron transitions that 
generate the UV/Vis bands. 
 
 
NTO analysis[169] of the UV/Vis transitions (Figure 38) obtained by time-dependent DFT (TD-
DFT, TPSSh/6-31G(d))[135,137] reveals the visible transition at 550 nm as the classical out-of-
plane πv*dxy LMCT with its lower intensity. With regard to symmetry and composition it is 
in accordance with the classical Cu2O2 theory.
[31] The broad shoulder stems from a transition 
originating from pyrazolyl π- and quinolinyl σ-donating orbitals into the same LUNTO. This is 
in accordance with the NTO analysis performed for the original pyridinyl peroxo system.[18] In 
comparison to the NTO analysis of P1[SbF6]2 (Figure 24) more NTOs contribute to the 
transition of the smaller wavelength, which is due to the quinolinyl moiety. So in this case 
NTOs 1–3 combine to the transition at 350 nm and NTOs 4–6 result in the transition at 
550 nm. NTOs 1–3 all have O2
2−-πσ* and Cu-dxz character, while NTOs 5–6 have Cu-dyz and 
O2
2−-πv* character in common. NTO 4 however shows Pz-π, Qu-σ and Cu- 2zd  properties. 
Figure 38. NTO-analysis of [Cu2O2{HC(3-tBuPz)2(Qu)}2]
2+ (P2).[141] 
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The UV transitions all have mixed character, being transitions between the in-plane πσ* 
orbital and the ligands into the dxy copper orbital. In P2, the pyrazolyl units donate stronger 
to copper than the quinolinyl units (Table 14). 
 
3.3.4 Summary 
Three new bis(pyrazolyl)methane copper(I) and copper(II) complexes, containing the ligands 
HC(3-tBuPz)2(Py) (L5) and HC(3-tBuPz)2(Qu) (L2) were synthesised (C2–C4). All four 
complexes are coordinated by only one heteroscorpionate ligand, due to steric shielding of 
alkyl groups in the 3-position of the pyrazolyls.[112,161] C2 and C3 have distorted tetrahedral 
geometry and C4 has a distorted square-pyramidal one. Bond lengths and angles were 
calculated too, with τ-values being predicted well.  
The donor situation was studied by NBO analysis, but no clear picture was found. Depending 
on the coordinative situation, both pyrazolyl and pyridinyl units can function as the stronger 
donor. 
In situ generated C2 serves as part of a precursor that can be used for the activation of 
oxygen in the modelling of the enzyme tyrosinase by formation of the peroxide species 
P2[SbF6]2. A self-assembly approach was tested successfully, showing catalytic hydroxylation 
catalysis by P2[SbF6]2 of phenols, resulting in a TON of 10 after 1h. 
 
Comparison of [Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2) and 
[Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2 (P2[SbF6]2): 
 
Looking back at the last two chapters, several differences between the two copper(II) peroxo 
species that were characterised (P1[SbF6]2 and P2[SbF6]2) can be determined. In the 
following the two are compared concerning their properties. 
The first and most prominent difference to notice is the blue-shift in the UV/Vis bands of 
P1[SbF6]2 compared to P2[SbF6]2. In general, (µ-η
2:η2)-peroxo complexes show LMCT-
transitions at 350 and 550 nm, which is the case for P2[SbF6]2 and also for the already 
mentioned [Cu2O2{HC(3-tBuPz)2(Py)}2][SbF6]2 ([Cu2O2(L5)2][SbF6]2).
[18,139] Because of that it 
can be deduced that the pyridinyl and quinolinyl moieties have similar electronic properties, 
due to a similar electronic structure of the ligands HC(3-tBuPz)2(Py) (L5) and HC(3-
tBuPz)2(Qu) (L2). The 1-methylimidazolyl moiety in L1 however increases the electron 
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density at this ligand, which was proven by NBO analysis (see 3.2.2.3). The stronger donor 
ability of the imidazolyl nitrogen atom was therefore defined as the reason for the shorter 
Cu-NIm bond length in the complex C1. 
In addition to the shifted UV/Vis transitions, differences can also be detected concerning the 
building velocity of P1[SbF6]2 and P2[SbF6]2. While P1[SbF6]2 is built completely in 10–15 
minutes, P2[SbF6]2 takes at least 8 hours to form completely, which is due to the quinolinyl 
moiety in P2. 
Concerning the stability of P1[SbF6]2 and P2[SbF6]2, P1[SbF6]2 is more stable at −78°C than 
P2[SbF6]2. While P2[SbF6]2 already partly decays whilst forming, the imidazolyl moiety 
containing peroxo compound is stable at −78°C for several days. Half-times of P1[SbF6]2 and 
P2[SbF6]2 at 0°C are 3.8 min and 1.5 min The parent species [Cu2O2(L5)2][SbF6]2 is formed fast 
as well and is stable at −78°C for weeks. 
Herres-Pawlis et al. could prove a diverse catalytic activity for [Cu2O2(L5)2][SbF6]2 concerning 
a variety of different substrates (with different electronic properties).[18] P1[SbF6]2 shows a 
similar catalytic activity, but with a much faster reaction for the 8-hydroxyquinoline 
substrate (TON of 14 after 10 minutes compared to 8 after 16 h). Stoichiometric experiments 
resulted in a quantitative catechol conversion for unsubstituted phenolate salts and for 
fluoride substituted ones, similar to [Cu2O2(L5)2][SbF6]2, while nitro-substituted phenolates 
yielded 60% catechol, which is less compared to >90% conversion with this substrate for 
[Cu2O2(L5)2][SbF6]2. 
First kinetic experiments showed a faster hydroxylation of phenols for P1[SbF6]2 compared 
to [Cu2O2(L5)2][SbF6]2.
[170] For P2[SbF6]2 with its slow building velocity, no stoichiometric 
conversions were performed, whereas a self-assembly approach has only been tested for 
P2[SbF6]2. The isopropyl substituted ligand HC(3-iPrPz)2(Py) (L3) did not show any signs of a 
peroxo complex formation. 
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3.4 Analysis and Characterisation of bis(pyrazolyl)methane 
nitrate complexes 
 
3.4.1 Introduction 
The activation of small molecules, like O2, NO or CO2 is a research field that earned large 
interest over decades and has significant impact in biology, medicine and industrial 
catalysis.[171] Its importance has grown due to climate change and the greenhouse effect. 
Taking the example of processing toxic gases, a possible area of application might be the 
cleaning of exhaust gases. In exhaust fumes various toxic gases containing nitrogen are 
present, including NO, NO2 and N2O.
[172] 
Another example of the processing of small molecules containing nitrogen, in order to 
obtain molecular nitrogen is the biosynthetic pathway of denitrification.[92] As was 
mentioned in the introduction, this multi-step process generates nitrogen from nitrate, with 
nitrite, nitrogen monoxide and nitrous oxide being intermediates. 
Analysing the crystal structures of bis(pyrazolyl)methane complexes concerning their 
coordination sphere and binding modes provides important insight into the influence of 
donor functions on the coordination sphere. Until now, monofacial bis(pyrazolyl)methane 
complexes are only known with the halides chloride and bromide in combination with the 
transition metals Co, Cu, Fe and Zn.[125] Chloride can be abstracted by the addition of a silver 
salt, resulting in a free coordination site. This free coordination site can be used for the 
reaction with oxygen (see 3.2.2, 3.3.2). Moreover in chapter 3.5.3 the reaction of a 
bis(pyrazolyl)methane complex with NO gas and NO transferring agents is described. 
In this thesis, it was possible to obtain X-ray structural data for bis(pyrazolyl)methane 
complexes using transition metal nitrate salts. These were found to favour a different 
coordination mode compared to all previously shown structures of C1–C7. 
3.4.2 Structural characterisation of bis(pyrazolyl)methane nitrate complexes 
Reaction of the Co(II)-nitrate salt with HC(3-tBuPz)2(Py) (L5) affords magenta coloured 
crystals, which crystallise monoclinically in the space group P21/c (C5, Figure 39), containing 
four units per elementary cell. 
70 
 
 
Figure 39. Molecular structure
[Co(NO
Scheme 24. Synthesis of [Co(NO
[Zn(NO
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s of [Co(NO3-κO)(NO3-κ
2
OO’){HC(3-tBuPz)
3-κO)(NO3-κ
2
OO’){HC(3-iPrPz)2(Py)}] (C6). 
3-κO)(NO3-κ
2
OO’){HC(3-tBuPz)2(Py)}] (C5), [Co
κ2OO’){HC(3-iPrPz)2(Py)}] (C6) and  
3-κO)(NO3-κ
2
OO’){HC(3-iPrPz)2(Py)}] (C7). 
 
2(Py)}] (C5) and 
(NO3-κO)(NO3-
 
In C5 the cobalt atom is coordinated six
bis(pyrazolyl)methane ligand and monodentate
groups of the cobalt salt. C6 is the analogous complex to 
ligand HC(3-iPrPz)2(Py) (L3) (Figure
which also is coordinated by L3
 
C6 contains one molecular unit per elementary cell, while 
elementary cell. C6 and C7 crystallise in the triclinic space group P
C7 possess the same coordination geometry
Table 17 lists the bond lengths and 
 
Table 17
Bond lengths [Å]
Co-NPz1 
Co-NPz2 
Co-NPy 
Co-Om 
Co-Ob1 
Co-Ob2 
 
Figure 40. Molecular structure of 
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-fold by the three coordination sites of the 
ly as well as bidentately 
C5 with the bis(pyrazolyl)methane 
 39), while C7 refers to the corresponding zinc complex
 (Figure 40). 
C7 contains two units per 
1. Complexes 
, which is distorted octahedral in each case. 
Table 18 the bond angles of C5, C6 and 
. Selected bond lengths for C5, C6 and C7. 
 C5 (M = Co) C6 (M = Co) C7 (M = Zn)
2.159(1) 2.076(3) 2.061(2)
2.174(1) 2.100(3) 2.124(2)
2.156(1) 2.166(3) 2.169(2)
2.044(1) 2.060(3) 2.096(1)
2.207(1) 2.166(3) 2.297(2)
2.134(1) 2.118(3) 2.091(2)
[Co(NO3-κO)(NO3-κ
2
OO’){HC(3-iPrPz)
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2(Py)}] (C6). 
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Table 18. Selected bond angles for C5, C6 and C7. 
Bond angles [°] C5 (M = Co) C6 (M = Co) C7 (M = Zn) 
Co-Om-N 128.2(1) 127.0(2) 126.4(1) 
Co-Ob1-N 90.7(1) 93.0(2) 88.2(1) 
Co-Ob2-N 94.0(1) 91.0(2) 96.8(1) 
 
All three monofacial complexes have two different M-NPz (M = metal) bond lengths, which 
means that no mirror plane exists in either structure. 
Analysing the metal-nitrogen and metal-oxygen bond lengths listed in Table 17, it strikes that 
M-NPy bond lengths are in general longer in the complexes with the isopropyl substituted 
ligand (C6, C7) than in C5 with the tertbutyl substituted one. For M-NPz bond lengths, the 
opposite is the case. Comparing the M-NPy and M-NPz distances in C6 and C7, the latter are 
shorter. C5 shows a mixed picture concerning this investigation, as one Co-NPz and the Co-
NPy distance are almost similar. Concerning the M-O distances a commonality can be found 
amongst all three nitrate complexes. Each M-Om bond length is shorter than the 
corresponding M-Ob ones.  
The M-Om-N angles are all similar. Each bidentate nitrate group is bound distorted, resulting 
in two different M-Ob-N angles, with C7 showing the largest distortion. 
 
Table 19. Selected octahedron angles of C5–C7. 
Bond angles [°] C5 (M = Co) C6 (M = Co) C7 (M = Zn) 
Ob1-M-Ob2 59.3(1) 60.4(1) 58.6(1) 
NPz-M-NPz 92.4(1) 89.9(1) 90.7(1) 
NPy-M-Om 169.5(1) 171.0(1) 169.9(1) 
Om-M-NPz1 94.4(1) 88.3(1) 93.1(1) 
Om-M-NPz2 85.9(1) 93.2(1) 86.0(1) 
Ob1-M-Om 100.1(1) 88.7(1) 101.3(1) 
Ob2-M-Om 96.2(1) 100.9(1) 90.4(1) 
 
From Table 19 it can be seen that all three octahedral complexes C5, C6 and C7 are 
distorted. The Ob1-M-Ob2 angle is around 60° for all three complexes and is therefore much 
smaller than the anticipated 90° angle. However considering that Ob1 and Ob2 are part of the 
bidentately bound nitrate anion, it is evident that this angle cannot be stretched to up to 
3  Results & Discussion 
73 
 
90°. The NPz-M-NPz angle however is close to 90° for all three complexes. Accordingly, the 
corresponding NPz-M-Ob angles are larger than 90°. The octahedron axis is defined by the 
atoms NPy, M and Om; the angle between those atoms should ideally be 180°. In reality the 
NPy-M-Om angle is about 170°. Therefore the axis is tilted towards the bis(pyrazolyl)methane 
ligand and away from the nitrate oxygen atoms. Om-M-NPz2 and Ob1-M-Om have similar 
values for C5 and C7, while values for the corresponding angle in C6 are different. 
 
3.4.3 Calculation of the binding mode 
That nitrate can bind on metals in two different coordination modes has been known for a 
long time.[173] In 1965 Curtis & Curtis conducted a study regarding nitrate-amine nickel(II) 
compounds with monodentate and bidentate nitrate ions.[173] They investigated the 
compounds [Ni(en)2(NO3)2] (18), [Ni(en)2NO3]X (19) (X = BF4
−, ClO4
−, I−) and Ni(dien(NO3)2) 
(20) by means of infrared spectroscopy. For species 18 the following infrared bands were 
found: 708, 728, 818, 1305 and 1420 cm−1. These were assigned to monodentately bound 
nitrates. Complex 19 showed infrared vibrations at 695, 743, 807, 1290 and 1475 cm−1, 
which is typical for bidentately bound nitrate. Analogously, 20 showed vibrations indicative 
of both mono- and bidentately bound nitrate, which led to the conclusion that both binding 
modes are present there. 20 is one of the few known examples, where a rather simple 
transition metal nitrate complex exhibits both binding modes in one complex.  
N
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Scheme 25. Structure of tris(3,5-dimethyl(pyrazolyl))methylamine (21) and synthesis of 
[Ni(21)(O2NO)][NO3] (22) and [Cd(21)(O2NO)(ONO2)].
adapted from [174,175] 
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In 1985 Reedijk et al. conducted experiments with transition metal nitrate salts and the 
pyrazolyl ligand tris(3,5-dimethyl(pyrazolyl))methylamine (21).[174] Scheme 25 depicts the 
structure of the according nickel (22) and cadmium (23) compound[175] based on X-ray 
diffraction anaylses. 21 hereby acts as a tripodal quadridentate ligand. The coordination 
geometry of 22 is distorted octahedral and for 23 distorted bicapped octahedral. The nickel 
complex is a cation in which one nitrate group is coordinated bidentately and the second 
nitrate is the counterion. In 23 both nitrate groups are bound on the central metal, once 
unisobidentately and once monodentately.  
In order to determine the binding mode concerning the nitrate groups, the calculation 
according to Figure 41, which was introduced by Reedijk et al.[175], was applied for each of 
the three complexes C5–C7. Hereby the atom distances l1, l2 and l3 are defined, as well as the 
bond angles A1, A2 and A3. Determination of l2−l1, A1−A2, l3−l2 and A3 results in values that can 
be assigned to one of three binding modes, which are monodentate, anisobidentate and 
bidentate (Table 20).  
 
binding mode monodentate anisobidentate bidentate 
l2−l1 >0.6 0.3–0.6 <0.3 
A1−A2 >28 14–28 <14 
l3−l2 <0.1 0.1–0.2 >0.2 
A3 <162 162–168 >168 
 
Table 20 prooves one monodentately and one bidentately bound nitrate group per complex, 
which is in accord with the image of the molecular structures. 
 
 
Figure 41. Quantification of the binding mode for the nitrate groups.[175]  
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Table 20. Binding modes for nitrate groups of C5, C6 and C7. 
 C1 C2 C3 
 1 2 1 2 1 2 
l2−l1 1.162 0.0734 1.285 0.022 1.257 0.206 
A1–A2 92.2 3.34 32 2 61.98 8.66 
l3–l2 −0.19 0.351 −0.337 0.342 −0.32 0.287 
A3 150 176.4 138 178.5 139.01 172.86 
 monodentate bidentate monodentate bidentate monodentate bidentate 
 
The complex geometry of Co(II) complexes is diverse and relies strongly on the surrounding 
ligands. Co(II)-O complexes often are not stable, unless for example polydentate O-donors, 
such as acetylacetonate or oxalate are applied. Common examples for such complexes are 
[Co(acac)3] and [Co(ox)3]
3−. These complexes show an octahedral geometry. Moreover less 
polarizable ligands, containing O and N atoms favour the formation of octahedral 
complexes.[83] So overall it does not surprise that complexes C5 and C6 have a distorted 
octahedral geometry, considering the polydentate bis(pyrazolyl)methane ligand and nitrate 
anions. With the octahedral geometry being the most stable option, it is not unusual that 
one nitrate anion is coordinated bidentately, in order to complete the octahedron.  
Zinc almost exclusively exists in the oxidative state +II in compounds. Because of its 10 
d-electrons no crystal field stabilisation energy can be gained and therefore Zn(II) complexes 
can generate any geometry. Which one is present, mostly depends on the steric demands of 
the ligands.  
Applying the formulas from Figure 41, a consistent determination of the binding mode of 
nitrate or similar anions through geometric parameters is possible. This method is more 
precise than the infrared spectroscopic one from Curtis, but it is obviously only possible 
when crystallographic data is present. 
 
3.4.4 Evaluation of NBO calculations  
In order to investigate the donor situation between competing N- and O-donors in C5–C7 
natural bond orbital calculations were performed. Second order perturbation theory 
calculations applying the BP86 functional and 6-31G(d) basis set[162] resulted in charge-
transfer energies concerning all binding partners of the central metal (Table 21). 
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Table 21. Charge-transfer energies [kcal mol−1] for C5–C7 (Gaussian09, BP86/6-31G(d) and 
NBO 6.0).[135,142,162] 
CT energies [kcal mol−1] C5 (M = Co) C6 (M = Co) C7 (M = Zn) 
Ob1M 17.89 19.40 42.45 
Ob2M 17.72 20.26 48.81 
OmM 26.44 25.92 65.08 
NPz1M 12.24 14.44 34.83 
NPz2M 11.74 14.34 33.91 
NPyM 11.70 9.95 27.49 
 
Regarding the M-N bonds of C6 and C7, charge-transfer energies for NPzCo/Zn are larger 
than for the corresponding NPy bonds, which is in accord with the bond lengths from 
Table 17, where M-NPz bonds are shorter. This is evidence for the stronger donor force of 
pyrazolyl moieties. Looking at the nitrate groups, CT energies for OmCo/Zn are larger than 
the values for the bidentate nitrate groups. Here as well CT energy values tie in with the 
corresponding bond lengths, resulting in overall shorter OmCo/Zn bonds. 
Table 22. NBO charge distribution in C5, C6 and C7 (Gaussian09, BP86/6-31G(d) and 
NBO 6.0).[135,142,162] 
 C5 (M = Co) C6 (M = Co) C7 (M = Zn) 
M +1.058 +1.027 +1.171 
Ob1 −0.496 −0.483 −0.511 
Ob2 −0.496 −0.491 −0.543 
Ob3 −0.343 −0.346 −0.343 
Nb +0.700 +0.695 +0.700 
Om −0.589 −0.580 −0.652 
Om2 −0.392 −0.403 −0.411 
Om3 −0.396 −0.395 −0.394 
Nm +0.695 +0.695 +0.697 
NPz1 −0.344 −0.345 −0.369 
NPz2 −0.335 −0.342 −0.361 
NPy −0.483 −0.465 −0.490 
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In addition to charge-transfer energies, NBO charges were investigated. Table 22 lists the 
values for the central metal, the donating bis(pyrazolyl)methane nitrogen atoms and all 
elements belonging to the nitrate groups. The metal has the highest positive partial charge, 
followed by Nb and Nm. All remaining atoms possess partial negative NBO charges. 
The study of NBO charges gives an idea of the electronic effects in the complexes, however 
they do not represent absolute charges. Starting with a comparison of NPz and NPy, the NBO 
charge is more negative at the pyridinyl nitrogen atom (hence more basic). However, the CT 
energy for NPzM is higher, making the pyrazolyl moiety the stronger donor (more 
nucleophilic), resulting in a shorter NPz-M bond length as well. Consulting the basicity of 
pyridine and pyrazole, pyridine is the stronger base with a pKB value of 8.8, compared to 
11.5 for pyrazole[176], so if only basicity is considered, the NPy-M bond should be the shorter 
one. However several effects play a role in the determination of a donor-acceptor bond. Not 
only basicity, but also nucleophilicity, spin state, Jahn-Teller distortion and steric effects have 
to be considered. The complex donor competition between pyrazolyl and pyridinyl moieties 
in bis(pyrazolyl)methane complexes has been observed and reviewed by Herres-Pawlis et 
al.[160,162], but it remains complex and case specific. 
In general, charge distribution within C5, C6 and C7 is very similar. Comparing the three, C7 
has the highest positive charge at the central atom and overall the largest negative values on 
all atoms which form bonds to the central metal. All atoms, which do not contribute to the 
N/OM bonds (marked in green) have similar NBO charge values, when C5, C6 and C7 are 
compared.  
 
3.4.5 Summary 
Three new bis(pyrazolyl)methane cobalt and zinc complexes (C5–C7) were synthesised by 
reacting the ligands HC(3-tBuPz)2(Py) (L5) and HC(3-iPrPz)2(Py) (L3) with the according nitrate 
salts. An infrequent coordination geometry resulted, showing one monodentately and one 
bidentately bound nitrate group, resulting in distorted octahedral complex geometries for all 
three complexes. The coordination mode of nitrate was calculated in each case, applying the 
formula of Reedijk et al.[175], which results in a consistent determination through the 
application of geometric parameters. 
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NBO calculations showed a larger CT energy for the NPzM bond, which is in accord with the 
shorter NPz-M in comparison to the NPy-M bond length. Evaluation of NBO charges showed 
similar charge distributions for all three complexes.  
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3.5 Investigations towards a copper(II)-superoxide mimic and 
NO activation with bis(pyrazolyl)methanes 
 
3.5.1 Introduction 
In the physiological context the NO molecule plays an important role because of its blood 
pressure lowering properties as well as its function in signal transduction.[177,178] In addition, 
NO is also an interesting ligand for coordination chemistry, as it is redox active and can bind 
on metals neutrally, as a cation or anion.[179] It is possible to introduce NO as ligand to a 
complex species in different ways. Besides the reaction with NO gas directly, NO can be 
generated in situ via the reaction of sodiumnitrite with concentrated sulphuric acid in a two 
phase reaction.[180,181] Another method is the addition of NO+ salts, such as NOBF4 or 
NOSbF6, which additionally provide bulky anions which facilitate crystallisation. Furthermore 
several compounds can transfer NO directly, such as diazald® or tritylthionitrite (TTN, 
Figure 42).[182,183] 
 
Nitrosobenzene on the other hand is a compound, which acts as a superoxide mimic. In 
nature such Cu(II) end-on superoxide structures are discussed as intermediates in the 
catalytic cycle of the monooxygenase dopamine-hydroxylase and others. Ottenwaelder et al. 
were able to crystallise nitrosobenzene Cu(I) species including nitrogen donors as superoxide 
mimics (Scheme 26).[184]  
Figure 42. Structure of NO transferring reagents diazald® and tritylthionitrite (TTN). 
Scheme 26. Synthesis of [Me6trenCu(PhNO-κO)]
+ adapted from [184]. 
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3.5.2 Copper nitrosobenzene species as superoxide mimics
As a superoxide is supposed to
experiments with a Cu(I) bis(pyrazolyl)methane precursor and nitrosobenzene were 
performed.[185] The copper(I) 
for the reaction with oxygen (
screened with a variety of solvents, reaction temperatures and amounts of nitrosobenzene.
As soon as nitrosobenzene was added to the precursor s
change to deep-red was observed.
Table 23. Overview of extinction coefficients of the reaction of [Cu{HC(3
nitrosobenzene at 
Solvent 
Temperature [°C] rt 
Equivalents 2 
ελ = 454 nm [Lmol
−1cm−1] 1940 
ελ = 558 nm [Lmol
−1cm−1] 1620 
 
It was determined that reactions in chloroform at low temperatures with 2
nitrosobenzene yielded the highest conversions. 
THF at any temperature, which mig
precursor. 
Figure 43. Experimental UV/Vis spectra of the reaction of [Cu{HC(3
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 be an intermediate in the catalytic cycle of tyrosinase as well, 
precursor was synthesised exactly like the one that 
see 3.2). Conditions for nitrosobenzene reactions were 
olution, an immediate colour 
 
-tBuPz)
λ = 454 and λ = 558 nm. 
CH2Cl2 THF 
−30 −78 −78 
2 2 1 2 4 1
1690 2500 / 1230 1430 2875
1490 2250 / 1160 1260 2561
The lowest absorption was observed w
ht be due to coordination of the solvent to the copper
-tBuPz)
with nitrosobenzene. 
 
was used 
 
2(Py}]
+ with 
CHCl3 
−60 
 2 4 
 4383 1973 
 3889 1706 
 eq of 
ith 
 
2(Py)}]
+ 
 
The UV/Vis spectra of the reactions performed under the 
three are shown in Figure 43. 
As it was not possible to obtain
structural optimisation and TD
performed. When comparing the stabilisation energies it shows that the singlet species is
favoured over the triplet state
(−3.44 kcal mol−1 for κN and 
indicated a preference for the 
optimisation of both the κO- 
barrier in favour of the κN-isomer of 2.4
 
Comparison of the calculated UV/Vis spectra 
(comparison between the according 
indicated a better agreement of the calculated singlet state to the experimental data
a more accurate determination whet
lists their according calculated absorption maxima.
 
 
 
 
Figure 44. Structural optimis
tBuPz)2(Py)}(PhNO
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conditions displayed in 
 crystals for structural analysis of the nitrosobenzene
-DFT calculations of the singlet and triplet compound were 
, no matter which coordination mode is investigated.
−1.67 kcal mol−1 for κO). Comparisons within the isomers 
κN binding mode each. In Figure 
and κN-compound of the singlet state are pictured
 kcal mol−1 was calculated. 
of the singlet and triplet 
κN- and κO-species only shows minor differences)
her the singlet κN- or κO-complex was built, 
 
 
ation of singlet [Cu{HC(3-tBuPz)2(Py)}(PhNO-κO
-κN)]+ (B3LYP, 6-31G(d), Gaussian09).[186]
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column 
 species, 
 
 
44 the structural 
. An energy 
 
κN-compounds 
 
.[186] For 
Table 24 
)]+ and [Cu{HC(3-
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Table 24. TD-DFT calculated UV/Vis absorption maxima for singlet [Cu{HC(3-tBuPz)2(Py)}(PhNO-
κO)]+ and [Cu{HC(3-tBuPz)2(Py)}(PhNO-κN)]
+ (B3LYP, 6-31G(d), Gaussian09) in comparison to 
experimental values.[186] 
 κO-species κN-species Exp. 
λmax.1 [nm] 195 190 301 
λmax.2 [nm] 287 295 454 
λmax.3 [nm] 488 406 558 
λmax.2 − λmax.1 [nm] 92 105 153 
λmax.3 − λmax.2 [nm] 201 111 104 
 
The number of three predicted absorption maxima λmax.1, λmax.2 and λmax.3 is in accord with 
the experimental spectra, but their position is off. Considering however the distance 
between the maxima, the κN-species seems more likely to have been built. This would also 
coincide with the calculated stabilisation energy. More theoretical analyses using broken-
symmetry DFT should be perfomed here. 
Only few compounds of copper with nitrosobenzene are known and structurally 
characterised. Besides Ottenwaelder's [Me6trenCu(PhNO-κO)]
+ species, [Cu(iPrPhNO-κN)3]
+ 
has been crystallised as an example for an N-bound nitrosobenzene complex, but 
considering its three substituted nitrosobenzene units and no nitrogen donor involved, this 
complex cannot serve for a comparison.[187,188] 
 
3.5.3 Diazald and TTN as NO transferring agents 
The reaction of [Cu{HC(3-tBuPz)2(Py)]
+ with TTN did not give any conclusive evidence of NO-
donating properties, as multiple products were built according to UV/Vis measurements that 
could not be characterised yet. 
Furthermore two separate experiments were performed in which [Cu{HC(3-tBuPz)2(Py)]
+ was 
reacted once with a solution of diazald® at rt and once with NO gas in a secluded gas 
injection system at −60°C. Figure 45 displays the UV/Vis spectra of both experiments. Here 
the NO transferring property of the reagent diazald® is clearly visible, as both spectra 
resemble each other largely and only differ in their absorption, which is evident, as NO gas 
was present in an extreme excess and diazald® only in 0.5 eq. Importantly, the reaction with 
diazald® does not indicate any minor products. Attempts to yield crystals of the expected 
product (Figure 46) failed so far. 
 
 
3.5.4 Summary 
In summary, experiments were conducted in order to firstly generate a superoxide mimic for
the enzyme tyrosinase and secondly with NO transferring agents, as well as NO gas to 
activate NO.  
Initially reaction conditions were optimised. 
showed a reaction with the Cu(I) precursor, generating a room temp
species. The reaction was followed by UV/Vis spectroscopy, but it was not possible to
determine definitely wheter the 
investigations indicated the formation of the 
Figure 45. UV/Vis spectra of the reaction of [Cu{HC(3
Figure 46. Expected reaction product of the reaction of 
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The experiments with nitrosobenzene clearly 
erature stable deep red 
κN- or κO-complex was built. Comparison with TD
κN-species. 
N N
N
tBu
N
N
tBu
H
C
Cu
N
O
+
-tBuPz)2(Py)}]
+ with diazald
gas (blue). 
[Cu{HC(3-tBuPz)2(Py)}]
agents. 
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-DFT 
® (black) and NO 
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The experiments with TTN did not give conclusive results, because several species were built 
that could not be characterised. 
Comparing the reaction of the Cu(I) precursor with NO gas and with diazald® proofed the NO 
transferring ability of diazald®, however the resulting product could not be characterised 
yet. 
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3.6 Basic studies on bis(pyrazolyl)methane ligands and their 
complexation behaviour 
 
3.6.1 Isomerisation and structural properties 
As mentioned in the introduction (1.13), the ligand class of bis(pyrazolyl)methanes is large, 
because of the wide variability of substituents at the pyrazolyl units, as well as the flexible 
third donor function. Figure 47 shows an overview of all the bis(pyrazolyl)methane ligands 
that were used in this thesis. L2 and L5–L7 were resynthesised according to the protocol 
established by Herres-Pawlis et al.[117] L3' and L4' represent the isomerised counterparts of 
L3 and L4. Scheme 27 depicts the synthesis of L3 and a mixture of L4 and L4' with L4' being 
part of the bisfacial cobalt complex C10. 
 
NN
N N
L3 L4
NN
N N
N N
NN
N N
L3'
N
L4'
NN
N N
N
L2*L1
NN
N N
NN
N N
N
N N
NN
N N
N
L5*
NN
N N
N
L6*
NN
N N
N
L7*
Figure 47. Structures of ligands L1–L7 as well as L3' and L4'. With * marked ligands were 
resynthesised according to [117]. 
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An often occuring side-effect concerning the synthesis of substituted bis(pyrazolyl)methane 
ligands is the rearrangement of the ligand moiety in the 3-position, resulting in mixed 
species with substituents in the 3- and 5-position.[189,190] This isomerisation can occur due to 
too much thermal energy during the distillation of the ligand or by Lewis acid catalysis during 
the reaction of the ligand with metal salts. 
 
Figure 48 shows the molecular structures of the known bis(pyrazolyl)methane ligand 
HC(3-tBuPz)2(Qu) (L2)
[117] and the new ligand HC(3-iPrPz)(5-iPrPz)(Py) (L3’). Both have a 
distorted tetrahedral geometry at the apical C-atom.  
L2 crystallises in the triclinic space group P1 with two molecular units per elementary cell 
and L3’ crystallises in the triclinic space group P1 as well, with four units per elementary cell. 
Table 25 displays key bond lengths and angles in L2 and L3’. 
1. NaH
THF, 0°C, 30 min.
2. SOCl2
THF, 0°C, 30 min.
rt, 45 min.
S
O
NN
N N
THF, reflux,
20 h, [CoCl2]
NN
N N
N
H
N
L3
N
O
H
N
O
H
L4'
NN
N N
N
N
L4
NN
N N
N
Scheme 27. Synthesis of HC(3-iPrPz)2(Py) (L3) and a mixture of HC(3-iPrPz)2Qu) (L4) and HC(3-
iPrPz)(5-iPrPz)(Qu) (L4'). 
 
The molecular structure of L3’
protocol for the reisomerisation of 3/5
thesis, which is based on the reisomerisation of tris(pyrazolyl)methanes.
the isomerised ligand is refluxed with catalytic amounts of 
resulting in the thermodynamically favoured 3/3 product.
The Lewis acid catalysed isomerisation has been investigated by Herres
Hereby the 3/3 substituted version of ligand 
attempt to generate monofacial iron complexes. However upon reaction is
occurred and complexes of the type 
that these systems attempt to avoid steric pressure. Theoretical studies proved a 
20 kcal mol−1 more stable [Fe{HC(3
Table 25. Key bond lengths [Å] and angles [°] in 
Bond lengths [Å]
Cap-NPz 
Cap-CQu*/Py
NPz-NPz 
Bond angles [°]
NPz-Cap-N
NPz-Cap-C
Figure 48. Molecular structures of HC(3
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 shows an isomerised ligand. As this is a common 
-substituted compounds was established in this 
p-toluenesulfonic a
[111,193] 
-Pawlis 
L3’ was reacted with various iron(II) salts in an 
[Fe{HC(3-iPrPz)(5-iPrPz)(Py)}2]
2+ were achieved. It seems 
-iPrPz)(5-iPrPz)(Py)}2]
2+ complex.[190] 
L2 and L3’.
 L2* L3’ 
1.437(4) 
1.448(4) 
1.456(2) 
1.451(2) 
 1.524(5) 1.519(3) 
1.373(4) 
1.347(4) 
1.362(2) 
1.365(2) 
   
Pz 111.4(3) 109.3(2) 
Qu*/Py 
112.8(3) 
111.6(3) 
112.2(2) 
113.4(2) 
 
-tBuPz)2(Qu) (L2) and HC(3-iPrPz)(5
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effect, a 
[111,191,192] Hereby, 
cid in toluene, 
et al. recently. 
omerisation 
 
-iPrPz)(Py) (L3'). 
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The bond lengths in L2 and L3’ are very similar. In general the Cap-NPz bond length is shorter 
than the Cap-CQu or Cap-CPy one. Bond angles confirm the slight distortedness of both 
structures compared to an ideal tetrahedron. 
 
3.6.2 Structural studies on cobalt bis(pyrazolyl)methane complexes 
In fundamental studies on the complexation behaviour of bis(pyrazolyl)methane ligands, we 
investigated several bisfacial complexes. Reaction of Co(NO3)2 with HC(Pz)2(Py) (L6)
[117] 
afforded the bisfacial Co complex [Co{HC(Pz)2(Py)}2][Co(NO3)4] (C8) and reaction of Co(OTf)2 
with HC(Pz)2(Qu) (L7)
[117] furnished [Co{HC(Pz)2(Qu)}2][(OTf)2] (C9) (Scheme 28, Figure 49). 
The molecular structure of the C8 cation, C82+, has been known since 1991.[162,194]  
It was synthesised by Astley et al. by adding a solution of L6 in acetone to a solution of the 
aqueous cobalt nitrate salt in acetone. Vapour diffusion of diethyl ether into an acetonitrile-
methanol (1:1) solution of the cobalt complex resulted in yellow crystals. 
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H
N
NN
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N
N N
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N
H
C
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2-
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Scheme 28. Synthesis of [Co{HC(Pz)2(Py)}2][Co(NO3)4] (C8) and [Co{HC(Pz)2(Qu)}2][(OTf)2] (C9). 
 
The difference between C82+ 
the [Co(NO3)4]
2− anion as counterpart and 
Table 26 lists various bond lengths and 
have a mirror plane, so that there is only one value for Co
 
Table 26. Key bond lengths [Å] and angles [°] in C8
Bond lengths [Å] 
Co-NPz1/3 
Co-NPz2/4 
Co-NPy/NQu 
Bond angles [°] 
NPz1-Co-NPz3 
NPz3-Co-NPz4 
NPz3-Co-NPz2 
NPz4-Co-NPz2 
NPz4-Co-NPy2/NQu2* 
NPz3-Co-NPy2/NQu2* 
 
Comparing C82+ and CC82+, bond lengths in 
2.106(4) Å to 2.130(5) Å. In CC8
Figure 49. Molecular structure of [Co{HC(Pz)
[Co(NO3)4] (C8) and of [Co{HC(Pz)
pyrazolyl and pyridinyl moieties are disordered. Here only one isomer is shown
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and Astley’s structure (CC82+) solely is the counterion. 
CC82+ single nitrate anions.  
angles in C82+, CC82+ and C92+. C8
-NPz and Co-NPy bond lengths.
2+, CC82+ and C9
C82+ CC82+[194] C9
1.913(11) 2.106(4) 2.095(16)
1.922(3) 2.130(5) 2.090(2)
1.972(11) 2.118(4) 2.238(2)
  
180.0(7) 180.0 180.0
91.1(3) 86.4(2) 89.73(6)
88.9(3) / 90.27(6)
180.0(1) 180.0 180.0
90.8(5) 84.5(2) 83.2(6)
86.8(5) 83.9(2) 82.72(6)
CC82+ are generally longer and range from 
2+ one Co-NPz bond length is the longest of the M
2(Py)}2]
2+[194] (C82+) in crystals of [
2(Qu)}2]
2+ (C92+) in crystals of [Co{HC(Pz)2(Qu)}
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C82+ has 
2+ and C92+ both 
 
2+. 
2+* 
 
 
 
 
 
 
 
 
 
 
-N bonds, 
Co{HC(Pz)2(Py)}2] 
2][(OTf)2] (C9). In C8 
 for clarity. 
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whereas in C82+ the Co-NPy bond length is the longest one. Bis(pyrazolyl)methane bite angles 
in CC82+ lie between 83.9(2) and 86.4(2)°. In C82+, those have values between 86.8(5) and 
91.1(3)°, which makes the geometry of C82+ slightly more distorted than CC82+. 
Bond lengths in C92+ are significantly longer than in C82+. Both have in common that the Co-
NPy, as well as the Co-NQu bond lengths are longer than the Co-NPz ones. Bite angles in C9
2+ 
vary from 82.7(1) to 89.7(1)° which lie more in the area of CC82+. 
 
For the study of catalytic activity, metal complexes with free coordination sites are required, 
or ones with weakly coordinating or easily abstractable anions. These requirements are met 
for example by bis(pyrazolyl)methane ligands of the second generation, which were 
introduced by Trofimenko a while ago.[101] With their alkyl substituents at the pyrazolyl 
moiety of the bis(pyrazolyl)methane ligand, a bisfacial coordination mode should be ruled 
out whereas ligands with unsubstituted pyrazolyls coordinate bisfacially at a central atom 
(see C8, C9). 
Reaction of a mixture of HC(3-iPrPz)2(Qu) L4 and its isomerised counterpart HC(3-iPrPz) 
(5-iPrPz)(Qu) (L4’) with Co(NO3)2 (Scheme 29) yielded red crystals, the molecular structure of 
the cationic unit of which is displayed in Figure 50.  
 
Complex C10 is bisfacial as well, because the isomerisation of the isopropyl groups reduces 
steric pressure. 
 
 
 
Scheme 29. Synthesis of [Co{HC(3-iPrPz)(5-iPrPz)(Qu)}2][(NO3)2] (C10). 
 
Table 27 lists key bond lengths and angles of 
substituted pyrazolyl moieties, whereas N
pyrazolyls. 
Table 27. 
Bond lengths
Co
Co
Co
Bond 
N
N
N
N
N
N
 
Here, just like in C82+ and C9
addition it strikes that Co-NPz1/3
This is due to the isomerised isopropyl groups, resulting in different Co
the 3- and 5-isomer. The Co-N
Figure 50. Molecular structure of [{HC(3
[Co{HC(3
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C102+. NPz1 and NPz3 represent
Pz2 and NPz4 belong to 5-iso
Key bond lengths [Å] and angles [°] in C102+. 
 [Å] C102+ 
-NPz1/3 2.122(1) 
-NPz2/4 2.074(1) 
-NQu 2.230(1) 
angles [°] 
Pz1-Co-NPz3 180.0(1) 
Pz3-Co-NPz4 88.3(1) 
Pz3-Co-NPz2 91.7(1) 
Pz4-Co-NPz2 180.0(1) 
Pz4-Co-NQu2 95.8(1) 
Pz3-Co-NQu2 95.0(1) 
2+, the Co-NQu bond length is longer than the Co
 in comparison to Co-NPz2/4 show a clear difference in length. 
-N
Pz bond length to the 3-isomer is longer in this case.
-iPrPz)(5-iPrPz)(Qu)}2Co]
2+ (C102+) 
-iPrPz)(5-iPrPz)(Qu)}2][(NO3)2] (C10). 
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Table 28. Key bond lengths [Å] and angles [°] in C11 and CC11[125] and τ5-values of both. 
 C11 CC11 
Bond lengths [Å]   
Co-NPz 
2.130(3) 
2.146(3) 
2.106(7) 
2.131(6) 
Co-NPy 2.220(3) 2.224(6) 
Co-Cl(2) 2.331(1) 2.309(2) 
Co-Cl(1) 2.309(1) 2.358(2) 
Cap-NPz 
1.466(4) 
1.445(4) 
1.441(9) 
1.444(9) 
Cap-CPy 1.523(5) 1.481(9) 
Bond angles [°]   
NPz-Co-Cl(2) 
97.5(1) 
95.6(1) 
97.2(1) 
95.3(2) 
NPz-Co-Cl(1) 
123.5(1) 
137.0(1) 
129.2(2) 
131.0(2) 
NPy-Co-Cl(1) 89.2(1) 89.4(2) 
NPy-Co-Cl(2) 174.2(1) 174.9(2) 
NPz-Co-NPz 95.9(1) 96.5(2) 
NPz-Co-NPy 
83.0(1) 
78.6(1) 
81.6(2) 
80.0(2) 
Cl(1)-Co-Cl(2)  95.3(1) 95.0(1) 
τ5
[195] 0.619 0.731 
 
Inspection of the τ5-value clearly shows the two different isomers of C11. Hereby CC11 is 
distorted more towards a trigonal bipyramid than C11. Furthermore Co-NPz bond lengths are 
more alike in C11, while Co-NPy bonds are longer than Co-NPz bonds in both, which is normal 
for such complexes. Co-Cl and Cap-NPz bond lengths are similar within C11 as well as in CC11. 
Lastly the Cap-CPy bond is longer in C11 than in CC11. 
 
3.6.3 Summary 
In this chapter two more molecular structures of bis(pyrazolyl)methane ligands were 
presented and the effect of isomerisation of alkyl substituents at the pyrazolyl moieties was 
discussed. Furthermore three bisfacial Co complexes were introduced. C8 and C9 
incorporate the HC(Pz)2(Qu) ligand, for which no other coordination geometry than bisfacial 
is expected. 
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C10 includes the isomerised ligand L4’ and shows the bisfacial coordination mode as well. 
Moreover, due to the 3/5-isomerisation Co-NPz bond lengths now differ. It shall be pointed 
out that the unisomerised HC(3-iPrPz)2(Py) ligand did not favour a bisfacial geometry (C6, see 
chapter 3.4) and isomerisation there did also not occur upon reaction with the cobalt salt. 
At last the two isomers of the Co(II) complexes C11 and CC11 were compared in order to find 
a larger distortion towards a trigonal bipyramidal geometry in CC11. 
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4 Conclusion & Outlook 
4.1 Conclusion 
 
The central aim of this thesis was the development of a new biomimetic tyrosinase model 
with efficient catalytic hydroxylation activity. Therefore, a synthetic route towards a new 
bis(pyrazolyl)methane ligand that can be applied in the activation of small molecules, had to 
be explored. Furthermore density functional theory investigations and the analysis of single 
crystal structural data of bis(pyrazolyl)methane transition metal complexes should shed 
more light on the complex donor competition between the different aromatic N-donor 
moieties. 
Bis(pyrazolyl)methanes (BPM) represent a versatile ligand class, that has been known for a 
long time and has been accessible through a one pot synthesis for a couple of years now[117], 
which allows for the simplified synthesis of a large variety of differently substituted ligands. 
Three new ligands of this class were synthesised in the course of this thesis (Figure 52). 
Figure 52. Structures of newly synthesised bis(pyrazolyl)methane ligands L1, L3 and L4/L4’. 
 
Complex synthesis with the new ligand L1 afforded the CuCl2 complex [CuCl2{HC(3-tBuPz)2 
(1-MeIm)}] (C1). Characterisation of C1 showed a shorter Cu-NIm bond length in comparison 
to the Cu-NPz bond, which is also shorter than other common Cu-Ndonor bonds (e.g. Cu-NPy), 
According charge-transfer energy investigations indicated a stronger donor-ability for the 
imidazolyl donor compared to the pyrazolyl donors. 
Formation of the (µ-η2:η2)-peroxo compound ([Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2, 
P1[SbF6]2) at −78°C was proven by UV/Vis spectroscopy, cryo-UHR ESI mass spectrometry 
and X-Ray absorption spectroscopy (XAS) and was completed in 10–15 minutes. UV/Vis 
spectroscopic analysis showed two characteristic LMCT bands at 334 and 534 nm. The blue-
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shift of these bands in comparison to the UV/Vis absorption bands of other tyrosinase model 
complexes, which lie at 350 and 550 nm[47,55], was investigated by theoretical means. All in 
all the blue-shift was traced back to the stronger NIm-donation, which leads to an increase of 
the LUMO, resulting in an energetically larger LMCT transition. 
By treating P1[SbF6]2 with phenolic substrates, catalytic activity according to tyrosinase could 
be observed. Formation of the corresponding quinones was followed by UV/Vis 
spectroscopy. Hereby catalytic conversion with the non-biological substrate 
8-hydroxyquinoline showed to be rapid and efficient with a TON of 14 after 20 min and 
treatment with the second substrate 4-methoxyphenol resulted in a TON of 2 after 18 h. In a 
second experiment, after addition of stoichiometric amounts of phenolic substrates, the 
reaction was stopped at low temperatures on the level of the catechol, amount of which was 
determined by NMR analysis and did not show any signs of a C-C coupling product. This fact 
suggests a reaction mechanism following an inner-sphere oxygen atom transfer analogous to 
tyrosinase. 
Besides P1[SbF6]2, the new copper(I) complex with the ligand HC(3-tBuPz)2(Qu) (L2) was 
treated with oxygen at low temperatures. Here as well a (µ-η2:η2)-peroxo compound 
([Cu2O2{HC(3-tBuPz)2(Qu)}2][SbF6]2, P2[SbF6]2) was verified by UV/Vis spectroscopy. The time 
until the complete formation of P2[SbF6]2 amounted to 8h. The position of the UV/Vis bands 
at 350 and 550 nm was similar to those of oxy-tyrosinase.[139] In a catalytic self-assembly 
approach, the addition of all components to the reaction mixture at once (precursor, phenol, 
NEt3, O2) led to the formation of the according quinone, which was proven by UV/Vis 
spectroscopy.[160] 
Both P1[SbF6]2 and P2[SbF6]2 contain similar bis(pyrazolyl)methanes, but show different 
properties. While P2[SbF6]2 already partly decays whilst forming, the imidazolyl moiety 
containing peroxo compound is stable at −78°C for several days. 
Against the background of understanding the reaction mechanism of tyrosinase in more 
detail, experiments were conducted in order to generate a copper superoxide mimic for the 
enzyme tyrosinase, as such a superoxide is believed to be an intermediate state in the 
catalytic cycle of tyrosinase. Treatment of [Cu{HC(3-tBuPz)2(Py)}]
+ with nitrosobenzene 
showed a reaction, generating a room temperature stable deep red species. Supported by 
theoretical calculations, formation of the singlet κN-nitrosobenzene species was suspected. 
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Regarding the activation of NO, the reaction of [Cu{HC(3-tBuPz)2(Py)}]
+ with NO gas and with 
diazald® resulted in the same species as could be proven by UV/Vis spectroscopy, which 
confirms that diazald® is able to deliver NO onto copper-BPM complexes.  
With the already characterised BPM ligand HC(3-tBuPz)2(Py)
[117] (L5) and L2 four 
bis(pyrazolyl)methane copper complexes (with copper in the oxidation states I and II) were 
synthesised and characterised (Figure 53). These complexes displayed coordination 
geometries from distorted tetrahedral to distorted square-pyramidal and distorted trigonal-
bipyramidal. The donor situation of all four complexes was studied by NBO analysis, but a 
mixed picture was found: depending on the coordinative situation both pyrazolyl and 
pyridinyl units can win this competition.  
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Figure 53. Structures of newly synthesised transition metal bis(pyrazolyl)methane complexes 
C1–C10. 
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A couple of transition metal nitrate complexes with the ligands HC(3-tBuPz)2(Py) (L5) and 
HC(3-iPrPz)2(Py) (L3) were presented as well (Figure 53), because they provide important 
insight into the geometry of combined N and O ligand systems. Here a rare nitrate binding 
mode, which consists of mono- and bidentately bound nitrate groups, could be shown and 
quantified. The geometry of all monofacial nitrate complexes is distorted octahedral. 
In order to understand the substituent effect of the ligands in more detail, bisfacial cobalt 
complexes with unsubstituted BMP ligands as well as a bisfacial complex incorporating an 
isopropyl unit at the pyrazolyl moieties of the ligand were investigated (Figure 53). Here the 
3/5-isomerisation effect of pyrazolyl was observed, which for example already occurred 
during the synthesis of L4/L4’. Normally BPM ligands of the second generation would not 
form bisfacial complexes; however, with one isopropyl group in the 3- and one in the 5-
position of the pyrazolyl moiety, steric hindrance is overcome and a bisfacial coordination 
mode is generated. All bisfacial cobalt complexes point towards the pyrazolyl N-donor to be 
the stronger donor in comparison to pyridine, although pyridine is the more basic one. In 
addition the monofacial cobalt complex [CoCl2{HC(3-tBuPz)2(Py)}] (C11) was synthesised and 
compared to its isomer (which has been characterised before[125]), showing a stronger 
distortion towards a trigonal bipyramidal geometry. 
 
During this thesis both the efficient stoichiometric oxidation of phenolates to catecholates at 
−80°C and catalytic oxidation of phenols to quinones at room temperature, through a 
reaction pathway consistent with the generally accepted enzymatic mechanism of tyrosinase 
could be shown applying the new HC(3-tBuPz)2(1-MeIm) ligand. With HC(3-tBuPz)2(Qu) the 
catalytic activity of the according (μ-η2:η2)-copper(II) species was shown via a self-assembly 
approach.[160] These results show that bis(pyrazolyl)methane copper complexes possess a 
large potential for further catalytic hydroxylation applications in synthetic organic chemistry. 
 
4.2 Outlook 
 
In order to understand the reaction mechanism concerning the formation as well as the 
subsequent catalytic reactions of ([Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 in more detail, 
stopped-flow measurements as well as Hammett correlations would be reasonable next 
steps. Additionally more different substrates should be tested concerning the transfer of 
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oxygen. Single crystals of both peroxo species would help in the further characterisation and 
the understanding of such complexes. 
Continuative experiments could also include the development of further 
bis(pyrazolyl)methane ligands for use in the activation of oxygen. While three 
bis(pyrazolyl)methane copper peroxo complexes have been characterised so far (two in this 
thesis and one by A. Hoffmann in 2011[18]), each of them can be optimised concerning for 
example their stability, effectivity or reaction time. So in order to avoid certain drawbacks, 
new bis(pyrazolyl)methane ligands could incorporate different third donor functions. 
Furthermore the analysis of more structural data of monofacial complexes containing the 
HC(3-tBuPz)2(1-MeIm) ligand would be helpful in the deeper understanding of the electronic 
structure of such complexes as well as the donor force of imidazolyl and its role in the band-
shift of the according UV/Vis bands. 
For continuative investigations concerning the superoxide mimic species, the detailed 
characterisation of reaction products as well as single crystals would be helpful. 
Another field to further investigate would be the activation of small molecules like NO or 
CO2 based on first results that were presented here. Hereby not only copper complexes but 
also those with other transition metals like cobalt, iron and zinc could be explored. 
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5 Experimental Section 
5.1 General 
All experiments involving moisture- and air-sensitive compounds were carried out by using 
standard Schlenk techniques. The solvents used were dried by standard literature 
procedures.[196] Nitrogen was obtained from the house supply and predried with sicapent 
and porous ceramics. 
5.2 Physical Methods 
Mass spectrometry 
HR-cryo-ESI: In cooperation with Prof. Dr. I. Ivanović-Burmazović at the FAU Erlangen-
Nürnberg, cryospray-ionisation MS (CSI-MS) measurements were performed on a UHR-TOF 
Bruker Daltonik (Bremen, Germany) maXis plus 5G, an ESI-ToF MS capable of resolution of at 
least 60,000 FWHM, which was coupled to a Bruker Daltonik Cryospray unit. Detection was 
in positive-ion mode and the source voltage was 4.5 kV. The flow rates were 250 µL/hour. 
The drying gas (N2), to aid solvent removal, was held at −75°C and the spray gas was held at -
80°C. The machine was calibrated prior to every experiment via direct infusion of the Agilent 
ESI-TOF low concentration tuning mixture, which provided an m/z range of singly charged 
peaks up to 2700 Da in both ion modes. 
FAB: Fast-atom bombardment (FAB) mass spectra were obtained with a Thermo Finnigan 
MAT 95 or a Jeol MStation sectorfield mass spectrometer. Ionisation was achieved with 
accelerated xenon atoms (8 kV) in a glycerin or 2-nitrobenzylalcohol matrix on a copper 
target. For low resolution measurements, the resolution was at about 1000 and for high 
resolution at about 5000. Depending on the method, areas between 40 and 3040 u were 
recorded. 
ESI: Electronspray ionisation (ESI) mass spectra were obtained from a Thermo Finnigan LTQ 
Ultra Fourier Transform Ion Cyclotron Resonance Mass Spectrometer. Resolution was 
adjusted to 100,000 at m/z = 400. Depending on the method areas between 50 and 2000 u 
were recorded. ESI measurements were performed at an IonMax ionic source with ESI-head. 
The source voltage was 4 kV with a spray capillary temperature of 250°C, a sheathgas 
flowrate of 25 and a sweepgas flowrate of 5 units. 
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X-Ray absorption spectroscopy 
X-Ray absorption spectroscopy measurements were performed by Prof. Dr. M. Bauer and 
coworkers of the University of Paderborn. 
Measurements at the Cu K-edge were carried out at the beamline BM23 of the European 
Synchrotron Radiation Facility ESRF (Grenoble, France) in fluorescence mode making use of a 
hyperpure solid state Ge detector. The sample was measured in frozen solution at liquid 
nitrogen temperature using CH2Cl2 as matrix. Due to the low concentration of 0.01 mol L
−1 
several scans were conducted and averaged to increase the signal to noise ratio. Data 
reduction followed standard procedures.[151] Due to the high residual noise Fourier filtering 
was applied in the range ∆r = 3–11.5 Å. 
 
NMR spectroscopy 
For the measurement of 1H- and 13C-spectra, a Jeol EX-400 or Jeol EX-270 nuclear resonance 
sprectrometer was used and spectra were recorded at 25°C. Assignment of NMR signals was 
done with the help of additional 2D experiments (DEPT-135, COSY, HMBC, HMQC). 
Deuterated chloroform was used as solvent and functioned as internal standard (CDCl3: 
7.26 ppm). Chemical shifts refer to the δ-scale and are listed in ppm. Spin-spin coupling 
constants (nJ) are given in Hertz (Hz) with n being the number of bonds between coupling 
nucleuses. The multiplicity of signals is described as follows: s = singlet, d = doublet, t = 
triplet, sept = septet, m = multiplet.  
Elemental analysis 
Elemental analyses were performed with a Vario EL or Vario MICRO CHNS analyser. 
UV/Vis spectroscopy 
UV/Vis spectra were recorded with a Varian Cary 60 spectrophotometer from Agilent 
Technologies in combination with a fibre-optic quartz glass immersion probe (Hellma, 1 mm) 
in a customised Schlenk measurement-cell. 
Infrared spectroscopy 
Infrared spectra were recorded with a Jasco FTIR 460 spectrophotometer in the range of 
650–3500 cm–1. Measurements took place at room temperature in the ATR measurement 
mode. 
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X-ray diffraction analysis 
The crystal data for L1, L2 and L3’ as well as C1–C10 are presented in Tables 30–36. 
The data was collected either with a KappaCCD (Bruker 396 AXS BV) (C2), a Bruker D8 Quest 
(C3, C5–C7, C9), a Bruker D8 Venture (C1, C4, C8) or an Oxford KM4 XCalibur2 (L1, L2, L3’, 
C10, C11) diffractometer with graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). 
Data reduction and absorption correction was performed with HKL Denzo and Scalepack 
(C2)[197], with SAINT and SADABS (C1 and C3–C9)[198] or with the programs CRYSALIS (Oxford, 
UK, 2008) and CRYSALIS RED (Oxford, UK, 2008) (L1–L3’, C10, C11). 
The structures were solved by direct and conventional Fourier methods and all non-
hydrogen atoms were refined anisotropically with full-matrix least-squares cycles based on 
F2 (XPREP,[199] SHELXS[200] and ShelXle[201]). Hydrogen atoms were derived from difference 
Fourier maps and placed at idealised positions, riding on their parent C atoms, with isotropic 
displacement parameters Uiso(H) = 1.2 Ueq(C) and 1.5 Ueq(C methyl). All methyl groups were 
allowed to rotate but not to tip. For refinement fullmatrix least-squares methods were 
applied (SHELXL97).[202] 
 
5.3 Computational details 
DFT calculations were performed with the Gaussian09 program suite.[135] The geometries of 
C1–C4 were optimised using the nonlocal hybrid meta GGA TPSSh functional[203] and the 
double-ζ basis set 6-31G(d) as implemented in Gaussian on all atoms. The starting 
geometries for complexes C1–C4 were generated from the molecular structures. Frequency 
calculations did not show imaginary values. NBO calculations for the complexes were 
accomplished by using the NBO 6.0 program suite.[142,163,164] 
Geometry optimisation and TD-DFT calculations of the singlet nitrosobenzene species was 
done by using the BP86 functional[204–206] and the double-ζ basis set 6-31G(d) as 
implemented in Gaussian on all atoms.[186] 
For the geometry optimisation of C5–C7 on which NBO analysis was based, the BP86 
functional and the double-ζ basis set 6-31G(d) as implemented in Gaussian was used on all 
atoms on the basis of the molecular structures.  
The geometries of the peroxo species were optimised by A. Hoffmann using the nonlocal 
hybrid meta GGA TPSSh functional[203] and the double-ζ basis set 6-31G(d) as implemented in 
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Gaussian on all atoms. Continuous spectra were plotted with the AOMix program by A. 
Hoffmann as well.[207,208] 
 
5.4 Chemicals 
The following chemicals were purchased and used as received without further purification, 
except from the oily suspension of sodium hydride, which was washed with dry pentane 
several times before use. 
n-Butyllithium (2.5M solution in hexane, Sigma-Aldrich), 1-methylimidazole (99%, Sigma-
Aldrich), cobalt(II) chloride (p.a., anhydrous, Sigma-Aldrich), deuterated chloroform (99.8% 
D, H2O < 0.01%, euriso-top), magnesiumsulphate (99%, Grüssing), sodiumchloride (≥ 99%, 
Bernd Kraft), sodiumhydride (57–63%, oily despersion, Alfa-Aesar), sodiumsulphate (p.a., 
Riedel-de-Haën), thionylchloride (>99.5%, Acros Organics), pyridine-2-carboxaldehyde (99%, 
ABCR), p-toluenesulfonic acid monohydrate (99%, ABCR), sodiumcarbonate (waterfree, 
VWR), copper(II)chloride dehydrate (99%, Applichem), copper(II)bromide (98%, Fluka), 
cobalt(II)nitrate hexahydrate (99.9%, Sigma-Aldrich), zincnitrate hexahydrate (98%, 
Applichem), silverhexafluoroantimonate (98%, ABCR), nitrosobenzene (≥ 97%, Sigma-
Aldrich), 8-hydroxyquinoline (98%, ABCR), 4-Methoxyphenol (≥ 98%, Alfa-Aesar), NEt3 (99%, 
Acros Organics), acetophenone (for synthesis, Merck) 
 
5.5 Syntheses 
5.5.1 Synthesis of starting materials 
The starting materials isopropylpyrazole[209], tertbutylpyrazole[161], pyrazole[210], quinolone-2-
carboxaldehyde[211], CuCl[212] were synthesised according to literature. Co(OTf)2 was available 
in the group and had been synthesised according to Funahashi et al.[213] 
The substituted phenolates 4-nitrophenolate, 4-methoxyphenolate, as well as phenolate 
were synthesised according to Casella et al.[214] 
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5.5.2 Synthesis of 1-methyl-2-imidazolealdehyde adapted from[215] 
At −78°C under nitrogen, n-BuLi (48.2 mL, 0.12 mol, 2.5 M solution in 
hexane, 1 eq) is added dropwise to a solution of  
1-methylimidazole (9.89 g, 0.12 mol, 1 eq) dissolved in 100 mL of dry 
THF. The solution is stirred at −78°C for 1h, before DMF (23.2 mL, 
0.30 mol, 2.5 eq) is added. The formation of a colourless precipitate 
can be observed. Following stirring for an additional hour at −78°C, 
the reaction mixture is warmed to room temperature and stirred 
overnight. The reaction is quenched by the addition of 150 mL of 
water, resulting in the dissolution of the colourless solid. The aqueous phase is extracted 
with CH2Cl2 (5 × 100 mL). The combined organic phases are washed with water (75 mL) and 
brine (75 mL) and dried over Na2SO4. The solvent is reduced under vacuum and the product 
is purified by vacuum distillation (44°C, 6.2 × 10−2 mbar), yielding 1-methyl-2-
imidazolealdehyde as a colourless wax (7.97 g, 72.4 mmol, 60%). 
1H-NMR (400 MHz, CDCl3, 25°C): δ [ppm] = 3.98 (s, 3H, 1-H), 7.07 (d, 
3JHH = 0.8 Hz, 1H, 2-H), 
7.23 (d, 3JHH = 0.8 Hz, 1H, 3-H), 9.77 (s, 1H, 4-H).  
13C-NMR (100 MHz, CDCl3, 25°C): δ [ppm] = 35.0 (C-a), 127.4 (C-b), 131.6 (C-c), 143.8 (C-d), 
182.2 (C-e). 
HR-EI+-MS (m/z (%)): 110.048 [M]+, (m/z calcd. for C5H6N2O = 110.056). 
Analytic data is in accord with the corresponding literature data.[215] 
 
5.5.3 Synthesis of ligands L2, L5, L6 and L7 
The ligands HC(3-tBuPz)2(Qu) (L2), HC(3-tBuPz)2(Py) (L5), HC(Pz)2(Py) (L6) and HC(Pz)2(Qu) 
(L7) were synthesised according to literature.[117] 
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5.5.3.1 Synthesis of 2-(1-methylimidazolyl)bis(3-tertbutylpyrazolyl)methane  
HC(3-tBuPz)2(1-MeIm) (L1) 
3-tertbutylpyrazole (5.00 g, 0.40 mol, 2 eq) is added in 
small portions to a slurry of NaH (1.00 g, 0.42 mol, 
2.1 eq) in 50 mL of freshly distilled, dry THF at 0°C under 
vigorous stirring, until no more gas evolution is visible. 
Next, thionylchloride (1.50 mL, 0.20 mol, 1 eq) is added 
dropwise to the yellow suspension at 0°C and stirred 
firstly at 0°C for 30 min and afterwards at room 
temperature for another 45 min 1-Methylimidazole-2-
carboxaldehyde (2.20 g, 0.20 mol, 1 eq) and catalytic 
amounts of CoCl2 (0.05 g) are added, before the mixture 
is refluxed overnight and the evolution of SO2 gas is visible. The solution changes colour to 
red-orange. After cooling the reaction mixture to room temperature, water (50 mL) and 
diethyl ether (50 mL) are added, followed by 2h of stirring. Lastly, the combined organic 
phases are extracted with diethyl ether (3 × 45 mL) and washed with water (2 × 50 mL) and 
brine (2 × 50 mL). The combined organic phases are dried over Na2SO4 and the solvent is 
reduced in vacuo. The product is gained by vacuum distillation (40°C, 1.4 × 10−2 bar) in the 
second fraction as single crystals in good yield (4.7 g, 0.14 mol, 69%). The crystals were 
characterised via X-ray diffraction analysis. 
1H-NMR (400 MHz, CDCl3, 25°C): δ [ppm] = 1.26 (s, 18H, 1-H), 3.45 (s, 3H, 2-H), 6.15 (d, 
3JHH = 
2.5 Hz, 2H, 3-H), 6.87 (d, 3JHH = 1.2 Hz, 1H, 4-H), 7.04 (d, 
3JHH = 1.2 Hz, 1H, 5-H), 7.44 (d, 
3JHH = 
2.5 Hz, 2H, 6-H), 7.64 (s, 1H, 7-H). 
13C-NMR (100 MHz, CDCl3, 25°C): δ [ppm] = 30.6 (C-a), 32.2 (C-b), 33.1 (C-c), 71.5 (C-d), 103.5 
(C-e), 122.8 (C-f), 128.0 (C-g), 129.4 (C-h), 142.0 (C-i), 163.1 (C-j). 
ATR-IR: 	
 [cm−1] = 2959 [w, (ν, CHaliph)], 2928 [w, (ν, CHaliph)], 2902 [w, (ν, CHaliph)], 2866 [vw, 
(ν, CHaliph)], 1531 (w), 1519 (m), 1501 (w), 1478 (w), 1461 (w), 1400 (w), 1362 (w), 1335 (m), 
1317 (w), 1281 (w), 1244 (m), 1225 (w), 1206 (w), 1189 (w), 1153 (m), 1135 (w), 1046 (m), 
1022 (w), 993 (w), 927 (w), 852 (w), 818 (m), 805 (s), 762 (vs), 724 (m), 698 (m), 664 (w). 
ESI+-MS (acetone) (m/z (%)): 364 (17) [(HC(3-tBuPz)2(1-MeIm)], +H, +Na]
+, 363 (100) [(HC(3-
tBuPz)2(1-MeIm)], +Na]
+, 341 (42) [(HC(3-tBuPz)2(1-MeIm)], +H]
+, 218 (10) [C10H19N4, +Na]
+, 
217 (96) [C12H17N4]
+, 214 (1) [C13H16N3]
+. 
HR-ESI+-MS (acetone) (m/z (%)): 363.227 [M+Na]+ (m/z calcd. for C19H28N6Na = 363.46). 
N
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EA: C19H28N6 (340.48 g/mol): calcd. C 67.0, H 8.3, N 24.7; found C 67.1, H 8.3, N 24.3. 
 
5.5.3.2 Synthesis of 2-(Pyridinyl)bis(3-isopropylpyrazolyl)methane 
HC(3-iPrPz)2(Py) (L3) 
3-Isopropylpyrazole (11.02 g, 0.10 mol, 2 eq) is added in 
small portions to a slurry of NaH (2.88 g, 0.12 mol, 
2.2 eq) in 100 mL of freshly distilled, dry THF at 0°C 
under vigorous stirring, followed by continuous stirring 
at 0°C, until no more gas evolution is visible. Next, 
thionylchloride (3.70 mL, 0.05 mol, 1 eq) is added 
dropwise to the yellow suspension. It follows stirring at 
0°C for 30 min and afterwards at room temperature for 
another 45 min Pyridin-2-carboxaldehyde (5.40 g, 
0.05 mol, 1 eq) and catalytic amounts of CoCl2 (0.17 g) are added, before the mixture is 
refluxed overnight and the evolution of SO2 gas is visible. After cooling the reaction mixture 
to room temperature, water (70 mL) and diethyl ether (70 mL) are added, followed by 2h of 
stirring. Lastly, the combined organic phases are extracted with diethyl ether (3 × 60 mL) 
and washed with water (70 mL). The combined organic phases are dried over Na2SO4 and the 
solvent is reduced in vacuo. The raw product mixture of the isomerised HC(3-iPrPz)(5-
iPrPz)(Py) and HC(3-iPrPz)2(Py) is obtained by vacuum distillation (130°C, 3 × 10
−3 bar) as the 
second fraction (8.26 g, 26.0 mmol, 53%). 
For the reisomerisation of HC(3-iPrPz)(5-iPrPz)(Py), the mixture is dissolved in 75 mL of 
toluene and catalytic amounts of p-toluenesulfonic acid (0.38 g, 2.00 mmol) are added. The 
mixture is heated to reflux for 24 h. After cooling to room temperature, a solution of Na2CO3 
(5%, 150 mL) is added for neutralisation. The organic phase is separated, washed with water 
(3 x 30 mL) and dried over MgSO4. At last the solvent is reduced in vacuo. The product is 
obtained by vacuum distillation as a yellow viscous oil (130°C, 2 × 10−3 bar, 6.84 g, 
22.1 mmol, 85%). 
1H-NMR (400 MHz, CDCl3, 25°C): δ [ppm] = 1.23 (d, 
3JHH = 10.0 Hz, 12H, 1-H), 2.98 (sept., 
3JHH = 10.0 Hz, 2H, 2-H), 6.12 (d, 
3JHH = 3.6 Hz, 2H, 3-H), 6.93 (d, 
3JHH = 11.8 Hz, 
4JHH = 0.8 Hz 
1H, 4-H), 7.21–7.26 (m, 1H, 5-H), 7.41 (d, 3JHH = 3.6 Hz, 2H, 6-H), 7.58 (s, 1H, 7-H), 7.66 (td, 
3JHH = 11.8 Hz, 
4JHH = 2.8 Hz, 1H, 8-H), 8.59–8.62 (m, 1H, 9-H). 
N
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13C-NMR (100 MHz, CDCl3, 25°C): δ [ppm] = 22.9 (C-a), 27.9 (C-b), 78.4 (C-c), 103.2 (C-d), 
122.2 (C-e), 123.7 (C-f), 130.1 (C-g), 137.1 (C-h), 149.7 (C-i), 155.5 (C-j), 160.5 (C-k). 
ATR-IR: 	
 [cm−1] = 2961 [w, (ν, CHaliph)],, 2930 [w, (ν, CHaliph)], 2870 [w, (ν, CHaliph)], 1589 (w), 
1573 (w), 1522 (m), 1471 (m), 1457 (w), 1436 (m), 1402 (w), 1380 (w), 1362 (w), 1326 (w), 
1288 (m), 1264 (w), 1215 (m), 1150 (w), 1094 (w), 1068 (m), 1048 (m), 996 (m), 926 (w), 
870 (w), 839 (w), 808 (m), 751 (vs), 719 (m), 673 (m). 
ESI+-MS (acetone) (m/z (%)): 333 (4) [(HC(3-iPrPz)2(Py), +H, +Na]
+, 332 (21) [(HC(3-iPrPz)2(Py), 
+Na]+, 201 (9) [C10H16N3, +Na]
+, 200 (100) [C12H14N3]
+, 158 (<1) [C9H8N3]
+. 
HR-ESI+-MS (acetone) (m/z (%)): 333.189 (10) [HC(3-iPrPz)2(Py), +H, +Na]
+, 332.185 (50) 
[HC(3-iPrPz)2(Py), +Na]
+, 310.203 (16) [HC(3-iPrPz)2(Py), +H]
+. (m/z calcd. for C18H24N5Na = 
333.19, C18H23N5Na = 332.19, C18H24N5 = 310.20) 
 
5.5.3.3 Synthesis of a mixture containing 2-(Quinolinyl)(3-isopropylpyrazolyl) 
(5-isopropylpyrazolyl)methane HC(3-iPrPz)(5-iPrPz)(Qu) (L4’) and 
2-(Quinolinyl)bis(3-isopropylpyrazolyl)methane HC(3-iPrPz)2(Qu) (L4) 
3-Isopropylpyrazole (18.40 g, 0.17 mol, 2.0 eq) is 
added in small portions to a slurry of NaH (4.00 g, 
0.12 mol, 2.0 eq) in 130 mL of freshly distilled, dry 
THF at 0°C under vigorous stirring, followed by 
continuous stirring at 0°C, until no more gas 
evolution is visible. Next, thionylchloride 
(6.50 mL, 0.09 mol, 1 eq) is added dropwise to 
the yellow suspension. It follows stirring at 0°C 
for 30 min and afterwards at room temperature 
for another 45 min Quinoline-2-carboxaldehyde (13.1 g, 0.09 mol, 1 eq) and catalytic 
amounts of CoCl2 (0.30 g) are added, before the mixture is refluxed overnight and the 
evolution of SO2 gas is visible. After cooling the reaction mixture to room temperature, 
water (160 mL) and diethyl ether (80 mL) are added, followed by 2h of stirring. Lastly, the 
combined organic phases are extracted with diethyl ether (3 × 80 mL) and washed with 
water (80 mL). The combined organic phases are dried over Na2SO4 and the solvent is 
reduced in vacuo. A mixture of the products HC(3-iPrPz)(5-iPrPz)(Qu) and HC(3-iPrPz)2(Qu) is 
obtained by vacuum distillation (170°C, 8 × 10−2 bar) as the second fraction. Attempts to 
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reisomerise the product failed, as the following distillation led to isomerisation and a 
mixture of HC(3-iPrPz)(5-iPrPz)(Qu) and HC(3-iPrPz)2(Qu) was obtained again. 
1H-NMR (270 MHz, CDCl3, 25°C): δ [ppm] = 1.19–1.41 (m, 12H, 1-H), 2.92–3.42 (m, 2H, 2-H), 
6.13–6.17 (m, 2H, 3-H), 7.14–7.21 (m, 1H, 4-H), 7.48 (d, 3JHH = 2.4 Hz, 1H, 5-H), 7.50 (d, 
3JHH = 2.7 Hz, 1H, 6-H), 7.52–7.58 (m, 1H, 7-H), 7.64–7.71 (m, 1H, 8-H), 7.77–7.83 (m, 1H, 9-
H), 7.84 (s, 1H, 10-H), 8.05 (t, 3JHH = 9.5 Hz, 1H, 11-H), 8.15 (dd, 
3JHH = 8.4 Hz, 
5JHH = 4.6 Hz, 
1H, 12-H). 
The presence of HC(3-iPrPz)2(Qu) and HC(3-iPrPz)(5-iPrPz)(Qu) leads to signal overlaps in the 
NMR spectrum. Due to this and the formation of byproducts, a more detailed 
characterisation is not possible. 
 
5.5.4  Synthesis of transition metal complexes 
5.5.4.1 Synthesis of (2-(1-Methylimidazolyl))bis(3-
tertbutylpyrazolyl)methanedichloridocopper(II) 
[CuCl2{HC(3-tBuPz)2(1-MeIm)}] (C1) 
Copper(II)chloride (0.17 g, 1.00 mmol) is suspended in 5 mL of 
methanol, resulting in a green-brown slurry. A solution of  
HC(3-tBuPz)2(1-MeIm) (0.34 g, 1.00 mmol) dissolved in 5 mL of 
methanol is added dropwise to the copper-salt mixture and after 
stirring for 16h at room temperature a deep green solid precipitates. 
Storage of the mixture at room temperature resulted in single-
crystals suitable for X-ray diffraction analysis (0.14 g, 0.29 mmol, 30%). 
ATR-IR: 	
 [cm−1] = 3100 [vw, (ν, CHarom)], 2902 [w, (ν, CHaliph)], 2865 [w, (ν, CHaliph)], 1518 (m), 
1474 (w), 1459 (w), 1417 (w), 1350 (m), 1229 (m), 1204 (w), 1152 (w), 1081 (w), 1054 (w), 
970 (w), 861 (m), 831 (w), 811 (m), 803 (vs), 782 (vs), 770 (vs), 756 (m), 728 (w), 699 (m), 
669 (w), 634 (w), 627 (w), 614 (m), 603 (m). 
FAB+-MS (m/z (%)): 440 (16) [Cu37Cl{(HC(3-tBuPz)2(1-MeIm)}]
+, 438 (20) [Cu35Cl{(HC(3-
tBuPz)2(1-MeIm)}]
+, 403 (40) [Cu{(HC(3-tBuPz)2(1-MeIm)}]
+, 342 (15) [HC(3-tBuPz)2(1-
MeIm)]+, 217 (100) [HC(3-tBuPz)(1-MeIm)]+, (m/z calcd. for C19H28ClCuN6
+ = 438.1). 
EA: C19H28Cl2CuN6 (474.92 g/mol): calcd. C 48.1, H 5.9, N 17.7; found C 47.9, H 6.0, N 17.7. 
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5.5.4.2 Synthesis of Bis(3-tertbutylpyrazolyl)(2-quinolinyl)methanechloridocopper(I) 
[CuCl{HC(3-tBuPz)2(Qu)}] (C2) 
A yellow solution of HC(3-tBuPz)2(Qu) (0.39 g, 1.00 mmol) dissolved in 
5 mL of acetone, is added dropwise to a colourless solution of CuCl 
(0.10 g, 1.00 mmol) dissolved in 20 mL of acetonitrile. The solution 
turns orange and after 18h a red solid precipitates. After filtering off 
the solid matter, red crystals are obtained from the filtrate at 5°C after 
several days (0.32 g, 0.66 mmol, 66%). The crystals are characterised 
via X-ray diffraction analysis.  
ATR-IR: 	
 [cm−1] = 3106 [vw (ν, CHarom)], 2960 [w, (ν, CHaliph)], 2904 [vw, (ν, CHaliph)], 
2862 [vw, (ν, CHaliph)], 1619 (vw), 1596 (w), 1572 (vw), 1556 (vw), 1518 (m), 1480 (w), 
1456 (w), 1439 (w), 1420 (w), 1392 (vw), 1378 (w), 1363 (w), 1352 (w), 1335 (w), 1307 (vw), 
1236 (m), 1186 (vw), 1157 (w), 1124 (vw), 1057 (m), 977 (w), 930 (w), 873 (vw), 842 (w), 
827 (w), 806 (m), 790 (m), 775 (vs), 746 (w), 727 (w), 687 (vw), 668 (w), 653 (vw). 
FAB+-MS ( m/z (%)): 487 (2) [Cu37Cl{HC(3-tBuPz)2(Qu)}]
+, 485 (2) [Cu35Cl{HC(3-tBuPz)2(Qu)}]
+, 
450 (26) [Cu{HC(3-tBuPz)2(Qu)}]
+, 389 (9) [{HC(3-tBuPz)2(Qu)}+H]
+, 275 (7) [{HC(Pz)2(Qu)}]
+
, 
(m/z calcd. for C24H29ClCuN5 = 485.1). 
EA: C24H29ClCuN5 (486.53 g/mol): calcd. C 59.3, H 6.0, N 14.4; found C 59.2, H 6.0, N 14.3. 
 
5.5.4.3 Synthesis of (2-Pyridinyl)bis(3-tertbutylpyrazolyl)methanechloridocopper(I) 
[CuCl{HC(3-tBuPz)2(Py)}] (C3) 
A yellow solution of HC(3-tBuPz)2(Py) (0.34 g, 1.00 mmol) dissolved in 
5 mL of acetone, is added dropwise to a colourless solution of CuCl 
(0.10 g, 1.00 mmol) dissolved in 20 mL of acetonitrile. The solution 
turns yellow and is stored at 5°C over night, where the solution turns 
light-green. Concentration of the solvent until a solid precipitates and 
storage of the filtrate at 5°C results in yellow crystals (0.11 g, 
0.25 mmol, 25%). The crystals are characterised via X-ray diffraction 
analysis. 
ATR-IR: 	
 [cm−1] = 3107 [vw (ν, CHarom)], 2957 [w, (ν, CHaliph)], 2904 [w, (ν, CHaliph)], 2862 [w, 
(ν, CHaliph)], 1597 (w), 1574 (vw), 1519 (m), 1478 (w), 1443 (w), 1415 (w), 1392 (vw), 
1362 (w), 1348 (w), 1335 (w), 1271 (w), 1236 (m), 1158 (w), 1053 (m), 1013 (w), 1004 (w), 
879 (w), 869 (w), 843 (m), 823 (w), 776 (s), 757 (vs), 737 (m), 728 (m), 675 (m), 656 (w). 
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FAB+-MS (m/z (%)): 437 (30) [Cu37Cl{HC(3-tBuPz)2(Py)}]
+, 435 (40) [Cu35Cl{HC(3-tBuPz)2(Py)}]
+, 
400 (100) [Cu{HC(3-tBuPz)2(Py)}]
+, 337 (<1) [HC(3-tBuPz)2(Py)]
+ (m/z calcd. for C20H27ClCuN5 
= 435.1). 
EA: C20H27ClCuN5 (436.47 g/mol): calcd. C 55.0, H 6.2, N 16.1; found C 54.9, H 6.3, N 16.1. 
 
5.5.4.4 Synthesis of (2-Pyridinyl)bis(3-tertbutylpyrazolyl)methanedibromidocopper(II) 
[CuBr2{HC(3-tBuPz)2(Py)}] (C4) 
A yellow solution of HC(3-tBuPz)2(Py) (0.34 g, 1.00 mmol) dissolved in 
5 mL of methanol, is added dropwise to a suspension of CuBr2 (0.22 g, 
1.00 mmol) in 7 mL of methanol. The mixture is stirred for 20h. 
During this time the solution turns dark green and a violet solid 
precipitates. Dark red crystals could be obtained by filtration and 
storage of the filtrate at 5°C for several days. The crystals are 
characterised via X-ray diffraction analysis (0.11 g, 0.20 mmol, 20%). 
ATR-IR: 	
 [cm−1] = 3106 [w (ν, CHarom)], 3068 [vw (ν, CHarom)], 2958 [w, (ν, CHaliph)], 2920 [w, 
(ν, CHaliph)], 2868 [vw, (ν, CHaliph)], 1604 (w), 1522 (m), 1475 (w), 1468 (w), 1447 (m), 
1435 (w), 1417 (w), 1393 (vw), 1362 (w), 1343 (w), 1302 (w), 1267 (m), 1236 (s), 1207 (m), 
1163 (m), 1111 (w), 1065 (m), 1022 (m), 1000 (w), 928 (vw), 880 (m), 838 (m), 819 (m), 
770 (vs), 739 (m), 727 (m), 677 (m), 643 (m), 608 (m). 
FAB+-MS (m/z (%)): 481 (53) [Cu81Br{HC(3-tBuPz)2(Py)}]
+, 479 (47) [Cu79Br{HC(3-
tBuPz)2(Py)}]
+, 401 (100) [Cu{HC(3-tBuPz)2(Py)}]
+, 337 (3) [HC(3-tBuPz)2(Py)]
+, 214 (98) [HC(3-
tBuPz)(Py)]+, (m/z calcd. for C20H27BrCuN5 = 479.1). 
EA: C20H27Br2CuN5 (560.82 g/mol): calcd. C 42.8, H 4.9, N 12.5; found C 42.5, H 4.9, N 12.4. 
 
5.5.4.5 Synthesis of (2-Pyridinyl)bis(3-tertbutylpyrazolyl)methanedinitratocobalt(II) 
[Co(NO3)2{HC(3-tBuPz)2(Py)}]∙CH2Cl2 (C5) 
A solution of HC(3-tBuPz)2(Py) (0.34 g, 1.00 mmol) dissolved in 5 mL of 
acetone is added dropwise to a solution of Co(NO3)2 · 6 H2O (0.29 g, 
1.00 mmol) dissolved in 5 mL of acetone as well. The solution turns 
dark magenta and a solid precipitates. The suspension is filtered and 
dried in vacuo. Dissolution of the solid in acetonitrile and diffusion of 
CH2Cl2 results in magenta crystals (0.40 g, 0.66 mmol, 66%), which are 
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characterised by single-crystal X-ray diffraction analysis. 
ATR-IR: 	
 [cm−1] = 3142 [vw (ν, CHarom)], 3127 [vw (ν, CHarom)], 3112 (vw, (ν, CHarom)), 
3078 [vw (ν, CHarom)], 2970 [w, (ν, CHaliph)], 2871 [vw, (ν, CHaliph)], 1739 (m), 1603 [w, (ν, NO)], 
1526 (w), 1507 (w), 1480 (w), 1446 (m), 1429 (m), 1412 (m), 1386 (m), 1339 [vs, (ν, NO)], 
1321 (vs), 1294 (m), 1271 (m), 1233 (m), 1216 (m), 1157 (w), 1102 (w), 1077 (m), 1053 (m), 
1036 (m), 1019 (w), 952 (w), 878 (m), 844 (m), 828 (m), 766 [s, (ν, NO)], 741 (m), 698 (w), 
676 (m). 
FAB+-MS (m/z (%)): 458 (100) [Co(NO3){HC(3-tBuPz)2(Py)}]
+, 338 (10) [C20H28N5]
+, (m/z calcd. 
for C20H27CoN6O3 = 458.2). 
FAB−-MS (m/z (%)): 62 (20) [NO3
−]. 
EA: C20H27CoN7O6·CH2Cl2 (605.34 g/mol): calcd. C 41.67, H 4.83, N 16.20; found C 41.73, 
H 4.77, N 16.28. 
 
5.5.4.6 Synthesis of ((2-Pyridinyl)bis(3-isopropylpyrazolyl)methanedinitratocobalt(II) 
[Co(NO3)2{HC(3-iPrPz)2(Py)}] ∙MeOH (C6) 
A solution of HC(3-iPrPz)2(Py) (0.31 g, 1.00 mmol) dissolved in 5 mL of 
acetone is added dropwise to a solution of Co(NO3)2 · 6 H2O (0.13 g, 
1.00 mmol) dissolved in 5 mL of acetone as well. Storage at 5°C results 
in the precipitation of magenta needles (0.11 g, 0.21 mmol, 21%), 
which are characterised by single-crystal X-ray diffraction analysis. 
ATR-IR: 	
 [cm−1] = 3112 [vw (ν, CHarom)], 3078 [vw (ν, CHarom)], 
2970 [w, (ν, CHaliph)], 2871 [vw, (ν, CHaliph)], 1739 (m), 1603 [w, (ν, NO)], 1526 (w), 1507 (w), 
1480 (w), 1446 (m), 1429 (m), 1412 (m), 1386 (m), 1339 [vs, (ν, NO)], 1321 (vs), 1294 (m), 
1271 (m), 1233 (m), 1216 (m), 1157 (w), 1102 (w), 1077 (m), 1053 (m), 1036 (m), 1019 (w), 
952 (w), 878 (m), 844 (m), 828 (m), 766 [s, (ν, NO)], 741 (m), 698 (w), 676 (m). 
ESI+-MS (CH3OH): 200 (100) [C10H10N5]
+ (decomposition). 
EA: C18H23CoN7O6·MeOH (524.40 g/mol): calcd. C 44.92, H 5.03, N 18.81; found C 44.87, 
H 4.86, N 19.46. 
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5.5.4.7 Synthesis of ((2-Pyridinyl)bis(3-isopropylpyrazolyl)methanedinitratozinc(II) 
[Zn(NO3)2{HC(3-iPrPz)2(Py)}] (C7) 
A solution of HC(3-iPrPz)2(Py) (0.16 g, 0.5 mmol) dissolved in 2.4 mL 
of acetone is added dropwise to a solution of Zn(NO3)2 · 6 H2O 
(0.15 g, 0.5 mmol) dissolved in 5 mL of acetone. Slow evaporation 
results in colourless crystals (0.46 g, 0.93 mmol, 93%), which are 
characterised by single-crystal X-ray diffraction analysis.  
ATR-IR: 	
 [cm−1] = 3146 [vw (ν, CHarom)], 3129 [vw (ν, CHarom)], 
2990 [w, (ν, CHaliph)], 2965 [w, (ν, CHaliph)], 2932 [vw, (ν, CHaliph)], 2871 [vw, (ν, CHaliph)], 
1602 (w), 1523 (w), 1495 (m), 1462 (m), 1447 (m), 1415 (m), 1391 (m), 1366 (w), 1348 (w), 
1321 (m), 1301 [s, (ν, NO)], 1273 (vs), 1236 (m), 1199 (m), 1065 (m), 1050 (m), 1041 (m), 
1016 (m), 969 (w), 875 (m), 838 (m), 825 (m), 810 (w), 783 [s, (ν, NO)], 761 (s), 735 (m), 
723 (m), 674 (m), 639 (m), 626 (w). 
FAB+-MS (m/z (%)): 437 (60) [66Zn(NO3){HC(3-iPrPz)2(Py)}]
+, 435 (100) [64Zn(NO3){HC(3-
iPrPz)2(Py)}]
+
, 309 (<1) [HC(3-iPrPz)2(Py)]
+ (m/z calc. for C18H23ZnN6O3 = 435.1). 
FAB−-MS (m/z (%)): 496 (5) [M-H]−, 62(89) [NO3
−]. 
EA: C18H23N7O6Zn (498.80 g/mol): calcd. C 43.34, H 4.65, N 19.66; found C 43.34, H 4.85, 
N 19.63. 
 
5.5.4.8 Synthesis of Bis((2-pyridinyl)bis(pyrazolyl)methane)cobalt(II) 
Tetranitratocobaltat 
[Co{HC(Pz)2(Py)}2][Co(NO3)4] ∙2C3H6O (C8) 
A light yellow solution of HC(Pz)2(Py) (0.23 g, 
1.00 mmol) dissolved in 2.5 mL of acetone is added 
dropwise to a solution of Co(NO3)2 · 6 H2O (0.29 g, 
1.00 mmol) dissolved in 2 mL of acetone. The 
solution turns dark and after several minutes the 
formation of a precipitate is noticable. The solid is 
filtered off and the filtrate is stored at 5°C. After 
several days red crystals are obtained (0.2 g, 
0.21 mmol, 21%), which are characterised by single-
crystal X-ray diffraction analysis. 
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ATR-IR: 	
 [cm−1] = 3123 [w (ν, CHarom)], 3077 [w (ν, CHarom)], 3008 [w (ν, CHarom)], 1738 (w), 
1703 (m), 1614 (vw), 1456 (s), 1414 (m), 1362 (s), 1315 (vs), 1281 (vs), 1262 (vs), 1227 (s), 
1106 (w), 1071 (m), 1024 (m), 916(w), 876 (w), 840 (w), 828 (w), 812 (m), 763 (s), 726 (m), 
681 (m), 661 (w), 634 (w). 
FAB+-MS (m/z (%)): 571 (22) [Co(NO3){HC(Pz)2(Py)}2]
+, 509 (13) [Co{HC(Pz)2(Py)}2]
+, 225 (<1) 
[HC(Pz)2(Py)}2]
+
, (m/z calc. for C24H22CoN10 = 509.1) 
FAB−-MS (m/z (%)): 62(31) [NO3
−]. 
 
5.5.4.9 Synthesis of Bis(bis(pyrazolyl)(2-quinolinyl) methane)cobalt(II) ditriflate 
[Co{HC(Pz)2(Qu)}2][OTf]2 (C9) 
An orange solution of HC(Pz)2(Qu) (0.28 g, 
1.00 mmol) dissolved in 5 mL of acetone is added 
dropwise to a solution of Co(OTf)2 (0.36 g, 
1.00 mmol) dissolved in 5 mL of acetone. The 
solution turns red-brown and a beige solid starts 
to precipitate after several minutes. The 
precipitate is dissolved in methanol and diffusion 
of diethyl ether results in yellow crystals (0.23 g, 
0.25 mmol, 25%), which are characterised by 
single-crystal X-ray diffraction analysis. 
ATR-IR: 	
 [cm−1] = 3141 [vw (ν, CHarom)], 3127 [w (ν, CHarom)], 3102 (vw, (ν, CHarom)), 1597 (w), 
1513 (m), 1460 (w), 1446 (w), 1436 (w), 1407 (m), 1380 (w), 1286 [s, (ν, CF3)], 1241 [s, (ν, 
CF3)], 1221 (m), 1163 (s), 1097 (m), 1078 (m), 1066 (m), 1028 [m, (ν, SO3)], 995  (m), 978 (m), 
930 (m), 920 (m), 876 (w), 850 (w), 839 (m), 807 (m), 792 (m), 772 (vs), 681 (w), 667 (w), 
637 (s), 631 (s), 607 (m). 
FAB+-MS (m/z (%)): 758 (15) [Co{HC(Pz)2(Qu)}2(OTf)]
+, 609 (11) [Co{HC(Pz)2(Qu)}2]
+, 333 (11) 
[C16H12CoN5]
+, 275 (<1) [HC(Pz)2(Qu)]
+, (m/z calc. for C33H26CoN10SF3O3 = 758.1). 
FAB−-MS (m/z (%)): 149 (79) [CF3SO3
−]. 
EA: C34H26CoF6N10O6S2 (907.07 g/mol): calcd. C 44.99, H 2.89, N 15.43, S 7.07; found C 44.51, 
H 3.07, N 14.99, S 6.98.  
 
H
C
N
N N
N
Co
C
H
N
N
N
NN
N
2+
2 OTf-
C34H26CoF6N10O6S2
907.69 g/mol
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5.5.4.10 Synthesis of Bis((3-isopropylpyrazolyl)(5-isopropylpyrazolyl)(2-quinolinyl)) 
methanecobalt(II) dinitrate 
[Co{HC(3-iPrPz)(5-iPrPz)(Qu)}2][NO3]2∙2MeOH (C10) 
A yellow solution of a mixture of HC(3-iPrPz) 
(5-iPrPz)(Qu) and HC(3-iPrPz)2(Qu) (0.36 g, 
1.00 mmol) dissolved in 5 mL of acetone is added 
dropwise to a magenta solution of Co(NO3)2 ·6 H2O 
(0.29 g, 1.00 mmol) dissolved in 5 mL of acetone, 
resulting in a red solution, which is stored at 5°C. 
After several days a light orange solid precipitates. 
The solid is filtered off and dried. Dissolving the 
solid in methanol and diffusion of diethyl ether 
yields orange crystals (0.23 g, 0.25 mmol, 25%), which are characterised by single-crystal X-
ray diffraction analysis. 
ATR-IR: 	
 [cm−1] =  3106 [vw (ν, CHarom)], 2967 [w (ν, CHaliph)], 1619 (vw), 1594 (w), 1529 (w), 
1510 (w), 1433 (s), 1415 (m), 1366 (m), 1310 (s), 1291 (vs), 1255 (m), 1242 (m), 1215 (m), 
1198 (w), 1146 (w), 1095 (w), 1070 (w), 1048 (w), 1028 (m), 978 (w), 951 (w), 930 (m), 
884 (w), 846 (m), 809 (m), 783 (vs), 734 (w), 695 (w), 679 (w), 647 (w), 631 (w), 622 (m). 
FAB+-MS (m/z (%)): 417 (3) [C22H24CoN5]
+, (m/z calc. for C22H24CoN5 = 417.1). 
FAB−-MS (m/z (%)): 62 (55) [NO3
−]. 
 
5.5.4.11 Resynthesis of (2-Pyridinyl)(3-tertbutylpyrazolyl)methanedichloridocobalt(II) 
[CoCl2{HC(3-tBuPz)2(Py)}]∙THF[125] (C11) 
A light yellow solution of HC(3-tBuPz)2(Py) (1.69 g, 5.00 mmol) 
dissolved in 50 mL of CH2Cl2 is added dropwise to a deep blue solution 
of CoCl2 (0.65 g, 5.00 mmol) dissolved in 25 mL of acetone. The 
solution turns violet and is stirred at room temperature for 90 min. 
The solvent is reduced in vacuo, yielding a violet solid. The solid is 
dissolved in methanol and diffusion of THF results in violet needles 
(1.31 g, 2.8 mmol, 86%), which are characterised by single-crystal X-ray diffraction analysis. 
ATR-IR: 	
 [cm−1] = 3117 [w (ν, CHarom)], 3069 [vw (ν, CHarom)], 3049 [vw (ν, CHarom)], 2963 (w), 
2908 [w (ν, CHaliph)], 2869 [vw (ν, CHaliph)], 2162 (vw), 2032 (vw), 1743 (vw), 1603 (w), 
1574 (vw), 1521 (m), 1488 (w), 1471 (w), 1459 (w), 1446 (m), 1393 (vw), 1362 (w), 1346 (w), 
N N
N
tBu
N
N
tBu
H
C
Co
Cl Cl
C20H27Cl2CoN5
467.30 g/mol
H
C
N
N N
N
Co
C
H
N
NN
NN
N
iPr
iPr
iPr
iPr
2 NO3
-
2+
C44H50CoN12O6
901.90 g/mol
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1303 (vw), 1270 (w), 1237 (m), 1206 (m), 1162 (w), 1106 (vw), 1066 (m), 1028 (w), 1017 (m), 
1009 (w), 984 (vw), 928 (vw), 882 (w), 840 (m), 821 (w), 775 (vs), 731 (m), 702 (w), 678 (m). 
The analytical data is in accord with the literature.[125] 
 
5.5.5 Synthesis of Bis(2-(1-Methylimidazolyl))bis(3-tertbutylpyrazolyl)methane)-
copper(II)peroxide dihexafluoridoantimonate 
[Cu2O2{HC(3-tBuPz)2(1-MeIm)}2][SbF6]2 (P1[SbF6]2) 
A solution of HC(3-tBuPz)2(1-MeIm) (0.54 g, 
0.16 mmol) dissolved in 5 mL of THF, is added in 
one portion to CuCl (0.17 g, 0.17 mmol,). The 
resulting suspension is stirred for 45 min to 1h. 
While vigorously shaking, a solution of AgSbF6 
(0.61 g, 0.17 mmol) dissolved in 250 μL of THF is 
added and AgCl precipitates, generating the 
precursor solution. In a UV/Vis measurement cell 9 mL of CH2Cl2 are provided and cooled to 
−80°C. Oxygen is bubbled through the solvent for 5 min to generate an oxygen-saturated 
liquid. It follows the addition of 1 mL of the precursor solution, resulting in an immediate 
colour change to deep violet. Formation of the peroxide complex is followed UV/Vis-
spectroscopically (see 3.2.2.1). The concentration of the peroxo complex in solution is 1.5 × 
10−3 mol L−1. 
 
5.5.6 Synthesis of Bis(bis(3-tert-butylpyrazolyl)(2-Quinolinyl)methanecopper(II)-
peroxide dihexafluoridoantimonate 
[Cu2O2{HC(3-tBuPz)2(Qu)}2] [SbF6]2 (P2[SbF6]2) 
A solution of HC(3-tBuPz)2(Qu) (0.62 g, 
0.16 mmol) dissolved in 5 mL of CH2Cl2 is 
added in one portion to CuCl (0.17 g, 
0.17 mmol). The resulting suspension is 
stirred for 45 min to 1h. While vigorously 
shaking, a solution of AgSbF6 (0.61 g, 
0.17 mmol) dissolved in 250 μL of THF is 
added and AgCl precipitates, generating the precursor solution. In a UV/Vis measurement 
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cell 9 mL of CH2Cl2 are provided and cooled to −80°C. Oxygen is bubbled through the solvent 
for 5 min to generate an oxygen-saturated liquid. It follows the addition of 1 mL of the 
precursor solution, and the solution is kept at −80°. A slow colour change to violet is visible 
and after 8h the formation of the peroxide complex is proven by UV/Vis spectroscopy (see 
3.3.2). The concentration of the peroxo complex in solution is 1.5 × 10 −3 mol L−1. 
 
5.5.7 Oxidation of catalytic amounts of exogenous substrate with (P1[SbF6]2) (25 eq of 
phenol, 50 eq. of NEt3) 
OH
O
[Cu2O2{(HC(3-tBuPz)2(1-Me-Im)}2]
2+
O
O
O
DCM, NEt3, -78°C to rt
[Cu2O2{(HC(3-tBuPz)2(1-Me-Im)}2]
2+
DCM, NEt3, -78°C to rt
N
OH
N
O
O
 
P1[SbF6]2 is prepared as described above (see 5.5.5) and its development is followed by 
UV/Vis-spectroscopy. After stabilisation of the optical spectrum, 200 μL of a CH2Cl2 solution 
containing 25eq. of phenol and 50 eq of NEt3 are added. The reaction solution is warmed to 
room temperature and stirred overnight. After 16–18h the reaction is quenched with 3 mL of 
0.5M HCl. The aqueous solution is extracted with CH2Cl2 (3 × 3 mL) and the combined 
organic phases are dried over MgSO4. The solvent is reduced in vacuo, followed by NMR 
spectroscopic characterisation. Turnover numbers are determined by dividing the 
concentration of the built quinone (which was determined from UV/Vis spectroscopical 
data) by the concentration of the peroxo complex. 
 
5.5.8 Oxidation of catalytic amounts of exogenous substrate with (P2[SbF6]2) (25 eq of 
phenol, 50 eq. of NEt3)[160,168] 
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This experiment was performed by A. Hoffmann. A solution of 4-methoxyphenol (25 eq.) and 
triethylamine (50 eq.) in CH2Cl2 (200 μL) was added to the solution of [Cu{HC(3-
tBuPz)2(Qu)}]SbF6 in CH2Cl2 at −78°C and with a fine needle O2 was bubbled through this 
solution. The reaction was monitored by means of UV/Vis spectroscopy. Upon bubbling 
through O2, an intense 418 nm feature developed owing to the formation of the 4-methoxy-
1,2-benzoquinone. The quantity of the quinone formed was determined from the extinction 
coefficient of the quinone minus the residual extinction coefficient of thermally decayed 
P[SbF6]2, thus yielding ten turnovers per dinuclear copper peroxide species after 1h. 
Turnover numbers are determined by dividing the concentration of the built quinone by the 
concentration of the peroxo complex. 
 
5.5.9 Oxidation of stoichiometric amounts (5 eq) of exogenous substrate with 
(P1(SbF6)2) 
 
 
The precursor is prepared according to 5.5.5. 
In a centrifuge tube that is closed with a septum, 5 mL of CH2Cl2 are cooled to −80°C, 
followed by saturation of the solvent with O2. 500 μL of the precursor solution is added and 
an instant colour change to deep violet can be observed. After 15–20 min excess O2 is 
removed by five cycles of vacuum/N2 purging and at least 5 min of purging the cell with N2. 
Next 250 μL of either a THF (R = H, OMe) or MeOH (R = NO2) stock solution containing 5 eq 
of substrate are added, starting the reaction time, which amounts to 5 min for the 
unsubstituted phenolate and 60 min for both the substituted phenolates. The colour of the 
solution changes hereby to black. Reactions are stopped by the addition of 3 mL of 0.5M HCl 
to the solution at −80°C. The aqueous phase freezes and is light yellow, while the organic 
phase turns slightly turquoise. After equilibration to room temperature, a known quantity of 
acetophenone is added to the solution as an internal standard. Following the removal of 
volatiles under vacuum, the residue is extracted with CH2Cl2 (3 × 5 mL) and the combined 
organic phases are passed through a column of MgSO4, before reduction of the solvent in 
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vacuo. The residue is dissolved in CDCl3 for 
1H-NMR spectroscopical characterisation. 
Quantification of the products is done by comparing the amount of product p-catechols and 
the unreacted p-phenolates against the acetophenone standard. 
Preparation of the stock solution: 
 
Sodium phenolate 
M = 116.09 g/mol 
Sodium 
4-methoxyphenolate 
M = 146.12 g/mol 
Sodium 
nitrophenolate 
M = 161.09 g/mol 
n [mmol] 5 5 5 
m [mg] 58 73 81 
Solvent THF (3 mL) THF (3 mL) MeOH (3 mL) 
 
 
5.5.10 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with nitrosobenzene 
HC(3-tBuPz)2(Py) (0.51 g, 0.15 mmol) is dissolved in 2.5 mL of 
the according solvent in which the measurement is 
perfomed (CH2Cl2, THF or CHCl3). The resulting solution is 
added to CuCl (0.17 g, 0.17 mmol) and the mixture is stirred 
at room temperature for 1h. While vigorously shaking, a 
solution of AgSbF6 (0.61 g, 0.17 mmol), dissolved in 250 μL of 
THF, is added and AgCl precipitates, generating the 
precursor solution. In a UV/Vis measurement cell 10 mL of 
the according solvent are provided and cooled to −78°C for 
CH2Cl2 and THF and to −60°C for CHCl3. 
A stock solution containing 0.34 mmol nitrosobenzene in 2.5 mL of solvent (again CH2Cl2, 
THF or CHCl3) is prepared. The according equivalents which are added to the peroxo complex 
are varied by the amount of the injected stock solution. After addition of nitrosobenzene the 
reaction solution turns deep red. 
Depending on the reaction temperature, now the solution is either kept cold or warmed up 
to the desired temperature. Reaction progress is followed by UV/Vis spectroscopy. 
 
 
 
 
N N
N
tBu
N
N
tBu
H
C
Cu
N
O
+
SbF6
-
C26H32CuF6N6OSb
743.88 g/mol
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5.5.11 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with NO gas 
The precursor solution of [Cu{HC(3-tBuPz)2(Py)}][SbF6] is 
prepared in CHCl3 according to 5.5.10. At −60°C NO gas is 
bubbled through the precursor solution for 15 min. Hereby 
the solution turns from light green to light brown. For UV/Vis 
measurements, 10 mL of CHCl3 are provided in a UV/Vis 
measurement cell and cooled to −60°C, followed by the 
addition of 500 μL of the precursor solution after NO 
addition. 
 
5.5.12 Conversion of [Cu{HC(3-tBuPz)2(Py)}][SbF6] with diazald® 
The precursor solution of [Cu{HC(3-tBuPz)2(Py)}][SbF6] is 
prepared in CH2Cl2 according to 5.5.10. For UV/Vis 
measurements, 10 mL of CH2Cl2 are provided in a UV/Vis 
measurement cell at room temperature, followed by the 
addition of 500 μL of the precursor solution. Finally 0.5 eq 
of diazald® dissolved in CH2Cl2 are added. 
 
 
N N
N
tBu
N
N
tBu
H
C
Cu
N
O
+
SbF6
-
C20H27CuF6N6OSb
666.77 g/mol
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Table 29. Crystallographic data collection and refinement information for L1 and C1. 
 L1 (so035) C1 (rv453) 
Empirical formula C19H28N6 C19H28Cl2CuN6 
Formula weight [gmol−1] 340.47 474.91 
Crystal size [mm] 0.37 × 0.31 × 0.10 0.09 × 0.04 × 0.04 
T [K] 173(2) 173(2) 
Crystal system triclinic triclinic 
Space group P P 
a [Å] 6.3373(4) 7.6934(6) 
b [Å] 10.2663(4) 8.0918(7) 
c [Å] 14.8859(7) 18.1881(15) 
α [°] 84.201(4) 89.787(2) 
β [°] 87.172(4) 88.0722(2) 
γ [°] 88.343(3) 84.734(2) 
V [Å3] 961.53(7) 1126.85(16) 
Z 2 2 
ρcalcd. [gcm
−3] 1.176 1.400 
µ [mm−1] 0.074 1.223 
λ [Å] 0.71073 0.71073 
F(000) 368 494 
hkl range −6/7, −12/10, ±18 ± 9, ± 10, ± 22 
Reflections collected 5216 20053 
Independent reflections 3882 4623 
Rint. 0.0149 0.0511 
Reflections observed 3882 4623 
Number of Parameters 233 260 
R1 [I≥2σ(I)] 0.0499 0.0460 
wR2 (all data) 0.1350 0.1128 
Goodness-of-fit 1.037 1.085 
Largest diff. peak, hole [eÅ−3] −0.213, 0.229 −0.512, 0.882 
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Figure 54. Molecular structure of HC(3-tBuPz)2(1-MeIm) (L1, top) and [CuCl2{HC(3-tBuPz)2 
(1-MeIm)] (C1, bottom). Thermal ellipsoids represent 50% particular probability. 
  
7  Appendix 
134 
 
Table 30. Crystallographic data collection and refinement information for C2 and C3. 
 C2 (qn245) C3 (qq075) 
Empirical formula C24H29ClCuN5 C20H27ClCuN5 
Formula weight [gmol−1] 486.51 436.46 
Crystal size [mm] 0.16 × 0.13 × 0.10 0.18 × 0.17 × 0.11 
T [K] 200(2) 200(2) 
Crystal system orthorhombic monoclinic 
Space group Pnma P21/c 
a [Å] 15.017(3) 15.9899(4) 
b [Å] 15.970(3) 16.4751(4) 
c [Å] 10.398(2) 16.5686(5) 
α [°] 90 90 
β [°] 90 94.819(2) 
γ [°] 90 90 
V [Å3] 2493.7(8) 4349.3(2) 
Z 4 8 
ρcalcd. [gcm
−3] 1.296 1.333 
µ [mm−1] 1.003 1.141 
λ [Å] 0.71073 0.71073 
F(000) 1016 1824 
hkl range ±18, ±19, −11/12 ±19, ±19, −19/20 
Reflections collected 15160 38340 
Independent reflections 2403 8081 
Rint. 0.0412 0.0400 
Reflections observed 2403 8081 
Number of Parameters 163 499 
R1 [I≥2σ(I)] 0.0318 0.0358 
wR2 (all data) 0.0851 0.0916 
Goodness-of-fit 1.083 1.080 
Largest diff. peak, hole [eÅ−3] −0.302, 0.269 −0.443, 0.479 
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Figure 55. Molecular structure of [CuCl{HC(3-tBuPz)2(Qu)}] (C2, top) and [CuCl{HC(3-tBuPz)2(Py)}] 
(C3, bottom). Thermal ellipsoids represent 50% particular probability. 
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Table 31. Crystallographic data collection and refinement information for C4 and C5. 
 C4 (rv360) C5 (qq032) 
Empirical formula C20H27Br2CuN5 C20H27CoN7O6 
Formula weight [gmol−1] 560.83 520.42 
Crystal size [mm] 0.17 × 0.11 × 0.09 0.210 × 0.19 × 0.087 
T [K] 173(2) 200(2) 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a [Å] 8.0820(6) 15.6689(4) 
b [Å] 17.3088(14) 9.7832(2) 
c [Å] 32.561(2) 17.8367(4) 
α [°] 90 90 
β [°] 91.680(2) 95.4430(10) 
γ [°] 90 90 
V [Å3] 4553.0(6) 2721.89(11) 
Z 8 4 
ρcalcd. [gcm
−3] 1.636 1.270 
µ [mm−1] 4.485 0.674 
λ [Å] 0.71073 0.71073 
F(000) 2248 1084 
hkl range ±10, ±21, −36/40 ±18, ±11, ±21 
Reflections collected 50615 42299 
Independent reflections 9286 5058 
Rint. 0.0327 0.0393 
Reflections observed 9286 5058 
Number of Parameters 517 313 
R1 [I≥2σ(I)] 0.0776 0.0348 
wR2 (all data) 0.1794 0.0896 
Goodness-of-fit 1.262 1.061 
Largest diff. peak, hole [eÅ−3] −0.851, 2.053 −0.222, 0.360 
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Figure 56. Molecular structure of [CuBr2{HC(3-tBuPz)2(Py)}] (C4, top) and [Co(NO3-κO)(NO3-
κ2OO’){HC(3-tBuPz)2(Py)}]∙CH2Cl2(C5, bottom). In C5 it was not possible to model the disordered 
solvent molecules of CH2Cl2 in an adequate manner, so the data set was treated with the SQUEEZE 
facility of PLATON.[216,217] Thermal ellipsoids represent 50% particular probability.  
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Table 32. Crystallographic data collection and refinement information for C6 and C7. 
 C6 (qq060) C7 (rq005) 
Empirical formula C39H52Co2N14O13 C18H23N7O6Zn 
Formula weight [gmol−1] 1042.81 498.80 
Crystal size [mm] 0.12 × 0.09 × 0.05 0.09 × 0.08 × 0.08 
T [K] 200(2) 173(2) 
Crystal system triclinic triclinic 
Space group P P 
a [Å] 9.2772(5) 9.1885(3) 
b [Å] 9.4075(6) 9.5114(3) 
c [Å] 15.9758(9) 14.6006(5) 
α [°] 90.453(4) 78.654(2) 
β [°] 96.796(3) 77.695(2) 
γ [°] 118.972(3) 61.603(2) 
V [Å3] 1207.81(12) 1089.93(6) 
Z 1 2 
ρcalcd. [gcm
−3] 1.434 1.520 
µ [mm−1] 0.762 1.177 
λ [Å] 0.71073 0.71073 
F(000) 542 516 
hkl range −11/10, ±11, −18/19 ±11, ±12, ±18 
Reflections collected 11617 21065 
Independent reflections 4210 4967 
Rint. 0.0421 0.0484 
Reflections observed 4210 4967 
Number of Parameters 329 293 
R1 [I≥2σ(I)] 0.0610 0.0339 
wR2 (all data) 0.1549 0.0732 
Goodness-of-fit 1.036 1.036 
Largest diff. peak, hole [eÅ−3] −0.445, 2.755* −0.411, 0.523 
* The rest electron density is located 2.5 Å from C11. 
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Figure 57. Molecular structure of [Co(NO3-κO)(NO3-κ
2
OO’){HC(3-iPrPz)2(Py)}] (C6, top) and [Zn(NO3-
κO)(NO3-κ
2
OO’){HC(3-iPrPz)2(Py)}] (C7, bottom). Thermal ellipsoids represent 50% particular 
probability.  
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Table 33. Crystallographic data collection and refinement information for L2 and L3’. 
 L2 (qo110) L3’ (qo117) 
Empirical formula C71.94 H78.90N15 C18H23N5 
Formula weight [gmol−1] 1153.68 309.41 
Crystal size [mm] 0.42 × 0.15 × 0.07 0.40 × 0.24 × 0.16 
T [K] 173(2) 293(2) 
Crystal system triclinic triclinic 
Space group P P 
a [Å] 10.8373(10) 11.2219(11) 
b [Å] 16.4284(15) 12.1606(13) 
c [Å] 20.0020(19) 13.9505(13) 
α [°] 75.454(8) 77.982(9) 
β [°] 85.936(8) 73.924(8) 
γ [°] 80.012(8) 74.881(9) 
V [Å3] 3393.4(5) 1746.9(3) 
Z 2 4 
ρcalcd. [gcm
−3] 1.129 1.176 
µ [mm−1] 0.069 0.073 
λ [Å] 0.71073 0.71073 
F(000) 1231 664 
hkl range −13/5, −19/18, −24/23 −12/13, ±14, −16/14 
Reflections collected 17601 9083 
Independent reflections 12248 6454 
Rint. 0.0678 0.0362 
Reflections observed 12248 6454 
Number of Parameters 824 423 
R1 [I≥2σ(I)] 0.0911 0.0574 
wR2 (all data) 0.2724 0.1605 
Goodness-of-fit 0.989 1.131 
Largest diff. peak, hole [eÅ−3] −0.360, 0.351 −0.346, 0.199 
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Figure 58. Molecular structure of HC(3-tBuPz)2(Qu) (L2, top) and of HC(3-iPrPz)(5-iPrPz)(Qu) 
(L3’, bottom). In L2 three molecules are present, two of which have one threefold disordered tBu-
group each. Refinement of those was not possible due to the minor quality of the data set. 
Thermal ellipsoids represent 50% particular probability.  
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Table 34. Crystallographic data collection and refinement information for C8 and C9. 
 C8 (qv083) C9 (qq074) 
Empirical formula C30H34Co2N14O14 C34H26CoF6N10O6S2 
Formula weight [gmol−1] 932.57 907.70 
Crystal size [mm] 0.13 × 0.10 × 0.07 0.24 × 0.10 × 0.08 
T [K] 100(2) 200(2) 
Crystal system monoclinic monoclinic 
Space group C2/c P21/c 
a [Å] 15.4948(7) 10.7845(3) 
b [Å] 14.3870(7) 8.0116(2) 
c [Å] 18.9064(9) 22.4651(7) 
α [°] 90 90 
β [°] 109.813(2) 101.7930(10) 
γ [°] 90 90 
V [Å3] 3965.2(3) 1900.04(9) 
Z 4 2 
ρcalcd. [gcm
−3] 1.562 1.587 
µ [mm−1] 0.920 0.651 
λ [Å] 0.71073 0.71073 
F(000) 1912 922 
hkl range ±18, ±17, ±22 ±13, ±9, ±27 
Reflections collected 28344 15280 
Independent reflections 3692 3529 
Rint. 0.0355 0.0311 
Reflections observed 3692 3529 
Number of Parameters 264 268 
R1 [I≥2σ(I)] 0.0467 0.0321 
wR2 (all data) 0.1061 0.0843 
Goodness-of-fit 1.076 1.045 
Largest diff. peak, hole [eÅ−3] −0.451, 0.511 −0.290, 0.367 
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Figure 59. Molecular structure of [Co{HC(Pz)2(Py)}2][Co(NO3)4]∙C3H6O (C8, top) and of 
[Co{HC(Pz)2(Qu)}2][(OTf)2] (C9, bottom). In C8 it was not possible to model the disordered solvent 
molecules of acetone in an adequate manner, the data set was treated with the SQUEEZE facility of 
PLATON.[216,217] Thermal ellipsoids represent 50% particular probability. 
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Table 35. Crystallographic data collection and refinement information for C10 and C11. 
 C10 (ro029) C11 (qo119) 
Empirical formula C46H58CoN12O8 C24H35Cl2CoN5O 
Formula weight [gmol−1] 965.97 539.40 
Crystal size [mm] 0.30 × 0.25 × 0.10 0.40 × 0.12 × 0.02 
T [K] 100(2) 173(2) 
Crystal system monoclinic monoclinic 
Space group P21/c P21/c 
a [Å] 10.5869(6) 21.5887(18) 
b [Å] 12.0375(7) 8.2140(5) 
c [Å] 18.5244(10) 15.8355(11) 
α [°] 90 90 
β [°] 101.362(5) 107.000(8) 
γ [°] 90 90 
V [Å3] 2314.5(2) 2685.4(3) 
Z 2 4 
ρcalcd. [gcm
−3] 1.386 1.334 
µ [mm−1] 0.438 0.863 
λ [Å] 0.71073 0.71073 
F(000) 1018 1132 
hkl range −10/13, −15/12, −21/13 −23/26, −9/8, ±19 
Reflections collected 13391 13797 
Independent reflections 4703 4965 
Rint. 0.0304 0.0431 
Reflections observed 4703 4965 
Number of Parameters 310 304 
R1 [I≥2σ(I)] 0.0336 0.0500 
wR2 (all data) 0.0826 0.1212 
Goodness-of-fit 1.052 1.100 
Largest diff. peak, hole [eÅ−3] −0.341, 0.293 −0.590, 0.614 
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Figure 60. Molecular structure of [Co{HC(iPrPz)2(Qu)}2][(NO3)2]∙2MeOH (C10, top) and of 
[CoCl2{HC(Pz)2(Py)}]∙THF (C11, bottom). Thermal ellipsoids represent 50% particular probability. 
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Overview of Ligands and Complexes 
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Figure 61. Overview of all newly synthesised bis(pyrazolyl)methane ligands and transition metal 
bis(pyrazolyl)methane complexes. 
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